Title: Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity.
Journal: Archives of toxicology 20180101
Title: Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Journal: Chemico-biological interactions 20161125
Title: Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20151225
Title: Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma.
Journal: Toxicology and applied pharmacology 20150715
Title: Interleukin-19 as a translational indicator of renal injury.
Journal: Archives of toxicology 20150101
Title: Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Journal: Bioorganic & medicinal chemistry 20131101
Title: Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
Journal: Biochimica et biophysica acta 20121201
Title: Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20121101
Title: Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction.
Journal: The Journal of steroid biochemistry and molecular biology 20121101
Title: The effect of systemically administrated zoledronic acid on the osseointegration of dental implants.
Journal: Oral diseases 20121101
Title: The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20121101
Title: Clinical usefulness of bone markers in prostate cancer with bone metastasis.
Journal: International journal of urology : official journal of the Japanese Urological Association 20121101
Title: Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws.
Journal: Medicina oral, patologia oral y cirugia bucal 20121101
Title: Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101
Title: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.
Journal: European journal of cancer (Oxford, England : 1990) 20121101
Title: Explaining objective responses to zoledronic acid.
Journal: Anti-cancer drugs 20121101
Title: (89)Sr imaging with bremsstrahlung in patients with metastatic breast cancer.
Journal: Clinical nuclear medicine 20121101
Title: Adjuvant bisphosphonates: a new standard of care?
Journal: Current opinion in oncology 20121101
Title: Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology 20121101
Title: Fracture risk and zoledronic acid therapy in men with osteoporosis.
Journal: The New England journal of medicine 20121101
Title: Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
Journal: Blood 20121018
Title: Class A scavenger receptor deficiency exacerbates lung tumorigenesis by cultivating a procarcinogenic microenvironment in humans and mice.
Journal: American journal of respiratory and critical care medicine 20121015
Title: [Should we treat thalassemia-induced osteoporosis: two case reports].
Journal: Praxis 20121003
Title: Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20121001
Title: Antiresorptive therapies in oncology and their effects on cancer progression.
Journal: Cancer treatment reviews 20121001
Title: Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20121001
Title: Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20121001
Title: Treatment with bortezomib in multiple myeloma is associated with only a transient and brief increase of bone specific alkaline phosphatase.
Journal: Leukemia research 20121001
Title: Incidence of serious side effects with intravenous bisphosphonate: a clinical audit.
Journal: QJM : monthly journal of the Association of Physicians 20121001
Title: Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewes.
Journal: Bone 20121001
Title: Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.
Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20121001
Title: Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20121001
Title: Current approaches to bone-targeted therapy in genitourinary malignancies.
Journal: Therapeutic advances in urology 20121001
Title: Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20121001
Title: Syntheses, characterizations and properties of [Mo2O2S2]-based oxothiomolybdenum wheels incorporating bisphosphonate ligands.
Journal: Dalton transactions (Cambridge, England : 2003) 20120907
Title: Persistence with intravenous zoledronate in elderly patients with osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120901
Title: Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.
Journal: Cancer immunology, immunotherapy : CII 20120901
Title: Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells.
Journal: Journal of cellular and molecular medicine 20120901
Title: Bone matters in lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120901
Title: Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120901
Title: Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro.
Journal: Prostate cancer and prostatic diseases 20120901
Title: Tooth extraction in patients on zoledronic acid therapy.
Journal: Oral oncology 20120901
Title: Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Journal: Bone 20120901
Title: Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments.
Journal: Journal of bone and mineral metabolism 20120901
Title: Renal complications from bisphosphonate treatment.
Journal: Current opinion in supportive and palliative care 20120901
Title: Transcriptome analysis and in vivo activity of fluvastatin versus zoledronic acid in a murine breast cancer metastasis model.
Journal: Molecular pharmacology 20120901
Title: Adjuvant bone-targeted therapy to prevent metastasis: lessons from the AZURE study.
Journal: Current opinion in supportive and palliative care 20120901
Title: Efficacy of intravenous zoledronic acid in the prevention and treatment of osteoporosis: a meta-analysis.
Journal: Asian Pacific journal of tropical medicine 20120901
Title: Preventing bone complications in prostate cancer.
Journal: Current opinion in supportive and palliative care 20120901
Title: Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120901
Title: [Therapeutic effect of zoledronic acid on primary osteoporosis in elderly patients].
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120901
Title: Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases.
Journal: Anticancer research 20120901
Title: Denosumab and bone metastases. No better than a bisphosphonate.
Journal: Prescrire international 20120901
Title: Clinical trials of bisphosphonates in multiple myeloma.
Journal: Clinical advances in hematology & oncology : H&O 20120901
Title: CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease.
Journal: Blood 20120816
Title: Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy.
Journal: International journal of cancer 20120815
Title: Zoledronic acid, an aminobisphosphonate, prolongs survival of skin allografts.
Journal: Clinical and investigative medicine. Medecine clinique et experimentale 20120804
Title: Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.
Journal: Investigational new drugs 20120801
Title: New treatment options for patients with metastatic castration-resistant prostate cancer.
Journal: Cancer treatment reviews 20120801
Title: Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature.
Journal: Cancer treatment reviews 20120801
Title: Low concentration amino-bisphosphonates stimulate human keratinocyte proliferation and in vitro wound healing.
Journal: International wound journal 20120801
Title: Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120801
Title: Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
Journal: Annals of the rheumatic diseases 20120801
Title: Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120801
Title: Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT).
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120801
Title: Health-economic review of zoledronic acid for the management of skeletal-related events in bone-metastatic prostate cancer.
Journal: Expert review of pharmacoeconomics & outcomes research 20120801
Title: A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
Journal: American journal of clinical oncology 20120801
Title: Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.
Journal: Breast (Edinburgh, Scotland) 20120801
Title: [Efficacy of adjuvant zoledronic acid in breast cancer therapy remains unclear].
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120801
Title: Breast cancer cell targeting by prenylation inhibitors elucidated in living animals with a bioluminescence reporter.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120801
Title: Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastases.
Journal: Clinical breast cancer 20120801
Title: Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial.
Journal: The Journal of clinical endocrinology and metabolism 20120801
Title: Efficacy and safety of denosumab for the treatment of bone metastases in patients with advanced cancer.
Journal: Japanese journal of clinical oncology 20120801
Title: Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120801
Title: Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices.
Journal: Urology 20120801
Title: [Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate].
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20120801
Title: Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis.
Journal: Revista brasileira de reumatologia 20120801
Title: [Treatment of bone metastasis - focusing on drug treatment].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120801
Title: [Management for bone metastasis of prostate cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120801
Title: [Management of bone metastasis originating from lung cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120801
Title: [Management of bone disease in multiple myeloma].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120801
Title: Effect and mechanism of zoledronate on prevention of collapse in osteonecrosis of the femoral head.
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20120801
Title: Effects of bone-targeted agents on cancer progression and mortality.
Journal: Journal of the National Cancer Institute 20120718
Title: Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.
Journal: Inorganic chemistry 20120716
Title: Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer.
Journal: Urologic oncology 20120701
Title: Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.
Journal: Journal of cellular and molecular medicine 20120701
Title: Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw.
Journal: Journal of bone and mineral metabolism 20120701
Title: Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120701
Title: Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes.
Journal: Archives of oral biology 20120701
Title: Complete remission and long-term survival in a child with relapsed medulloblastoma with extensive osteosclerotic bony metastasis with a novel metronomic chemobiological approach.
Journal: Journal of pediatric hematology/oncology 20120701
Title: Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population.
Journal: Arthritis care & research 20120701
Title: Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120701
Title: Zoledronic acid improves bone mineral density in pediatric spinal cord injury.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120701
Title: Evaluation of the clinical benefit of long-term (beyond 2 years) treatment of skeletal-related events in advanced cancers with zoledronic acid.
Journal: Current medical research and opinion 20120701
Title: Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701
Title: Treatment of chronic hypercalcemia.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates)) 20120701
Title: Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model.
Journal: Acta pharmacologica Sinica 20120701
Title: What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120701
Title: Management of osteoporosis among the elderly with other chronic medical conditions.
Journal: Drugs & aging 20120701
Title: SEOM guidelines for the treatment of bone metastases from solid tumours.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120701
Title: [A survey of the dosage of zoledronic acid and investigation of the relationship between renal function and adverse events].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120701
Title: Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.
Journal: Expert review of clinical pharmacology 20120701
Title: [Zoledronic acid incorporated in chitosan/calcium phosphate ceramic: characterization and in vitro response of osteoblast cells].
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120701
Title: Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer.
Journal: British journal of cancer 20120626
Title: Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.
Journal: Blood 20120607
Title: Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.
Journal: Medical oncology (Northwood, London, England) 20120601
Title: Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care 20120601
Title: Small cell carcinoma of the urinary bladder with hypercalcemia.
Journal: Medical oncology (Northwood, London, England) 20120601
Title: Suppurative arthritis of the temporomandibular joint associated with bisphosphonate: a case report.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120601
Title: New role for an established drug? Bisphosphonates as potential anticancer agents.
Journal: Prostate cancer and prostatic diseases 20120601
Title: Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice.
Journal: Breast cancer research and treatment 20120601
Title: Lip ulceration associated with intravenous administration of zoledronic acid: report of a case.
Journal: Head and neck pathology 20120601
Title: A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?
Journal: Irish journal of medical science 20120601
Title: Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results.
Journal: Breast cancer research and treatment 20120601
Title: Calcium phosphate cement delivering zoledronate decreases bone turnover rate and restores bone architecture in ovariectomized rats.
Journal: Biomedical materials (Bristol, England) 20120601
Title: Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men.
Journal: The Journal of clinical endocrinology and metabolism 20120601
Title: Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
Journal: Bone 20120601
Title: Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.
Journal: The Journal of clinical endocrinology and metabolism 20120601
Title: Inflammatory rheumatic disorders and bone.
Journal: Current rheumatology reports 20120601
Title: Progress in the treatment of bone metastases in cancer patients.
Journal: Expert opinion on investigational drugs 20120601
Title: Cost-effectiveness of denosumab versus zoledronic acid in the management of skeletal metastases secondary to breast cancer.
Journal: Clinical therapeutics 20120601
Title: Use of zoledronate for treatment of a bone fragility disorder in horses.
Journal: Journal of the American Veterinary Medical Association 20120601
Title: Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
Journal: Australian dental journal 20120601
Title: Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.
Journal: Clinics in orthopedic surgery 20120601
Title: Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy.
Journal: BJU international 20120601
Title: New developments in castrate-resistant prostate cancer.
Journal: BJU international 20120601
Title: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Journal: The Canadian journal of urology 20120601
Title: Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
Journal: The Canadian journal of urology 20120601
Title: [The importance of bone management for cancer bone disease--positioning of zoledronic acid for multiple myeloma, genitor-urinary cancers (renal cancer and prostate cancer), lung cancer and breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120601
Title: Atypical subtrochanteric femur fracture in patient with metastatic breast cancer treated with zoledronic Acid.
Journal: Journal of breast cancer 20120601
Title: [Bisphosphonate related osteonecrosis of the jaws: a case report and review of the literature].
Journal: Shanghai kou qiang yi xue = Shanghai journal of stomatology 20120601
Title: Bisphosphonates in multiple myeloma: a network meta-analysis.
Journal: The Cochrane database of systematic reviews 20120516
Title: Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates.
Journal: Critical reviews in oncology/hematology 20120501
Title: Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120501
Title: Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20120501
Title: Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cells.
Journal: Oncology reports 20120501
Title: 'Atypical femoral fractures' during bisphosphonate exposure in adult hypophosphatasia.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501
Title: Novel strategies in the treatment of castration-resistant prostate cancer (Review).
Journal: International journal of oncology 20120501
Title: Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.
Journal: Bone 20120501
Title: Development of superior bone scintigraphic agent from a series of (99m)Tc-labeled zoledronic acid derivatives.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20120501
Title: Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report.
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20120501
Title: Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20120501
Title: Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
Journal: The Lancet. Oncology 20120501
Title: Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma.
Journal: American journal of hematology 20120501
Title: Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).
Journal: Calcified tissue international 20120501
Title: Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120501
Title: Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.
Journal: PharmacoEconomics 20120501
Title: 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.
Journal: Joint, bone, spine : revue du rhumatisme 20120501
Title: Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration.
Journal: The oncologist 20120501
Title: Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.
Journal: International journal of clinical pharmacology and therapeutics 20120501
Title: [Current approaches in multiple myeloma and other cancer-related bone diseases].
Journal: Deutsche medizinische Wochenschrift (1946) 20120501
Title: Orthodontic tooth movement and root resorption in ovariectomized rats treated by systemic administration of zoledronic acid.
Journal: American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20120501
Title: Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
Journal: Journal of managed care pharmacy : JMCP 20120501
Title: Prostate cancer: New light shed on the anticancer effects of zoledronic acid.
Journal: Nature reviews. Urology 20120424
Title: [Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon human nasopharyngeal carcinoma cell line HNE1].
Journal: Zhonghua yi xue za zhi 20120424
Title: Bisphosphonates for osteoporosis in people with cystic fibrosis.
Journal: The Cochrane database of systematic reviews 20120418
Title: Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.
Journal: Cancer 20120415
Title: Pathophysiology and new strategies for the treatment of Legg-Calvé-Perthes disease.
Journal: The Journal of bone and joint surgery. American volume 20120404
Title: An extensive hemimelic polyostotic fibrous dysplasia: a case report.
Journal: Rheumatology international 20120401
Title: Effects of zoledronic acid on sutural bone formation: a computed tomography study.
Journal: European journal of orthodontics 20120401
Title: Is ¹⁵³Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer?
Journal: World journal of urology 20120401
Title: Awareness and education of patients receiving bisphosphonates.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20120401
Title: The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120401
Title: Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120401
Title: The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer.
Journal: Breast cancer research and treatment 20120401
Title: Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.
Journal: Cancer immunology, immunotherapy : CII 20120401
Title: Bisphosphonates as antimyeloma drugs.
Journal: Leukemia 20120401
Title: Possible zoledronic acid-induced dermatomyositis.
Journal: Clinical and experimental dermatology 20120401
Title: Lessons learned from an osteoporosis clinical trial in frail long-term care residents.
Journal: Clinical trials (London, England) 20120401
Title: Lower dose dexamethasone/thalidomide and zoledronic acid every 3 weeks in previously untreated multiple myeloma.
Journal: Clinical lymphoma, myeloma & leukemia 20120401
Title: The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery.
Journal: Acta neurochirurgica 20120401
Title: Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120401
Title: [Steroid-induced osteoporosis].
Journal: Presse medicale (Paris, France : 1983) 20120401
Title: CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
Journal: Laboratory investigation; a journal of technical methods and pathology 20120401
Title: Pharmacotherapy of Paget's disease of bone.
Journal: Expert opinion on pharmacotherapy 20120401
Title: Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
Journal: Calcified tissue international 20120401
Title: Therapeutic options for advanced prostate cancer: 2011 update.
Journal: Current urology reports 20120401
Title: Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20120401
Title: An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw.
Journal: Biomarkers in medicine 20120401
Title: Effect of Sangu Decoction () on metastatic bone destruction in rats with mammary cancer.
Journal: Chinese journal of integrative medicine 20120401
Title: Bisphosphonate-associated orbital inflammation--a case report and review.
Journal: Orbit (Amsterdam, Netherlands) 20120401
Title: Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.
Journal: Therapeutic advances in urology 20120401
Title: Efficacy of vinorelbine and zoledronate combination therapy against postoperative recurrence of lung cancer.
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120401
Title: Myeloma: diagnosis complications and supportive care.
Journal: Hematology (Amsterdam, Netherlands) 20120401
Title: Castration-resistant prostate cancer: systemic therapy in 2012.
Journal: Clinics (Sao Paulo, Brazil) 20120401
Title: Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi study.
Journal: Hospital practice (1995) 20120401
Title: Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20120328
Title: Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy.
Journal: Spine 20120315
Title: Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20120313
Title: Coercing bisphosphonates to kill cancer cells with nanoscale coordination polymers.
Journal: Chemical communications (Cambridge, England) 20120311
Title: Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America.
Journal: Rheumatology international 20120301
Title: Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120301
Title: Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301
Title: Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
Journal: Prostate cancer and prostatic diseases 20120301
Title: Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens.
Journal: Cancer immunology, immunotherapy : CII 20120301
Title: Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301
Title: Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
Journal: Cancer 20120301
Title: Data from extension trials: denosumab and zoledronic acid.
Journal: Current osteoporosis reports 20120301
Title: Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20120301
Title: [Renal insufficiency and breast cancer].
Journal: Bulletin du cancer 20120301
Title: Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301
Title: Femoral stress fractures associated with long-term bisphosphonate treatment.
Journal: Clinical orthopaedics and related research 20120301
Title: Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells.
Journal: Bone 20120301
Title: Denosumab for the management of bone disease in patients with solid tumors.
Journal: Expert review of anticancer therapy 20120301
Title: Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro.
Journal: Bone 20120301
Title: Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.
Journal: Veterinary and comparative oncology 20120301
Title: Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?
Journal: Clinical genitourinary cancer 20120301
Title: Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model.
Journal: Calcified tissue international 20120301
Title: Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.
Journal: Current osteoporosis reports 20120301
Title: An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
Journal: The Annals of pharmacotherapy 20120301
Title: [Effect and role of teriparatide in the treatment of osteoporosis].
Journal: Clinical calcium 20120301
Title: [Combination or sequential treatment using PTH and anti-resorption therapies].
Journal: Clinical calcium 20120301
Title: Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.
Journal: Annals of laboratory medicine 20120301
Title: Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor.
Journal: Pharmacotherapy 20120301
Title: Paget disease of bone - an update.
Journal: Australian family physician 20120301
Title: [Bisphosphonates treatment in patients with osteoporosis].
Journal: Therapeutische Umschau. Revue therapeutique 20120301
Title: Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates.
Journal: The Korean journal of internal medicine 20120301
Title: Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
Journal: Singapore medical journal 20120301
Title: Metastatic spinal tumor.
Journal: Asian spine journal 20120301
Title: Five cases report of solid tumor synchronously with hematologic malignancy.
Journal: Cancer research and treatment : official journal of Korean Cancer Association 20120301
Title: Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.
Journal: Journal of the National Cancer Institute 20120222
Title: Bisphosphonates and other bone agents for breast cancer.
Journal: The Cochrane database of systematic reviews 20120215
Title: Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Journal: Clinical oral investigations 20120201
Title: The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Journal: Clinical oral investigations 20120201
Title: Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201
Title: Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201
Title: Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201
Title: Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis.
Journal: BJU international 20120201
Title: Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201
Title: Bisphosphonates and breast cancer prevention.
Journal: Anti-cancer agents in medicinal chemistry 20120201
Title: Bisphosphonate anticancer activity in prostate cancer and other genitourinary cancers.
Journal: Anti-cancer agents in medicinal chemistry 20120201
Title: Anticancer activity of bisphosphonates in breast cancer.
Journal: Anti-cancer agents in medicinal chemistry 20120201
Title: Bisphosphonates in lung cancer: can they provide benefits beyond prevention of skeletal morbidity?
Journal: Anti-cancer agents in medicinal chemistry 20120201
Title: Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial.
Journal: Clinical breast cancer 20120201
Title: Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
Journal: Cytotherapy 20120201
Title: Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?
Journal: Current oncology reports 20120201
Title: Additive effect of zoledronic acid on serum prostate-specific antigen changes for hormone-sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade.
Journal: International journal of urology : official journal of the Japanese Urological Association 20120201
Title: The Medical Research Council Myeloma IX Trial: new clinical insights on the anticancer effects of zoledronic acid in patients with multiple myeloma.
Journal: Clinical lymphoma, myeloma & leukemia 20120201
Title: The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120201
Title: Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
Journal: Histopathology 20120201
Title: Words of wisdom. Re: Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
Journal: European urology 20120201
Title: The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120201
Title: Should the denosumab metastasis prevention trial change practice for men with nonmetastatic prostate cancer?
Journal: The oncologist 20120201
Title: Bisphosphonate therapy for osteoporosis: the long and short of it.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120201
Title: Emerging novel therapies for advanced prostate cancer.
Journal: Therapeutic advances in urology 20120201
Title: Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201
Title: [The clinical merit of anti-RANKL antibody denosumab in prostate cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120201
Title: [Multiple myeloma].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20120201
Title: [Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].
Journal: Vnitrni lekarstvi 20120201
Title: Atypical insufficiency type femoral stress fractures in patient on bisphosphonates.
Journal: Medicine and health, Rhode Island 20120201
Title: Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases.
Journal: Cancer letters 20120128
Title: MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Journal: Oncogene 20120126
Title: Significant addition to treatment options for bone metastasis in prostate cancer.
Journal: Cancer biology & therapy 20120115
Title: Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.
Journal: Blood 20120112
Title: Breast-cancer adjuvant therapy with zoledronic acid.
Journal: The New England journal of medicine 20120112
Title: Denosumab in patients with cancer-a surgical strike against the osteoclast.
Journal: Nature reviews. Clinical oncology 20120110
Title: Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120101
Title: Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Journal: Biotechnology advances 20120101
Title: Zoledronate and pamidronate depress neutrophil functions and survival in mice.
Journal: British journal of pharmacology 20120101
Title: Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration.
Journal: Advances in urology 20120101
Title: Number needed to treat is incorrect without proper time-related considerations.
Journal: Journal of clinical epidemiology 20120101
Title: Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: A rare location of metastasis from prostate cancer: hydronephrosis associated with ureteral metastasis.
Journal: Advances in urology 20120101
Title: Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to bone.
Journal: Anti-cancer drugs 20120101
Title: Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
Journal: Oral oncology 20120101
Title: A reappraisal of generic bisphosphonates in osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer.
Journal: Cancer science 20120101
Title: The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.
Journal: European journal of haematology 20120101
Title: Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Journal: Clinical transplantation 20120101
Title: Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Journal: Advances in urology 20120101
Title: The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
Journal: Biomaterials 20120101
Title: Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan.
Journal: Journal of medical economics 20120101
Title: Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits.
Journal: Bone 20120101
Title: Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study.
Journal: European journal of endocrinology 20120101
Title: Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate.
Journal: Bone 20120101
Title: Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.
Journal: The Journal of clinical endocrinology and metabolism 20120101
Title: Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.
Journal: Calcified tissue international 20120101
Title: The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.
Journal: European journal of cancer (Oxford, England : 1990) 20120101
Title: Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.
Journal: Endocrinology 20120101
Title: Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells.
Journal: Prostate cancer 20120101
Title: Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancers.
Journal: Journal of medical economics 20120101
Title: Local regeneration of dentin-pulp complex using controlled release of fgf-2 and naturally derived sponge-like scaffolds.
Journal: International journal of dentistry 20120101
Title: Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastases.
Journal: Journal of medical economics 20120101
Title: Ischemic stroke in rats enhances bone resorption in vitro.
Journal: Journal of Korean medical science 20120101
Title: Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.
Journal: Prostate cancer 20120101
Title: Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
Journal: Journal of managed care pharmacy : JMCP 20120101
Title: Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database.
Journal: BMJ open 20120101
Title: [Anti-RANKL antibody for treatment of patients with bone metastasis from breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120101
Title: [A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120101
Title: [Bone metastasis in prostate cancer].
Journal: Der Urologe. Ausg. A 20120101
Title: Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis.
Journal: Clinical medicine insights. Arthritis and musculoskeletal disorders 20120101
Title: Bisphosphonate-associated osteonecrosis of the jaw: are we dealing with a localized non-traditional calciphylaxis?
Journal: The open dentistry journal 20120101
Title: The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer.
Journal: International journal of breast cancer 20120101
Title: Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20120101
Title: Bisphosphonates: prevention of bone metastases in breast cancer.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20120101
Title: Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report.
Journal: Journal of medical case reports 20120101
Title: Cost-effectiveness of zoledronic acid vs clodronic acid for newly-diagnosed multiple myeloma from the United Kingdom healthcare system perspective.
Journal: Journal of medical economics 20120101
Title: [Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall].
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20120101
Title: Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses.
Journal: Scientific reports 20120101
Title: Site specific effects of zoledronic acid during tibial and mandibular fracture repair.
Journal: PloS one 20120101
Title: Cinacalcet for hypercalcemia caused by pulmonary squamous cell carcinoma producing parathyroid hormone-related Peptide.
Journal: Case reports in oncology 20120101
Title: Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis.
Journal: Case reports in oncology 20120101
Title: Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States.
Journal: Journal of medical economics 20120101
Title: Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis.
Journal: Cancer management and research 20120101
Title: Effect of local zoledronate on implant osseointegration in a rat model.
Journal: BMC musculoskeletal disorders 20120101
Title: Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats.
Journal: BMC musculoskeletal disorders 20120101
Title: Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients.
Journal: Journal of biological regulators and homeostatic agents 20120101
Title: Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial.
Journal: PloS one 20120101
Title: Active Referral Intervention following Fragility Fractures Leads to Enhanced Osteoporosis Follow-Up Care.
Journal: Journal of osteoporosis 20120101
Title: Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report.
Journal: Journal of medical case reports 20120101
Title: Castration-resistant prostate cancer: mechanisms, targets, and treatment.
Journal: Prostate cancer 20120101
Title: Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.
Journal: Journal of thyroid research 20120101
Title: Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors.
Journal: Biologics : targets & therapy 20120101
Title: Bone loss after allogeneic haematopoietic stem cell transplantation: a pilot study on the use of zoledronic Acid.
Journal: Chemotherapy research and practice 20120101
Title: Computationally-optimized bone mechanical modeling from high-resolution structural images.
Journal: PloS one 20120101
Title: Mifepristone increases the cytotoxicity of uterine natural killer cells by acting as a glucocorticoid antagonist via ERK activation.
Journal: PloS one 20120101
Title: Estimated number of prevalent cases of metastatic bone disease in the US adult population.
Journal: Clinical epidemiology 20120101
Title: Osteoporosis in men.
Journal: Journal of osteoporosis 20120101
Title: Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates.
Journal: BMJ case reports 20120101
Title: The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer.
Journal: Journal of oncology 20120101
Title: Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection.
Journal: PloS one 20120101
Title: Teriparatide - Indications beyond osteoporosis.
Journal: Indian journal of endocrinology and metabolism 20120101
Title: Osteoanabolics.
Journal: Indian journal of endocrinology and metabolism 20120101
Title: Osteonecrosis of jaw associated with bisphosphonate use.
Journal: Indian journal of endocrinology and metabolism 20120101
Title: Cherubism: best clinical practice.
Journal: Orphanet journal of rare diseases 20120101
Title: Clinical guidelines for the management of craniofacial fibrous dysplasia.
Journal: Orphanet journal of rare diseases 20120101
Title: Pathophysiology and medical treatment of pain in fibrous dysplasia of bone.
Journal: Orphanet journal of rare diseases 20120101
Title: Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment.
Journal: OncoTargets and therapy 20120101
Title: Vitamin D and cancer.
Journal: Frontiers in endocrinology 20120101
Title: Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.
Journal: Clinical & developmental immunology 20120101
Title: Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells.
Journal: PloS one 20120101
Title: Management of biochemical recurrence after primary localized therapy for prostate cancer.
Journal: Frontiers in oncology 20120101
Title: The first European interdisciplinary ewing sarcoma research summit.
Journal: Frontiers in oncology 20120101
Title: Emerging targeted therapies for castration-resistant prostate cancer.
Journal: Frontiers in endocrinology 20120101
Title: Plasma cell myeloma associated with Epstein-Barr virus infection in an 11-year-old girl.
Journal: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 20120101
Title: Remarkable regression of an osteolytic lesion of large cell lung cancer treated with zoledronic Acid: a case report.
Journal: Case reports in oncology 20120101
Title: An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.
Journal: Case reports in medicine 20120101
Title: A Macroporous Bioreactor Super Activated by the Recombinant Human Transforming Growth Factor-β(3).
Journal: Frontiers in physiology 20120101
Title: Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay.
Journal: BMC cancer 20120101
Title: Treatment of osteonecrosis of the jaw (ONJ) by medical ozone gas insufflation. A case report.
Journal: Tumori 20120101
Title: Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.
Journal: PloS one 20120101
Title: Zoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cells.
Journal: PloS one 20120101
Title: Well-differentiated hand liposarcoma with bone metastases treated successfully with zoledronic acid: a molecular mechanism.
Journal: Onkologie 20120101
Title: Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20120101
Title: [Gallbladder metastasis from breast carcinoma: a new case report].
Journal: Revue medicale de Bruxelles 20120101
Title: Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review.
Journal: Journal of oral and maxillofacial pathology : JOMFP 20120101
Title: Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
Journal: Endokrynologia Polska 20120101
Title: The effect on implant fixation of soaking tricalcium phosphate granules in bisphosphonate.
Journal: The open orthopaedics journal 20120101
Title: Management of bone metastases in refractory prostate cancer--role of denosumab.
Journal: Clinical interventions in aging 20120101
Title: Denosumab: a new option in the treatment of bone metastases from urological cancers.
Journal: OncoTargets and therapy 20120101
Title: Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.
Journal: PloS one 20120101
Title: Severe toxicity with a generic formulation of zoledronic Acid: a case report.
Journal: Clinical medicine insights. Case reports 20120101
Title: Short-term effects of zoledronate on the histomorphology of osteoclast in young albino rats.
Journal: Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 20111220
Title: Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care 20111201
Title: Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20111201
Title: RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111201
Title: Consensus on the utility of bone markers in the malignant bone disease setting.
Journal: Critical reviews in oncology/hematology 20111201
Title: Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20111201
Title: Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes.
Journal: Nanomedicine : nanotechnology, biology, and medicine 20111201
Title: In vivo assessment of local effects after application of bone screws delivering bisphosphonates into a compromised cancellous bone site.
Journal: Clinical biomechanics (Bristol, Avon) 20111201
Title: Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients.
Journal: Breast cancer research and treatment 20111201
Title: Anti-osteoporotic drug release from ordered mesoporous bioceramics: experiments and modeling.
Journal: AAPS PharmSciTech 20111201
Title: Chimeric aptamers in cancer cell-targeted drug delivery.
Journal: Critical reviews in biochemistry and molecular biology 20111201
Title: Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.
Journal: Clinical genitourinary cancer 20111201
Title: A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20111201
Title: Subtrochanteric fractures in bisphosphonate-naive patients: results from the HORIZON-recurrent fracture trial.
Journal: Calcified tissue international 20111201
Title: Zoledronic acid modulates maturation of human monocyte-derived dendritic cells.
Journal: Experimental biology and medicine (Maywood, N.J.) 20111201
Title: Re: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
Journal: The Journal of urology 20111201
Title: Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells.
Journal: Journal of Korean medical science 20111201
Title: Pilot study of a pediatric metronomic 4-drug regimen.
Journal: Oncotarget 20111201
Title: Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma.
Journal: The Yale journal of biology and medicine 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: [Factors associated with acute febrile reaction in elderly patients receiving intravenous zoledronic acid for osteoporosis].
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201
Title: Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study.
Journal: Cancer research and treatment : official journal of Korean Cancer Association 20111201
Title: Effects of zoledronate on two- and three-dimensional osteoblast cultures.
Journal: Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie 20111122
Title: AZURE subgroup analysis shows adjuvant therapy with zoledronic acid may benefit breast cancer patients postmenopausal >5 years.
Journal: Oncology (Williston Park, N.Y.) 20111115
Title: Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data.
Journal: Clinical lung cancer 20111101
Title: Modern management of malignant hypercalcemia.
Journal: The American journal of hospice & palliative care 20111101
Title: Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production.
Journal: Journal of cellular biochemistry 20111101
Title: Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20111101
Title: Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111101
Title: Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
Journal: Lasers in medical science 20111101
Title: Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.
Journal: Bone 20111101
Title: Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.
Journal: PharmacoEconomics 20111101
Title: A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro.
Journal: Journal of lipid research 20111101
Title: In vitro generation of mature human osteoclasts.
Journal: Calcified tissue international 20111101
Title: Economic evaluation of clodronate and zoledronate in patients diagnosed with metastatic bone disease from the perspective of public and third party payors in Brazil.
Journal: Clinical therapeutics 20111101
Title: Antiangiogenic effects of zoledronate on cancer neovasculature.
Journal: Future oncology (London, England) 20111101
Title: [A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascular coagulation].
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111101
Title: Zoledronic acid in breast cancer: latest findings and interpretations.
Journal: Therapeutic advances in medical oncology 20111101
Title: Once-yearly zoledronic acid in older men compared with women with recent hip fracture.
Journal: Journal of the American Geriatrics Society 20111101
Title: The case of the overlooked osteoclasts.
Journal: ONS connect 20111101
Title: Tris(dicyclo-hexyl-ammonium) hydrogen [1-hy-droxy-2-(1H-imidazol-1-yl)-1-phospho-natoethane]-phospho-nate ethanol monosolvate mono-hydrate.
Journal: Acta crystallographica. Section E, Structure reports online 20111101
Title: Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva.
Journal: Harvard women's health watch 20111101
Title: Breast-cancer adjuvant therapy with zoledronic acid.
Journal: The New England journal of medicine 20111013
Title: Treatment of hypertrophic osteoarthropathy with zoledronic acid: case report and review of the literature.
Journal: Seminars in arthritis and rheumatism 20111001
Title: Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII 20111001
Title: Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
Journal: Clinical & experimental metastasis 20111001
Title: Physiology of the aging bone and mechanisms of action of bisphosphonates.
Journal: Biogerontology 20111001
Title: Effects of antiresorptive treatment on nonvertebral fracture outcomes.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20111001
Title: Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: preclinical studies and case report of an osteosarcoma pediatric patient.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20111001
Title: Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
Journal: Bone 20111001
Title: Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells.
Journal: Bone 20111001
Title: Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20111001
Title: Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20111001
Title: Decompressive surgery in combination with preoperative transcatheter arterial embolization: successful improvement of ambulatory function in renal cell carcinoma patients with metastatic extradural spinal cord compression.
Journal: International journal of urology : official journal of the Japanese Urological Association 20111001
Title: Breast cancer medications and vision: effects of treatments for early-stage disease.
Journal: Current eye research 20111001
Title: Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma.
Journal: Journal of cancer research and clinical oncology 20111001
Title: New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune response.
Journal: Cancer investigation 20111001
Title: Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
Journal: Journal of managed care pharmacy : JMCP 20111001
Title: [Secondary and tertiary prevention of urological tumors].
Journal: Der Urologe. Ausg. A 20111001
Title: Adjuvant zoledronic acid for breast cancer: mechanism of action?
Journal: The Lancet. Oncology 20111001
Title: Zoledronic acid in early-stage breast cancer.
Journal: The Lancet. Oncology 20111001
Title: [Inflammation of the jaws during treatment with bisphosphonates].
Journal: Deutsche medizinische Wochenschrift (1946) 20111001
Title: [Inhibitory effects of osthole, psoralen and aconitine on invasive activities of breast cancer MDA-MB-231BO cell line and the mechanisms].
Journal: Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20111001
Title: Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.
Journal: Journal of Korean medical science 20111001
Title: Multiple myeloma with hypercalcemia and chloride resistant metabolic alkalosis.
Journal: Tennessee medicine : journal of the Tennessee Medical Association 20111001
Title: Colles' fracture - is it a signal of osteoporosis?
Journal: Mymensingh medical journal : MMJ 20111001
Title: Past, present & future scenario of thalassaemic care & control in India.
Journal: The Indian journal of medical research 20111001
Title: DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes.
Journal: Blood 20110908
Title: Zoledronate activates NK cells.
Journal: Blood 20110908
Title: Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.
Journal: British journal of cancer 20110906
Title: Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis.
Journal: American journal of therapeutics 20110901
Title: Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate.
Journal: Lasers in medical science 20110901
Title: Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78.
Journal: International orthopaedics 20110901
Title: Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110901
Title: Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110901
Title: Animal studies of 99mTc-i-PIDP: a new bone imaging agent.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110901
Title: New targets, new drugs for metastatic bone pain: a new philosophy.
Journal: Expert opinion on emerging drugs 20110901
Title: A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: the IVORY trial Methodological considerations.
Journal: Contemporary clinical trials 20110901
Title: A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110901
Title: Osteopenia: a diagnostic and therapeutic challenge.
Journal: Current osteoporosis reports 20110901
Title: Osteoclast formation and function in pigmented villonodular synovitis.
Journal: The Journal of pathology 20110901
Title: Antitumor effects of bisphosphonates: from the laboratory to the clinic.
Journal: Current opinion in supportive and palliative care 20110901
Title: Denosumab: benefits of RANK ligand inhibition in cancer patients.
Journal: Current opinion in supportive and palliative care 20110901
Title: Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate.
Journal: Clinical therapeutics 20110901
Title: Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.
Journal: Therapeutic advances in medical oncology 20110901
Title: Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case.
Journal: The New Zealand dental journal 20110901
Title: Bisphosphonate related osteonecrosis of the jaws: report of two cases.
Journal: Imaging science in dentistry 20110901
Title: [Inhibitory effects of zoledronic acid on cell proliferation and invasion in human nasopharyngeal carcinoma cell line HNE1].
Journal: Zhonghua yi xue za zhi 20110830
Title: Further analyses of the Myeloma IX Study.
Journal: Lancet (London, England) 20110827
Title: Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid.
Journal: The Journal of biological chemistry 20110819
Title: Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110815
Title: Dosing of zoledronic acid throughout the treatment continuum in breast cancer.
Journal: Critical reviews in oncology/hematology 20110801
Title: Metastatic skull tumors: MRI features and a new conventional classification.
Journal: Journal of neuro-oncology 20110801
Title: Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110801
Title: Association between timing of zoledronic acid infusion and hip fracture healing.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110801
Title: Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat.
Journal: World journal of urology 20110801
Title: High-resolution computed tomography for clinical imaging of bone microarchitecture.
Journal: Clinical orthopaedics and related research 20110801
Title: Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110801
Title: Early bone growth on the surface of titanium implants in rat femur is enhanced by an amorphous diamond coating.
Journal: Acta orthopaedica 20110801
Title: A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.
Journal: British journal of haematology 20110801
Title: Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII 20110801
Title: Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20110801
Title: Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Journal: Calcified tissue international 20110801
Title: Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20110801
Title: A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
Journal: Pediatric blood & cancer 20110801
Title: A single bisphosphonate infusion does not accelerate fracture healing in high tibial osteotomies.
Journal: Acta orthopaedica 20110801
Title: Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma.
Journal: Clinical lymphoma, myeloma & leukemia 20110801
Title: Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110801
Title: Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab.
Journal: Clinical breast cancer 20110801
Title: Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.
Journal: The Journal of bone and joint surgery. British volume 20110801
Title: Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.
Journal: The Lancet. Oncology 20110801
Title: Zoledronic acid for all patients with newly diagnosed multiple myeloma?
Journal: The Lancet. Oncology 20110801
Title: Pharmacist-run zoledronic acid clinic.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110801
Title: Bone health medications: research questions versus clinical choices.
Journal: Menopause (New York, N.Y.) 20110801
Title: Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density.
Journal: Menopause (New York, N.Y.) 20110801
Title: [Treatment of bone metastasis with anti-RANKL antibody].
Journal: Clinical calcium 20110801
Title: Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer.
Journal: Nagoya journal of medical science 20110801
Title: Teriparitide update.
Journal: Rheumatic diseases clinics of North America 20110801
Title: Osteoporosis in men: insights for the clinician.
Journal: Therapeutic advances in musculoskeletal disease 20110801
Title: Synthesis and biological evaluation of novel (99m)Tc-labelled bisphosphonates as superior bone imaging agents.
Journal: Molecules (Basel, Switzerland) 20110725
Title: CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.
Journal: Cancer research 20110715
Title: Determination of zoledronic acid in human urine and blood plasma using liquid chromatography/electrospray mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110715
Title: Locally administered zoledronic Acid therapy for giant cell tumor of bone.
Journal: Orthopedics 20110707
Title: Bisphosphonates in Paget's disease.
Journal: Bone 20110701
Title: Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women.
Journal: Bone 20110701
Title: The kidney and bisphosphonates.
Journal: Bone 20110701
Title: Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20110701
Title: Osteoclast activity modulates B-cell development in the bone marrow.
Journal: Cell research 20110701
Title: The relationship between the chemistry and biological activity of the bisphosphonates.
Journal: Bone 20110701
Title: Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
Journal: Bone 20110701
Title: Seizures associated with zoledronic acid for osteoporosis.
Journal: The Journal of clinical endocrinology and metabolism 20110701
Title: New developments for treatment and prevention of bone metastases.
Journal: Current opinion in oncology 20110701
Title: Bisphosphonates inhibit expression of p63 by oral keratinocytes.
Journal: Journal of dental research 20110701
Title: Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701
Title: Pharmacokinetic evaluation of zoledronic acid.
Journal: Expert opinion on drug metabolism & toxicology 20110701
Title: The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial.
Journal: Diabetes care 20110701
Title: Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Journal: The Lancet. Oncology 20110701
Title: High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.
Journal: Cancer research 20110701
Title: Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701
Title: Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease--a short communication.
Journal: European journal of cancer (Oxford, England : 1990) 20110701
Title: Rubber dam clamp trauma, root canal therapy, and osteonecrosis of the jaw.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110701
Title: Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
Journal: International journal of hematology 20110701
Title: Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
Journal: Nuclear medicine and biology 20110701
Title: Effects of bisphosphonates on sutural bone formation and relapse: A histologic and immunohistochemical study.
Journal: American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20110701
Title: Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.
Journal: Immunotherapy 20110701
Title: Zoledronic acid: multiplicity of use across the cancer continuum.
Journal: Expert review of anticancer therapy 20110701
Title: [Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110701
Title: Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer.
Journal: Anticancer research 20110701
Title: Bone health in primary ovarian insufficiency.
Journal: Seminars in reproductive medicine 20110701
Title: [Effects of local application of zoledronic acid on bone healing of tooth extraction in rats].
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology 20110701
Title: Safety and efficacy of zoledronic acid in multiple myeloma.
Journal: Lancet (London, England) 20110625
Title: Safety and efficacy of zoledronic acid in multiple myeloma.
Journal: Lancet (London, England) 20110625
Title: Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110610
Title: Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.
Journal: Medical oncology (Northwood, London, England) 20110601
Title: The influence of zoledronic acid and cyclophosphamide on microcirculation regeneration in healing oral mucosal flaps.
Journal: Archives of oral biology 20110601
Title: Managing bone health with zoledronic acid: a review of randomized clinical study results.
Journal: Climacteric : the journal of the International Menopause Society 20110601
Title: Rubber dam clamp trauma during endodontic treatment: a risk factor of bisphosphonate-related osteonecrosis of the jaw?
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110601
Title: Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer.
Journal: International journal of clinical oncology 20110601
Title: Effects of zoledronic acid on healing of mandibular fractures: an experimental study in rabbits.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110601
Title: Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110601
Title: Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study.
Journal: Annals of the rheumatic diseases 20110601
Title: Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.
Journal: Journal of cellular biochemistry 20110601
Title: Advances in glucocorticoid-induced osteoporosis.
Journal: Current rheumatology reports 20110601
Title: Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.
Journal: Breast cancer research and treatment 20110601
Title: Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.
Journal: International journal of oral and maxillofacial surgery 20110601
Title: Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
Journal: Bone 20110601
Title: Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT.
Journal: Bone 20110601
Title: Activated protein C inhibits bisphosphonate-induced endothelial cell death via the endothelial protein C receptor and nuclear factor-κB pathways.
Journal: International journal of molecular medicine 20110601
Title: A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate.
Journal: British journal of haematology 20110601
Title: Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.
Journal: International journal of hematology 20110601
Title: Intravenous bisphosphonates for post-menopausal osteoporosis: adherence to a network guideline.
Journal: Journal of clinical pharmacy and therapeutics 20110601
Title: Zoledronic acid to prevent bone loss in Chinese men receiving androgen deprivation therapy for prostate cancer.
Journal: Asia-Pacific journal of clinical oncology 20110601
Title: The effects of zoledronic acid and hyperbaric oxygen on posterior lumbar fusion in a rabbit model.
Journal: The Journal of bone and joint surgery. British volume 20110601
Title: Glucocorticoid-induced osteoporosis in men.
Journal: Journal of endocrinological investigation 20110601
Title: Atypical fractures of the femur and ulna and complications of fracture healing in a 76-year-old woman with Sjögren's syndrome.
Journal: Journal of musculoskeletal & neuronal interactions 20110601
Title: Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasis.
Journal: Clinical breast cancer 20110601
Title: [A case of recurrent endometrial cancer metastasis successfully treated with zoledronic Acid].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110601
Title: [A case of prostate cancer with disseminated carcinomatosis of bone marrow which responded to Zoledronic acid].
Journal: Hinyokika kiyo. Acta urologica Japonica 20110601
Title: No deleterious effect of low dose methotrexate on titanium implant osseointegration in a rabbit model.
Journal: Clinics (Sao Paulo, Brazil) 20110601
Title: Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
Journal: Acta clinica Croatica 20110601
Title: Treatment of transient osteoporosis of the hip with intravenous zoledronate - a case report -.
Journal: Annals of rehabilitation medicine 20110601
Title: Denosumab: in the prevention of skeletal-related events in patients with bone metastases from solid tumours.
Journal: Drugs 20110528
Title: Prostate cancer: targeted therapy for prostate cancer metastases to bone.
Journal: Nature reviews. Urology 20110517
Title: Denosumab for bone metastases from breast cancer: a new therapy option?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510
Title: Advances in imaging and the management of myeloma bone disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510
Title: Osteoporosis quality indicators using healthcare utilization data.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501
Title: Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501
Title: The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis.
Journal: Journal of bone and mineral metabolism 20110501
Title: Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts.
Journal: Archives of oral biology 20110501
Title: Effect of zoledronic acid on bone healing subsequent to mini-implant insertion.
Journal: The Angle orthodontist 20110501
Title: No effect of rosuvastatin in the zoledronate-induced acute-phase response.
Journal: Calcified tissue international 20110501
Title: IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
Journal: Journal of leukocyte biology 20110501
Title: Clinical risk factors for recurrent fracture after hip fracture: a prospective study.
Journal: Calcified tissue international 20110501
Title: Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate.
Journal: The Journal of pharmacology and experimental therapeutics 20110501
Title: Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
Journal: Oral diseases 20110501
Title: Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and bisphosphonate administration.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110501
Title: CCN1, a candidate target for zoledronic acid treatment in breast cancer.
Journal: Molecular cancer therapeutics 20110501
Title: Contemporary management of metastatic castration-resistant prostate cancer.
Journal: Current opinion in urology 20110501
Title: Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110501
Title: Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome.
Journal: Yonsei medical journal 20110501
Title: The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.
Journal: The oncologist 20110501
Title: Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab.
Journal: Journal of the American Dental Association (1939) 20110501
Title: Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110501
Title: Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110501
Title: [A successful case treated with S-1 and zoledronic acid for multiple bone metastasis of breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110501
Title: Denosumab for the prevention of osteoporotic fractures in postmenopausal women.
Journal: Health technology assessment (Winchester, England) 20110501
Title: Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
Journal: The Indian journal of medical research 20110501
Title: [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system].
Journal: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110501
Title: Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
Journal: Biochemical and biophysical research communications 20110422
Title: Three cases of bone metastases in patients with gastrointestinal stromal tumors.
Journal: Rare tumors 20110404
Title: A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer.
Journal: Cancer chemotherapy and pharmacology 20110401
Title: Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells.
Journal: Leukemia research 20110401
Title: In vivo effects of zoledronic acid on oral mucosal epithelial cells.
Journal: Oral diseases 20110401
Title: The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110401
Title: Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery.
Journal: Nanomedicine : nanotechnology, biology, and medicine 20110401
Title: Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acid.
Journal: European urology 20110401
Title: Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Journal: Biochimica et biophysica acta 20110401
Title: Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
Journal: Oncology reports 20110401
Title: Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases.
Journal: European journal of cancer (Oxford, England : 1990) 20110401
Title: Bisphosphonates for post-menopausal osteoporosis: are they all the same?
Journal: QJM : monthly journal of the Association of Physicians 20110401
Title: The use of zoledronic acid in pediatric cancer patients.
Journal: Pediatric blood & cancer 20110401
Title: EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Journal: European urology 20110401
Title: Zoledronic acid induces autophagic cell death in human prostate cancer cells.
Journal: The Journal of urology 20110401
Title: Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.
Journal: Clinical & experimental metastasis 20110401
Title: Zoledronic acid for prevention and treatment of osteoporosis.
Journal: Expert opinion on pharmacotherapy 20110401
Title: A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial.
Journal: The American journal of gastroenterology 20110401
Title: Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line.
Journal: Cell proliferation 20110401
Title: Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density: a bone chamber study in rats.
Journal: Acta orthopaedica 20110401
Title: Trials define anti-tumor effects of anti-resorptive agents: denosumab ahead of zoledronate 2 to 1.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110401
Title: Pamidronate and zoledronate effects in the increment of bone mineral density and histomorphometry in rats.
Journal: Acta cirurgica brasileira 20110401
Title: Osteonecrosis of the jaw.
Journal: Journal of the American Dental Association (1939) 20110401
Title: More about osteonecrosis.
Journal: Journal of the American Dental Association (1939) 20110401
Title: Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20110401
Title: Bisphosphonates in breast cancer: antitumor effects.
Journal: Clinical advances in hematology & oncology : H&O 20110401
Title: [Effects of zoledronic acid in the treatment of breast cancer].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110401
Title: Bisphosphonates and atrial fibrillation: clinical trial data suggest possible link.
Journal: Prescrire international 20110401
Title: Re: The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.
Journal: The Journal of urology 20110401
Title: Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320
Title: American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320
Title: Effect of zoledronate on oral wound healing in rats.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110315
Title: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
Journal: Lancet (London, England) 20110305
Title: Unravelling the role of denosumab in prostate cancer.
Journal: Lancet (London, England) 20110305
Title: The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells.
Journal: Journal of cellular and molecular medicine 20110301
Title: Zoledronic acid and atrial fibrillation in cancer patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110301
Title: The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
Journal: Cancer chemotherapy and pharmacology 20110301
Title: Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301
Title: The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110301
Title: Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Journal: Oral diseases 20110301
Title: Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110301
Title: Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110301
Title: Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110301
Title: Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110301
Title: Osteoporosis in men: what has changed?
Journal: Current osteoporosis reports 20110301
Title: Proposed new approach for treating Paget's disease of bone.
Journal: Irish journal of medical science 20110301
Title: Defining zoledronate's duration of action and optimal dosing interval for an effective therapy.
Journal: Current osteoporosis reports 20110301
Title: Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.
Journal: International journal of oral and maxillofacial surgery 20110301
Title: The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population.
Journal: Prostate cancer and prostatic diseases 20110301
Title: Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20110301
Title: Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.
Journal: Cancer immunology, immunotherapy : CII 20110301
Title: The effects of zoledronic acid on neointimal hyperplasia: a rabbit carotid anastomosis model.
Journal: Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110301
Title: Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study.
Journal: Oral oncology 20110301
Title: Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20110301
Title: Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.
Journal: European journal of cancer (Oxford, England : 1990) 20110301
Title: Castration-resistant prostate cancer: targeted therapies and individualized treatment.
Journal: The oncologist 20110301
Title: Breast cancer bone metastases: denosumab or zoledronic acid?
Journal: Nature reviews. Endocrinology 20110301
Title: [Parathyroid crisis due to a cystic parathyroid adenoma].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20110301
Title: [Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
Journal: Clinical calcium 20110301
Title: [Encounter of cancer cells with bone. Management of bone metastasis arising from prostate cancer].
Journal: Clinical calcium 20110301
Title: Multiple hydrogen bonds in cytosinium zoledronate trihydrate.
Journal: Acta crystallographica. Section C, Crystal structure communications 20110301
Title: [The 2010 news: highlights of the ASCO-GU, UAE, ASCO, AUA congress…].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20110301
Title: [A case of castration-refractory prostate cancer showing marked decrease of serum PSA level after zoledronic acid treatment with estramustine phosphate and prednisolone].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110301
Title: Unexpected AZURE results lead to rethink for Zometa(®).
Journal: Expert review of anticancer therapy 20110301
Title: Zoledronic acid for adjuvant use in patients with breast cancer.
Journal: Expert review of anticancer therapy 20110301
Title: Bone-targeted agents in the treatment of bone metastases: RANK outsider or new kid on the block?
Journal: Future oncology (London, England) 20110301
Title: Direct antitumour activity of zoledronic acid: preclinical and clinical data.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110301
Title: Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdom.
Journal: Clinical therapeutics 20110301
Title: Saudi Oncology Society clinical management guidelines for prostate cancer.
Journal: Urology annals 20110301
Title: Regression of a primary pulmonary adenocarcinoma after zoledronic acid monotherapy.
Journal: Hiroshima journal of medical sciences 20110301
Title: Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients.
Journal: Journal of gastric cancer 20110301
Title: 'Disappointing' trial results offer hope for older women with breast cancer.
Journal: JAMA 20110223
Title: Involvement of CD56brightCD11c+ cells in IL-18-mediated expansion of human γδ T cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20110215
Title: Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasites.
Journal: The Journal of biological chemistry 20110204
Title: [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110204
Title: The effects of estrogen deficiency and bisphosphonate treatment on tissue mineralisation and stiffness in an ovine model of osteoporosis.
Journal: Journal of biomechanics 20110203
Title: Osteonecrosis of the jaw and the role of macrophages.
Journal: Journal of the National Cancer Institute 20110202
Title: Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Journal: Clinical oral investigations 20110201
Title: Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic.
Journal: Internal medicine journal 20110201
Title: Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201
Title: Clinical risk factor assessment had better discriminative ability than bone mineral density in identifying subjects with vertebral fracture.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201
Title: Bisphosphonate remains highly localized after elution from porous implants.
Journal: Clinical orthopaedics and related research 20110201
Title: The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.
Journal: Seminars in arthritis and rheumatism 20110201
Title: Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
Journal: Head & neck 20110201
Title: Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.
Journal: Acta biomaterialia 20110201
Title: Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
Journal: Bone 20110201
Title: The use of bisphosphonates in cancer treatment.
Journal: Annals of the New York Academy of Sciences 20110201
Title: Denosumab in breast cancer.
Journal: Current oncology reports 20110201
Title: Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 20110201
Title: Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201
Title: Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110201
Title: Zoledronate inhibits intimal hyperplasia in balloon-injured rat carotid artery.
Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20110201
Title: Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis.
Journal: Expert opinion on pharmacotherapy 20110201
Title: Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
Journal: European journal of immunology 20110201
Title: Surgery for skeletal metastases in lung cancer.
Journal: Acta orthopaedica 20110201
Title: The role of RANK-ligand inhibition in cancer: the story of denosumab.
Journal: The oncologist 20110201
Title: Development of multiple myeloma in a case of longstanding ankylosing spondylitis: more than a coincidence?
Journal: International journal of rheumatic diseases 20110201
Title: Gorham-Stout syndrome of the pelvic girdle treated by radiation therapy: a case report.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110201
Title: Zoledronic acid: a framework of emerging anticancer evidence throughout the cancer continuum.
Journal: Critical reviews in oncology/hematology 20110201
Title: Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease.
Journal: Critical reviews in oncology/hematology 20110201
Title: Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?
Journal: Critical reviews in oncology/hematology 20110201
Title: The backbone of progress--preclinical studies and innovations with zoledronic acid.
Journal: Critical reviews in oncology/hematology 20110201
Title: Anticancer evidence for zoledronic acid across the cancer continuum.
Journal: Critical reviews in oncology/hematology 20110201
Title: An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis.
Journal: JRSM short reports 20110201
Title: [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology 20110201
Title: [Osteoporosis].
Journal: Revue medicale suisse 20110119
Title: Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.
Journal: International journal of pharmaceutics 20110117
Title: Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases.
Journal: International journal of cancer 20110115
Title: [Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20110110
Title: Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines.
Journal: Molecular biology reports 20110101
Title: Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101
Title: Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101
Title: Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101
Title: Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20110101
Title: Treatment and prevention of bone complications from prostate cancer.
Journal: Bone 20110101
Title: Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110101
Title: Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110101
Title: The response of dental pulp-derived cells to zoledronate depends on the experimental model.
Journal: International endodontic journal 20110101
Title: Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
Journal: Cytotherapy 20110101
Title: Skeletal complications and survival in renal cancer patients with bone metastases.
Journal: Bone 20110101
Title: Combined effects of zoledronate and mechanical stimulation on bone adaptation in an axially loaded mouse tibia.
Journal: Clinical biomechanics (Bristol, Avon) 20110101
Title: Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.
Journal: Clinical rheumatology 20110101
Title: Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01).
Journal: Breast cancer research and treatment 20110101
Title: Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression.
Journal: Anti-cancer drugs 20110101
Title: Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110101
Title: The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide.
Journal: Experimental hematology 20110101
Title: Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
Journal: Clinical rheumatology 20110101
Title: New approaches to the treatment of osteoporosis.
Journal: Annual review of medicine 20110101
Title: Bone scans, bisphosphonates, and a lack of acute changes within the mandible.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20110101
Title: Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association 20110101
Title: Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis.
Journal: Current medical research and opinion 20110101
Title: PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis.
Journal: Cancer research 20110101
Title: Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase.
Journal: Current medicinal chemistry 20110101
Title: Zoledronic acid.
Journal: Expert opinion on drug safety 20110101
Title: Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.
Journal: American journal of hematology 20110101
Title: Current therapeutic approaches in metastatic and recurrent ewing sarcoma.
Journal: Sarcoma 20110101
Title: Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
Journal: Drugs 20110101
Title: Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw.
Journal: Frontiers in bioscience (Elite edition) 20110101
Title: A roadmap to the brittle bones of cystic fibrosis.
Journal: Journal of osteoporosis 20110101
Title: The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands.
Journal: Journal of medical economics 20110101
Title: Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.
Journal: Sarcoma 20110101
Title: Zoledronic acid use in cancer patients: more than just supportive care?
Journal: Cancer 20110101
Title: Bisphosponates and dental implants: a case report and a brief review of literature.
Journal: Minerva stomatologica 20110101
Title: γδ T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection.
Journal: Clinical & developmental immunology 20110101
Title: Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
Journal: BMC cancer 20110101
Title: Malignant pigmented villonodular synovitis in the knee - report of a case with rapid clinical progression.
Journal: The open orthopaedics journal 20110101
Title: The potential application of zoledronic acid as anticancer therapy in patients with non-small-cell lung cancer.
Journal: Clinical lung cancer 20110101
Title: Two cases of drug-induced orbital inflammatory disease.
Journal: Orbit (Amsterdam, Netherlands) 20110101
Title: Zoledronic acid treatment in children with osteogenesis imperfecta.
Journal: Hormone research in paediatrics 20110101
Title: Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.
Journal: Journal of carcinogenesis 20110101
Title: The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro.
Journal: Head & face medicine 20110101
Title: Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model.
Journal: PloS one 20110101
Title: New strategies to prevent and manage bone complications in cancer.
Journal: Clinical advances in hematology & oncology : H&O 20110101
Title: Updated recommendations for the diagnosis and management of osteoporosis: a local perspective.
Journal: Annals of Saudi medicine 20110101
Title: The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.
Journal: Journal of osteoporosis 20110101
Title: Longitudinal erythronychia: the value of cosmetic alterations in nail findings.
Journal: Skinmed 20110101
Title: Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies.
Journal: BMC clinical pharmacology 20110101
Title: What do we know about the ocular adverse effects associated with intravenous bisphosphonates?
Journal: Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery 20110101
Title: Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
Journal: PloS one 20110101
Title: [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
Journal: Revista espanola de medicina nuclear 20110101
Title: Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
Journal: Breast cancer research : BCR 20110101
Title: Results of a multicenter open-label randomized trial evaluating infusion duration of zoledronic acid in multiple myeloma patients (the ZMAX trial).
Journal: The journal of supportive oncology 20110101
Title: Cost effectiveness of zoledronic acid in the management of skeletal metastases in hormone-refractory prostate cancer patients in France, Germany, Portugal, and the Netherlands.
Journal: Journal of medical economics 20110101
Title: Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study.
Journal: BMC musculoskeletal disorders 20110101
Title: Atrial fibrillation and the use of oral bisphosphonates.
Journal: Therapeutics and clinical risk management 20110101
Title: A review on composite liposomal technologies for specialized drug delivery.
Journal: Journal of drug delivery 20110101
Title: Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines.
Journal: International journal of immunopathology and pharmacology 20110101
Title: Supportive therapy in multiple myeloma.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101
Title: [Disseminated carcinomatosis of the bone marrow in two patients with prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20110101
Title: Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.
Journal: Head & face medicine 20110101
Title: Denosumab an option for patients with bone metastasis from breast cancer.
Journal: CA: a cancer journal for clinicians 20110101
Title: A case of acquired Fanconi syndrome induced by zoledronic acid.
Journal: Internal medicine (Tokyo, Japan) 20110101
Title: Estimating minimally important differences for the worst pain rating of the Brief Pain Inventory-Short Form.
Journal: The journal of supportive oncology 20110101
Title: Therapeutic targets for bone metastases in breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: Role of zoledronic acid in the prevention and treatment of osteoporosis.
Journal: Clinical interventions in aging 20110101
Title: Bone health in patients with multiple sclerosis.
Journal: Journal of osteoporosis 20110101
Title: Bisphosphonates and atypical fractures of femur.
Journal: Journal of osteoporosis 20110101
Title: Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.
Journal: PloS one 20110101
Title: Emerging strategies and therapies for treatment of Paget's disease of bone.
Journal: Drug design, development and therapy 20110101
Title: PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis.
Journal: PloS one 20110101
Title: Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
Journal: Cancer management and research 20110101
Title: Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.
Journal: Indian journal of palliative care 20110101
Title: From bone to breast and back - the bone cytokine RANKL and breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.
Journal: Sarcoma 20110101
Title: Bone Induction: Regeneration through Chaos.
Journal: Frontiers in physiology 20110101
Title: Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.
Journal: International journal of nephrology 20110101
Title: Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.
Journal: Pathology research international 20110101
Title: Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts.
Journal: BMC health services research 20110101
Title: Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis.
Journal: Therapeutics and clinical risk management 20110101
Title: If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy.
Journal: Therapeutics and clinical risk management 20110101
Title: Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model.
Journal: Arthritis research & therapy 20110101
Title: Antimetastatic effects of Phyllanthus on human lung (A549) and breast (MCF-7) cancer cell lines.
Journal: PloS one 20110101
Title: Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro.
Journal: BMC musculoskeletal disorders 20110101
Title: Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies.
Journal: Journal of translational medicine 20110101
Title: A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy.
Journal: Case reports in oncology 20110101
Title: Clinical utility of denosumab for treatment of bone loss in men and women.
Journal: Clinical interventions in aging 20110101
Title: Collet-Sicard syndrome as an initial presentation of prostate cancer: a case report.
Journal: Journal of medical case reports 20110101
Title: [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Journal: Actas urologicas espanolas 20110101
Title: Freezing of rat tibiae at -20°c does not affect the mechanical properties of intramedullary bone/implant-interface: brief report.
Journal: The open orthopaedics journal 20110101
Title: Osteonecrosis of the jaw in patients with metastatic breast cancer: ethnic and socio-economic aspects.
Journal: The breast journal 20110101
Title: Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.
Journal: PloS one 20110101
Title: Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma.
Journal: Radiation oncology (London, England) 20110101
Title: Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice.
Journal: BMC musculoskeletal disorders 20110101
Title: The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men.
Journal: Journal of osteoporosis 20110101
Title: [Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios].
Journal: Reumatismo 20110101
Title: Orbital inflammatory disease in a patient treated with zoledronate.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101
Title: Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD study.
Journal: BMC musculoskeletal disorders 20110101
Title: Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis.
Journal: Journal of experimental & clinical cancer research : CR 20110101
Title: Life-threatening hyperkalemia following zoledronic acid infusion for Paget's disease: a case report.
Journal: Journal of medical case reports 20110101
Title: Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.
Journal: Journal of translational medicine 20110101
Title: The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions.
Journal: Breast cancer research : BCR 20110101
Title: Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.
Journal: Head & face medicine 20110101
Title: Increased fracture rate in women with breast cancer: a review of the hidden risk.
Journal: BMC cancer 20110101
Title: A rare case of zolendronate infusion complication leading to glaucoma filtration surgery.
Journal: Clinical ophthalmology (Auckland, N.Z.) 20110101
Title: Transient changes in thyroid functions tests after zoledronic acid infusion.
Journal: Endocrine journal 20110101
Title: Hypocalcemia associated with zoledronic acid for osteogenesis imperfecta.
Journal: Hormone research in paediatrics 20110101
Title: HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity.
Journal: PloS one 20110101
Title: Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature.
Journal: Scandinavian journal of rheumatology 20110101
Title: Expansion of human peripheral blood γδ T cells using zoledronate.
Journal: Journal of visualized experiments : JoVE 20110101
Title: Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving 'metronomic' zoledronic acid.
Journal: BMC cancer 20110101
Title: Cancer patient-centered home care: a new model for health care in oncology.
Journal: Therapeutics and clinical risk management 20110101
Title: Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report.
Journal: Journal of medical case reports 20110101
Title: The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.
Journal: BMC musculoskeletal disorders 20110101
Title: Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.
Journal: Genome medicine 20110101
Title: Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report.
Journal: Journal of medical case reports 20110101
Title: Hutchinson-Gilford progeria syndrome with severe calcific aortic valve stenosis.
Journal: Annals of pediatric cardiology 20110101
Title: Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.
Journal: Tumori 20110101
Title: Pain in castration-resistant prostate cancer with bone metastases: a qualitative study.
Journal: Health and quality of life outcomes 20110101
Title: Osteoimmunology and osteoporosis.
Journal: Arthritis research & therapy 20110101
Title: Bisphosphonates for osteoarthritis.
Journal: Arthritis research & therapy 20110101
Title: Tumour macrophages as potential targets of bisphosphonates.
Journal: Journal of translational medicine 20110101
Title: RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis.
Journal: Journal of osteoporosis 20110101
Title: Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
Journal: BMC cancer 20110101
Title: Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
Journal: PloS one 20110101
Title: A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
Journal: Journal of translational medicine 20110101
Title: Antibody-based therapies in multiple myeloma.
Journal: Bone marrow research 20110101
Title: Going on a drug holiday?
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101
Title: GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.
Journal: BMC cancer 20110101
Title: New and emerging agents for the treatment of castration-resistant prostate cancer.
Journal: Urologic oncology 20110101
Title: Minimal residual disease and circulating tumor cells in breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: The microenvironment in breast cancer progression: biology and implications for treatment.
Journal: Breast cancer research : BCR 20110101
Title: Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
Journal: Clinical Medicine Insights. Oncology 20110101
Title: Assessment of the effects of zoledronic Acid therapy on bone metabolic indicators in hormone-resistant prostate cancer patients with bone metastatasis.
Journal: ISRN urology 20110101
Title: Metastatic bladder cancer: a review of current management.
Journal: ISRN urology 20110101
Title: Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
Journal: Drug design, development and therapy 20110101
Title: Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone.
Journal: PloS one 20110101
Title: Bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel.
Journal: Prostate cancer 20110101
Title: Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.
Journal: International journal of surgery case reports 20110101
Title: Effect of zoledronic Acid on bone mineral density in men with prostate cancer receiving gonadotropin-releasing hormone analog.
Journal: Prostate cancer 20110101
Title: An update on the changing indications for androgen deprivation therapy for prostate cancer.
Journal: Prostate cancer 20110101
Title: Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients.
Journal: Journal (Canadian Dental Association) 20110101
Title: Therapy of osteoporosis in men with teriparatide.
Journal: Journal of osteoporosis 20110101
Title: Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws in an experimental rat model.
Journal: International journal of medical sciences 20110101
Title: Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient.
Journal: The open dentistry journal 20110101
Title: [Use of zoledronic acid in patients with prostate cancer bone metastases: control of pain and musculoskeletal complications].
Journal: Urologia 20110101
Title: Bisphosphonates and breast cancer incidence and recurrence.
Journal: Breast disease 20110101
Title: Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
Journal: Breast disease 20110101
Title: Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
Journal: Breast disease 20110101
Title: Bone turnover markers: tools for prognosis and monitoring response to bisphosphonates?
Journal: Breast disease 20110101
Title: Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Journal: BMJ (Clinical research ed.) 20110101
Title: The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial.
Journal: Oncology 20110101
Title: Well-differentiated hand liposarcoma with bone metastases treated successfully with zoledronic Acid.
Journal: Onkologie 20110101
Title: A feasibility study of zoledronic acid combined with carboplatin/nedaplatin plus paclitaxel in patients with non-small cell lung cancer with bone metastases.
Journal: Tumori 20110101
Title: Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.
Journal: Clinical & developmental immunology 20110101
Title: Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases.
Journal: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20110101
Title: Regression of late onset choroidal metastasis from a breast carcinoma with letrozole.
Journal: Case reports in ophthalmology 20110101
Title: Biochemical bone turnover markers and osteoporosis in older men: where are we?
Journal: Journal of osteoporosis 20110101
Title: [Innovative approaches to diagnosis and treatment of occupational diseases (on joint diseases model)].
Journal: Meditsina truda i promyshlennaia ekologiia 20110101
Title: Osteopenia and osteoporosis in people living with HIV: multiprofessional approach.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis.
Journal: Drug, healthcare and patient safety 20110101
Title: Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer.
Journal: Drug, healthcare and patient safety 20110101
Title: Physiopathology of spine metastasis.
Journal: International journal of surgical oncology 20110101
Title: Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
Journal: General dentistry 20110101
Title: Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101
Title: Primary systemic therapy in breast cancer--an update for gynecologic oncologists.
Journal: European journal of gynaecological oncology 20110101
Title: A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis.
Journal: Indian journal of palliative care 20110101
Title: Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone.
Journal: ISRN rheumatology 20110101
Title: Recommendations for Diagnosis and Management of Osteoporosis in COPD Men.
Journal: ISRN rheumatology 20110101
Title: Multiple myeloma and bisphosphonate-related osteonecrosis of the mandible associated with dental implants.
Journal: Case reports in dentistry 20110101
Title: Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.
Journal: Cancer research 20101215
Title: Zoledronic acid in myeloma: MRC Myeloma IX.
Journal: Lancet (London, England) 20101211
Title: Recurrent scrotal hemangiomas during treatment with sunitinib.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101210
Title: Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101210
Title: Cancer and renal insufficiency results of the BIRMA study.
Journal: British journal of cancer 20101207
Title: First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
Journal: Lancet (London, England) 20101202
Title: Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.
Journal: Journal of cellular and molecular medicine 20101201
Title: Solid-state forms of zoledronic acid: polymorphism in hydrates.
Journal: Journal of pharmaceutical sciences 20101201
Title: Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20101201
Title: Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma.
Journal: British journal of haematology 20101201
Title: Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.
Journal: Breast cancer research and treatment 20101201
Title: Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology 20101201
Title: Effects of zoledronate in the repair of chronically infarcted rat myocardium.
Journal: Journal of cardiovascular pharmacology 20101201
Title: Management of osteoporosis in patients hospitalized for hip fractures.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101201
Title: The effects of topical application of bisphosphonates on replanted rat molars.
Journal: Dental traumatology : official publication of International Association for Dental Traumatology 20101201
Title: Osteonecrosis of the maxilla associated with the use of bisphosphonates.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20101201
Title: Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies.
Journal: Expert review of anticancer therapy 20101201
Title: Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20101201
Title: [Actualities in prostate cancer in ASCO annual meeting 2010].
Journal: Bulletin du cancer 20101201
Title: [gammadelta T cells stimulated by zoledronate kill osteosarcoma cells].
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20101201
Title: The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial.
Journal: Clinical breast cancer 20101201
Title: Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System.
Journal: Clinical breast cancer 20101201
Title: Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer.
Journal: Clinical breast cancer 20101201
Title: [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Journal: Wiener medizinische Wochenschrift (1946) 20101201
Title: [Prosthetic rehabilitation after osteonecrosis of the jaws due to histiocytosis X and treatment with bisphosphonates apropos of a case].
Journal: Odonto-stomatologie tropicale = Tropical dental journal 20101201
Title: Effect of single dose intravenous zoledronic acid on bone mineral density in post-menopausal osteoporosis of Bangladeshi women.
Journal: Bangladesh Medical Research Council bulletin 20101201
Title: Poly[diaqua-bis-[μ-1-hy-droxy-2-(imidazol-3-ium-1-yl)ethane-1,1-diyldiphospho-nato]tricopper(II)].
Journal: Acta crystallographica. Section E, Structure reports online 20101201
Title: Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.
Journal: Journal of children's orthopaedics 20101201
Title: The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain.
Journal: European journal of cancer care 20101101
Title: Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101101
Title: Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue.
Journal: Breast cancer research and treatment 20101101
Title: Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20101101
Title: Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.
Journal: Journal of bone and mineral metabolism 20101101
Title: Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
Journal: Cancer immunology, immunotherapy : CII 20101101
Title: Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study.
Journal: Bone 20101101
Title: Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.
Journal: Pediatric nephrology (Berlin, Germany) 20101101
Title: Osteoporosis therapies: evidence from health-care databases and observational population studies.
Journal: Calcified tissue international 20101101
Title: Future directions of bone-targeted therapy for metastatic breast cancer.
Journal: Nature reviews. Clinical oncology 20101101
Title: Surface immobilized zoledronate improves screw fixation in rat bone: a new method for the coating of metal implants.
Journal: Journal of materials science. Materials in medicine 20101101
Title: Anticancer properties of zoledronic acid.
Journal: Cancer investigation 20101101
Title: Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.
Journal: Cancer research 20101101
Title: Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: a case report and literature review.
Journal: Journal of pediatric hematology/oncology 20101101
Title: Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20101101
Title: The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.
Journal: Expert opinion on pharmacotherapy 20101101
Title: The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.
Journal: Journal of the American Dental Association (1939) 20101101
Title: Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.
Journal: Orthodontics & craniofacial research 20101101
Title: Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.
Journal: The oncologist 20101101
Title: Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer.
Journal: Urology 20101101
Title: Chronic indurated gingival ulceration. Bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Journal: Archives of dermatology 20101101
Title: Burden of metastatic bone disease from genitourinary malignancies.
Journal: Expert review of anticancer therapy 20101101
Title: Oxidant and antioxidant activity in rabbit livers treated with zoledronic acid.
Journal: Transplantation proceedings 20101101
Title: The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands.
Journal: Anticancer research 20101101
Title: Management of osteonecrosis of the jaws in patients with history of bisphosphonates therapy.
Journal: The Journal of craniofacial surgery 20101101
Title: Glucocorticoid-induced osteoporosis in rheumatic diseases.
Journal: Clinics (Sao Paulo, Brazil) 20101101
Title: Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20101015
Title: A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101001
Title: [Maxillary osteonecrosis associated with the use of zoledronate: Presentation of three cases].
Journal: Atencion primaria 20101001
Title: Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment.
Journal: Breast (Edinburgh, Scotland) 20101001
Title: Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101001
Title: Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101001
Title: Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101001
Title: Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease.
Journal: Pediatrics international : official journal of the Japan Pediatric Society 20101001
Title: The role of zoledronic acid in the management of osteoporosis.
Journal: Clinical rheumatology 20101001
Title: Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice.
Journal: Calcified tissue international 20101001
Title: Prognostic factors for skeletal complications from metastatic bone disease in breast cancer.
Journal: Breast cancer research and treatment 20101001
Title: Disease progression increases the risk of skeletal-related events in patients with bone metastases from castration-resistant prostate cancer, lung cancer, or other solid tumors.
Journal: Cancer investigation 20101001
Title: Effect of withdrawal of zoledronic acid treatment on bone remodelling markers in multiple myeloma.
Journal: British journal of haematology 20101001
Title: Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease.
Journal: Osteoarthritis and cartilage 20101001
Title: Predicting skeletal complications in metastatic breast cancer raises challenges.
Journal: Breast cancer research and treatment 20101001
Title: Short-term zoledronic acid reduces trabecular bone remodeling in dogs.
Journal: European journal of oral sciences 20101001
Title: Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients.
Journal: Cancer research 20101001
Title: Bisphosphonates as anticancer therapy for early breast cancer.
Journal: Clinical breast cancer 20101001
Title: Prevention and treatment of side-effects of systemic treatment: bone loss.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20101001
Title: Implications of bone metastases and the benefits of bone-targeted therapy.
Journal: Seminars in oncology 20101001
Title: Zolendronate associated inflammatory orbital disease.
Journal: The New Zealand medical journal 20100924
Title: Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial.
Journal: Cancer biology & therapy 20100915
Title: Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
Journal: Cancer research 20100915
Title: Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
Journal: Blood 20100909
Title: Bisphosphonates and atypical femoral fractures.
Journal: The New England journal of medicine 20100909
Title: Bisphosphonates and atypical femoral fractures.
Journal: The New England journal of medicine 20100909
Title: Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100901
Title: Flare-up of hand osteoarthritis caused by zoledronic acid infusion.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100901
Title: Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100901
Title: Preparation and preclinical pharmacological study on a novel bone imaging agent (99m)Tc-EMIDP.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20100901
Title: Bone-marker levels in patients with prostate cancer: potential correlations with outcomes.
Journal: Current opinion in supportive and palliative care 20100901
Title: Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites.
Journal: Biomaterials 20100901
Title: Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
Journal: Journal of clinical immunology 20100901
Title: Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100901
Title: Characterization of and risk factors for the acute-phase response after zoledronic acid.
Journal: The Journal of clinical endocrinology and metabolism 20100901
Title: Update on the use of zoledronic acid in the management of osteoporosis.
Journal: Current osteoporosis reports 20100901
Title: Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
Journal: Calcified tissue international 20100901
Title: Updates on osteonecrosis of the jaw.
Journal: Current opinion in supportive and palliative care 20100901
Title: Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid.
Journal: The Annals of pharmacotherapy 20100901
Title: Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.
Journal: Nature chemical biology 20100901
Title: Acute effects of intravenous administration of pamidronate in patients with osteoporosis.
Journal: Journal of Korean medical science 20100901
Title: [A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100901
Title: [Relationship between osteonecrosis of the jaw and bisphosphonate treatment].
Journal: Arhiv za higijenu rada i toksikologiju 20100901
Title: [Bisphosphonates in adjuvant therapy of breast cancer].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20100901
Title: Inhibition of heat-shock protein 27 expression eliminates drug resistance of osteosarcoma to zoledronic acid.
Journal: Anticancer research 20100901
Title: [Preparation of zoledronic-acid-loaded collagen membrane].
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20100901
Title: A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.
Journal: Cancer letters 20100828
Title: Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.
Journal: British journal of cancer 20100824
Title: Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20100817
Title: Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801
Title: Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801
Title: A single pretreatment by zoledronic acid converts metastases from osteolytic to osteoblastic in the rat.
Journal: Microscopy research and technique 20100801
Title: The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100801
Title: A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer.
Journal: International journal of clinical oncology 20100801
Title: Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Journal: Breast cancer research and treatment 20100801
Title: In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
Journal: Clinical and experimental immunology 20100801
Title: Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases.
Journal: Journal of cancer research and clinical oncology 20100801
Title: Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100801
Title: [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].
Journal: Bulletin du cancer 20100801
Title: Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer.
Journal: Clinical breast cancer 20100801
Title: Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100801
Title: [Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].
Journal: Vnitrni lekarstvi 20100801
Title: Diffuse skeletal pain after administration of alendronate.
Journal: Indian journal of pharmacology 20100801
Title: In postmenopausal women with osteoporosis, is zoledronic acid (Reclast) superior in improving T-scores and decreasing fracture rates when compared with placebo?
Journal: The Journal of the Oklahoma State Medical Association 20100801
Title: [Effect of zoledronic acid on the differentiation and osteoprotegerin production of osteoblasts in rabbit].
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology 20100801
Title: [Active pharmacosurveillance of patients affiliated to the Colombian general social security/health system].
Journal: Revista de salud publica (Bogota, Colombia) 20100801
Title: Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model.
Journal: International journal of cancer 20100715
Title: Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells.
Journal: The Biochemical journal 20100715
Title: Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100701
Title: Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100701
Title: Response to zolendronic acid in children with type III osteogenesis imperfecta.
Journal: Journal of bone and mineral metabolism 20100701
Title: Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100701
Title: Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100701
Title: A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites.
Journal: Bone 20100701
Title: Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100701
Title: Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.
Journal: The American journal of pathology 20100701
Title: Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100701
Title: A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
Journal: International journal of oncology 20100701
Title: Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
Journal: Oncology reports 20100701
Title: Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100701
Title: Osteoporosis: Zoledronic acid for osteoporosis treatment--a matter of time.
Journal: Nature reviews. Rheumatology 20100701
Title: Bisphosphonates for bone pain #113.
Journal: Journal of palliative medicine 20100701
Title: [Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100701
Title: Combined effects of bisphosphonate and radiation on osteosarcoma cells.
Journal: Anticancer research 20100701
Title: Effective salvage treatment of recurrent Ewing sarcoma utilizing chemotherapy and zoledronic acid.
Journal: Clinical advances in hematology & oncology : H&O 20100701
Title: Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
Journal: Therapeutic delivery 20100701
Title: F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for Vgamma9Vdelta2 T cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20100615
Title: Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.
Journal: Cancer research 20100615
Title: Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100615
Title: [The role of bisphosphonates of adjuvant therapy in breast cancer].
Journal: Medicina clinica 20100612
Title: Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100601
Title: Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.
Journal: Clinical oral investigations 20100601
Title: Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Journal: Clinical oral investigations 20100601
Title: Characteristics of Paget's disease of bone in the city of Recife, Brazil.
Journal: Rheumatology international 20100601
Title: Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601
Title: Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100601
Title: Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100601
Title: Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats.
Journal: Calcified tissue international 20100601
Title: [Bone and joint diseases in children. Bisphosphonates in osteogenesis imperfecta].
Journal: Clinical calcium 20100601
Title: Zoledronate complexes. III. Two zoledronate complexes with alkaline earth metals: [Mg(C(5)H(9)N(2)O(7)P(2))(2)(H(2)O)(2)] and [Ca(C(5)H(8)N(2)O(7)P(2))(H(2)O)](n).
Journal: Acta crystallographica. Section C, Crystal structure communications 20100601
Title: Postmenopausal osteoporosis: another approach to management.
Journal: The Journal of family practice 20100601
Title: The neurological safety of epidural pamidronate in rats.
Journal: The Korean journal of pain 20100601
Title: Long term zoledronic acid during androgen blockade for prostate cancer.
Journal: The Canadian journal of urology 20100601
Title: [Efficacy of zoledronic acid combined with chemotherapy in treatment of skeletal metastases of non-small cell lung cancer and the bone metabolic markers].
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100601
Title: The evolving role of bone-conserving therapy in patients with breast cancer.
Journal: Seminars in oncology 20100601
Title: Therapeutic options in the management of myeloma bone disease.
Journal: Seminars in oncology 20100601
Title: Maintaining bone health in prostate cancer throughout the disease continuum.
Journal: Seminars in oncology 20100601
Title: Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer.
Journal: Seminars in oncology 20100601
Title: Bisphosphonates in lung cancer: more than a palliative therapy?
Journal: Seminars in oncology 20100601
Title: Potential anticancer properties of bisphosphonates.
Journal: Seminars in oncology 20100601
Title: Safety considerations for use of bone-targeted agents in patients with cancer.
Journal: Seminars in oncology 20100601
Title: Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Journal: The New England journal of medicine 20100513
Title: Evolving data about subtrochanteric fractures and bisphosphonates.
Journal: The New England journal of medicine 20100513
Title: Evidence of drug confinement into silica mesoporous matrices by STEM spherical aberration corrected microscopy.
Journal: Chemical communications (Cambridge, England) 20100507
Title: An in vitro assay to measure targeted drug delivery to bone mineral.
Journal: ChemMedChem 20100503
Title: A pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100501
Title: Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
Journal: Cancer chemotherapy and pharmacology 20100501
Title: Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Journal: Journal of bone and mineral metabolism 20100501
Title: Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis.
Journal: European journal of haematology 20100501
Title: A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20100501
Title: Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501
Title: Additive effects of estrogen replacement therapy and bisphosphonates on osseointegration of hydroxyapatite-coated titanium screws in ovariectomized rats.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100501
Title: Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501
Title: A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20100501
Title: Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100501
Title: The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.
Journal: Urology 20100501
Title: Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease.
Journal: European journal of cancer (Oxford, England : 1990) 20100501
Title: Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.
Journal: The Lancet. Oncology 20100501
Title: Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease.
Journal: Leukemia 20100501
Title: Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Journal: Translational research : the journal of laboratory and clinical medicine 20100501
Title: The role of the orthopaedic surgeon in minimizing mortality and morbidity associated with fragility fractures.
Journal: The Journal of the American Academy of Orthopaedic Surgeons 20100501
Title: Editorial comment.
Journal: Urology 20100501
Title: Zoledronic acid reduces osteoporotic fractures and ensures medication compliance for 1 year.
Journal: Postgraduate medicine 20100501
Title: [A case report of a patient treatable by home palliative care, administered zoledronic acid used for bladder cancer with hypercalcemia].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100501
Title: Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
Journal: Anticancer research 20100501
Title: Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.
Journal: Anticancer research 20100501
Title: Medical applications and toxicities of gallium compounds.
Journal: International journal of environmental research and public health 20100501
Title: [Expert consensus for the diagnosis and treatment of bone metastasis from prostate cancer].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100501
Title: [Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon DU145 prostate cancer cells].
Journal: Zhonghua yi xue za zhi 20100413
Title: Zoledronate reduces unwanted bone resorption in intercalary bone allografts.
Journal: International orthopaedics 20100401
Title: The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100401
Title: Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
Journal: Cancer chemotherapy and pharmacology 20100401
Title: Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study.
Journal: Photomedicine and laser surgery 20100401
Title: Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer.
Journal: BJU international 20100401
Title: Zoledronic acid decreases mRNA six-transmembrane epithelial antigen of prostate protein expression in prostate cancer cells.
Journal: Journal of endocrinological investigation 20100401
Title: Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.
Journal: Breast (Edinburgh, Scotland) 20100401
Title: Long-term use of bisphosphonates in osteoporosis.
Journal: The Journal of clinical endocrinology and metabolism 20100401
Title: Exercise and zoledronic acid on lipid profile and bone remodeling in ovariectomized rats: a paradoxical negative association?
Journal: Lipids 20100401
Title: Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401
Title: Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401
Title: Zoledronate complexes. II. catena-Poly[[tetraaquabis[hemihydrogen mu3-1-hydroxy-2-(imidazol-3-ium-1-yl)ethylidene-1,1-diphosphonato-kappa3O:O':O'']bis[mu3-1-hydroxy-2-(imidazol-3-ium-1-yl)ethylidene-1,1-diphosphonato-kappa4O:O,O':O'']trisodium] dihydrate].
Journal: Acta crystallographica. Section C, Crystal structure communications 20100401
Title: Medical oncology: Zoledronic acid for breast cancer therapy-induced bone loss.
Journal: Nature reviews. Clinical oncology 20100401
Title: [Primary hyperparathyroidism in a patient with Paget's bone disease].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100401
Title: Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study.
Journal: Current oncology (Toronto, Ont.) 20100401
Title: Bisphosphonates in adjuvant treatment of early breast cancer.
Journal: Critical reviews in oncology/hematology 20100401
Title: Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.
Journal: Critical reviews in oncology/hematology 20100401
Title: The anti-tumor effect of bisphosphonates ABCSG-12, ZO-FAST and more ..
Journal: Critical reviews in oncology/hematology 20100401
Title: Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20100401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100401
Title: Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of periodontal & implant science 20100401
Title: Generalized melanosis and melanuria in a patient with metastatic melanoma.
Journal: Clinical and experimental dermatology 20100401
Title: Health trends.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20100401
Title: Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
Journal: Prescrire international 20100401
Title: The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer.
Journal: British journal of cancer 20100330
Title: Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.
Journal: British journal of cancer 20100316
Title: V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20100315
Title: Case 36-2009: A man with cough, hoarseness, and abnormalities on chest imaging.
Journal: The New England journal of medicine 20100311
Title: Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.
Journal: British journal of cancer 20100302
Title: Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands) 20100301
Title: Improving bone density at the rotator cuff footprint increases supraspinatus tendon failure stress in a rat model.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100301
Title: The effect of soaking allograft in bisphosphonate: a pilot dose-response study.
Journal: Clinical orthopaedics and related research 20100301
Title: Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
Journal: Biochemical pharmacology 20100301
Title: Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Journal: Journal of bone and mineral metabolism 20100301
Title: No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site.
Journal: Bone 20100301
Title: Bone health and prostate cancer.
Journal: Prostate cancer and prostatic diseases 20100301
Title: A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients.
Journal: Bone 20100301
Title: Jaw bone changes in rats after treatment with zoledronate and pamidronate.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100301
Title: Use of zoledronic acid in the treatment of Gorham's disease.
Journal: International journal of pediatric otorhinolaryngology 20100301
Title: Effect of osteoporosis treatment on mortality: a meta-analysis.
Journal: The Journal of clinical endocrinology and metabolism 20100301
Title: Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
Journal: Journal of medical economics 20100301
Title: Scintigraphic evaluation of mandibular bone turnover in patients with solid tumors receiving zoledronic acid.
Journal: Oral oncology 20100301
Title: The effect of zoledronate during bone healing.
Journal: Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20100301
Title: Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100301
Title: Effects of risedronate on osteoarthritis of the knee.
Journal: Yonsei medical journal 20100301
Title: [Assessment and treatment of osteoporotic hip fractures].
Journal: Ugeskrift for laeger 20100301
Title: Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301
Title: Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20100301
Title: [Difference in treatment for metastatic bone tumors due to differences in opinion among departments--the role of medical teams for metastatic bone tumors].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100301
Title: Bone disease in prostate cancer.
Journal: Asia-Pacific journal of clinical oncology 20100301
Title: Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis.
Journal: Clinical therapeutics 20100301
Title: Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301
Title: Denosumab reduces the incidence of new vertebral fractures in men with prostate cancer.
Journal: Current osteoporosis reports 20100301
Title: Intravenous zoledronic acid: what are the indications for male osteoporosis?
Journal: Current osteoporosis reports 20100301
Title: Glucocorticoid-induced osteoporosis: management update.
Journal: Current osteoporosis reports 20100301
Title: Renal cell carcinoma bone metastases: clinical advances.
Journal: Therapeutic advances in medical oncology 20100301
Title: Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
Journal: British journal of cancer 20100216
Title: FDA drug information that never reaches clinicians.
Journal: The New England journal of medicine 20100211
Title: Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.
Journal: Clinical oral investigations 20100201
Title: Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment: case report.
Journal: Investigational new drugs 20100201
Title: Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment.
Journal: Clinical oral investigations 20100201
Title: Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases.
Journal: American journal of clinical oncology 20100201
Title: The impact of zoledronic acid on regenerate and native bone after consolidation and removal of the external fixator: an animal model study.
Journal: Bone 20100201
Title: Examining patient conceptions: a case of metastatic breast cancer in an African American male to female transgender patient.
Journal: Journal of general internal medicine 20100201
Title: Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.
Journal: The Journal of clinical endocrinology and metabolism 20100201
Title: Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.
Journal: Journal of the American Geriatrics Society 20100201
Title: Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting.
Journal: Current cancer drug targets 20100201
Title: [Bone and Men's Health. Bisphosphonate therapy for prostate cancer].
Journal: Clinical calcium 20100201
Title: Management of glucocorticoid-induced osteoporosis.
Journal: Nature reviews. Rheumatology 20100201
Title: Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results.
Journal: Clinical breast cancer 20100201
Title: Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma.
Journal: Anticancer research 20100201
Title: Zoledronic Acid for the treatment and prevention of primary and secondary osteoporosis.
Journal: Therapeutic advances in musculoskeletal disease 20100201
Title: Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.
Journal: British journal of cancer 20100119
Title: Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1.
Journal: British journal of cancer 20100119
Title: Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
Journal: International journal of cancer 20100115
Title: Lysosomal-mitochondrial axis in zoledronic acid-induced apoptosis in human follicular lymphoma cells.
Journal: The Journal of biological chemistry 20100115
Title: [Osteoporosis].
Journal: Revue medicale suisse 20100113
Title: Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100101
Title: Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.
Journal: Cancer letters 20100101
Title: Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101
Title: Potential mediators of the mortality reduction with zoledronic acid after hip fracture.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101
Title: The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation.
Journal: International journal of cancer 20100101
Title: Non-persistent effect of short-term bisphosphonate treatment in preventing fractures after liver transplantation.
Journal: Transplant international : official journal of the European Society for Organ Transplantation 20100101
Title: Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
Journal: Bone 20100101
Title: Differences between bisphosphonates in binding affinities for hydroxyapatite.
Journal: Journal of biomedical materials research. Part B, Applied biomaterials 20100101
Title: Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma.
Journal: European journal of cancer (Oxford, England : 1990) 20100101
Title: Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.
Journal: Lung cancer (Amsterdam, Netherlands) 20100101
Title: Is zoledronate toxic to human periodontal fibroblasts?
Journal: Journal of dental research 20100101
Title: Dysuria caused by pelvic metastasis from breast carcinoma was alleviated by multi-modality therapy with zoledronic acid.
Journal: The breast journal 20100101
Title: Zoledronic acid: an unending tale for an antiresorptive agent.
Journal: Expert opinion on pharmacotherapy 20100101
Title: Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100101
Title: Brigham fracture intervention team initiatives for hospital patients with hip fractures: a paradigm shift.
Journal: International journal of endocrinology 20100101
Title: IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
Journal: Pathology 20100101
Title: Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis.
Journal: Joint, bone, spine : revue du rhumatisme 20100101
Title: Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines.
Journal: The Journal of bone and joint surgery. American volume 20100101
Title: Zoledronate complexes. I. Poly[[mu2-aqua[mu3-1-hydroxy-2-(1H,3H-imidazol-3-ium-1-yl)ethylidenediphosphonato]potassium(I)] monohydrate].
Journal: Acta crystallographica. Section C, Crystal structure communications 20100101
Title: No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.
Journal: Nutrition journal 20100101
Title: Atrial fibrillation and bisphosphonate therapy.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101
Title: A novel 3-D mineralized tumor model to study breast cancer bone metastasis.
Journal: PloS one 20100101
Title: Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.
Journal: Orphanet journal of rare diseases 20100101
Title: Bisphosphonates and risk of atrial fibrillation: a meta-analysis.
Journal: Arthritis research & therapy 20100101
Title: A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws.
Journal: Journal of the Massachusetts Dental Society 20100101
Title: EVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantage.
Journal: BMC clinical pharmacology 20100101
Title: Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101
Title: A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis.
Journal: Fibrogenesis & tissue repair 20100101
Title: Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.
Journal: Clinical & developmental immunology 20100101
Title: Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancer.
Journal: Case reports in medicine 20100101
Title: Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
Journal: Breast cancer research : BCR 20100101
Title: Inherited multicentric osteolysis: case report of three siblings treated with bisphosphonate.
Journal: Pediatric rheumatology online journal 20100101
Title: Risk factors contributing to the development of hypocalcemia after zoledronic acid administration in patients with bone metastases of solid tumor.
Journal: Biological & pharmaceutical bulletin 20100101
Title: Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Journal: BMC cancer 20100101
Title: Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.
Journal: PloS one 20100101
Title: Adding zoledronic acid to endocrine therapy in the adjuvant treatment of hormone-sensitive breast cancer in premenopausal women: a new care standard or a provocative idea?
Journal: Current oncology reports 20100101
Title: Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel?
Journal: Journal of vascular research 20100101
Title: Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis.
Journal: Therapeutics and clinical risk management 20100101
Title: Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009.
Journal: International journal of general medicine 20100101
Title: Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review.
Journal: Journal of cancer research and therapeutics 20100101
Title: Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis.
Journal: Journal of biological regulators and homeostatic agents 20100101
Title: Beta-thalassemia.
Journal: Orphanet journal of rare diseases 20100101
Title: Zoledronic acid treatment of osteoporosis: effects in men.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101
Title: Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.
Journal: Head & neck oncology 20100101
Title: Rapid cell culture and pre-clinical screening of a transforming growth factor-beta (TGF-beta) inhibitor for orthopaedics.
Journal: BMC musculoskeletal disorders 20100101
Title: Five-year follow-up of Japanese patients with Paget's disease of the bone after treatment with low-dose oral alendronate: a case series.
Journal: Journal of medical case reports 20100101
Title: [Effects of zoledronic acid in adults with osteogenesis imperfecta].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100101
Title: Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Journal: Onkologie 20100101
Title: Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.
Journal: Therapeutics and clinical risk management 20100101
Title: Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases.
Journal: BMC cancer 20100101
Title: Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101
Title: Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition.
Journal: Breast cancer research : BCR 20100101
Title: A case of severe hemorrhagic cystitis caused by melphalan with successful bladder preservation by ligation of bilateral internal iliac arteries.
Journal: Case reports in medicine 20100101
Title: Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.
Journal: Head & face medicine 20100101
Title: The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.
Journal: Head & face medicine 20100101
Title: Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.
Journal: Journal of biomedicine & biotechnology 20100101
Title: Titration of dosage for the protective effect of zoledronic acid on bone loss in patients submitted to androgen deprivation therapy due to prostate cancer: a prospective open-label study.
Journal: Urologia internationalis 20100101
Title: Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study.
Journal: Onkologie 20100101
Title: An open cohort study of bone metastasis incidence following surgery in breast cancer patients.
Journal: BMC cancer 20100101
Title: Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
Journal: Therapeutics and clinical risk management 20100101
Title: State-of-the-Art Management of Complications of Myeloma and Its Treatment.
Journal: Advances in hematology 20100101
Title: Primary squamous cell carcinoma of the urinary bladder presenting as peritoneal carcinomatosis.
Journal: Advances in urology 20100101
Title: Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR 20100101
Title: Radiation-induced DNA damage and repair in human gammadelta and alphabeta T-lymphocytes analysed by the alkaline comet assay.
Journal: Genome integrity 20100101
Title: Zoledronate stimulates gamma delta T cells in prostate cancer patients.
Journal: Oncology research 20100101
Title: Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis.
Journal: Patient preference and adherence 20100101
Title: Therapeutic effect of oral bisphosphonates on choroidal neovascularization in the human eye.
Journal: Journal of ophthalmology 20100101
Title: A multiparameter approach to monitor disease activity in collagen-induced arthritis.
Journal: Arthritis research & therapy 20100101
Title: The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.
Journal: Arthritis research & therapy 20100101
Title: Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
Journal: BMC cancer 20100101
Title: Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
Journal: Molecular cancer 20100101
Title: Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway.
Journal: Journal of experimental & clinical cancer research : CR 20100101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100101
Title: Current and emerging treatments for the management of osteogenesis imperfecta.
Journal: Therapeutics and clinical risk management 20100101
Title: Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy.
Journal: Case reports in medicine 20100101
Title: Oral lesions and lymphoproliferative disorders.
Journal: Journal of oncology 20100101
Title: ExaCT: automatic extraction of clinical trial characteristics from journal publications.
Journal: BMC medical informatics and decision making 20100101
Title: [Effect of a single dose of zoledronic acid in a case of Paget bone disease].
Journal: Medicina 20100101
Title: Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis.
Journal: Arthritis research & therapy 20100101
Title: Aging, human immunodeficiency virus, and bone health.
Journal: Clinical interventions in aging 20100101
Title: Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features.
Journal: Journal of translational medicine 20100101
Title: Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women.
Journal: Journal of osteoporosis 20100101
Title: A longitudinal study of the effect of genistein on bone in two different murine models of diminished estrogen-producing capacity.
Journal: Journal of osteoporosis 20100101
Title: Human γδ T lymphocytes for immunotherapeutic strategies against cancer.
Journal: F1000 medicine reports 20100101
Title: Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Journal: Arthritis research & therapy 20100101
Title: Osteoporosis syndrome in thalassaemia major: an overview.
Journal: Journal of osteoporosis 20100101
Title: Superparamagnetic bifunctional bisphosphonates nanoparticles: a potential MRI contrast agent for osteoporosis therapy and diagnostic.
Journal: Journal of osteoporosis 20100101
Title: Sclerostin.
Journal: Journal of osteoporosis 20100101
Title: [Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].
Journal: Chirurgia narzadow ruchu i ortopedia polska 20100101
Title: Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain.
Journal: PloS one 20100101
Title: Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
Journal: Oncology 20100101
Title: Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
Journal: General dentistry 20100101
Title: Breast cancer in young women.
Journal: Breast cancer research : BCR 20100101
Title: Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.
Journal: Cancer immunity 20100101
Title: Profile of teriparatide in the management of postmenopausal osteoporosis.
Journal: International journal of women's health 20100101
Title: Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma.
Journal: Bulletin de la Societe belge d'ophtalmologie 20100101
Title: Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid.
Journal: Hormones (Athens, Greece) 20100101
Title: Abstracts of the 5th European Workshop on Immune-Mediated Inflammatory Diseases. Sitges-Barcelona, Spain. December 1-3, 2010.
Journal: Journal of translational medicine 20100101
Title: The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service.
Journal: BMC cancer 20100101
Title: Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.
Journal: Drug design, development and therapy 20100101
Title: A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.
Journal: Therapeutics and clinical risk management 20100101
Title: Zoledronic acid infusion for prevention and treatment of osteoporosis.
Journal: International journal of women's health 20100101
Title: Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.
Journal: International journal of molecular sciences 20100101
Title: Prevention of bone metastases and management of bone health in early breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Breast cancer metastasis to the bone: mechanisms of bone loss.
Journal: Breast cancer research : BCR 20100101
Title: Anti-tumour activity of bisphosphonates in preclinical models of breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases.
Journal: BMC urology 20100101
Title: Effect of zoledronic acid used in the root surface treatment of late replanted teeth: a study in rats.
Journal: Brazilian dental journal 20100101
Title: Evaluation of degarelix in the management of prostate cancer.
Journal: Cancer management and research 20100101
Title: Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures.
Journal: Clinical and experimental rheumatology 20100101
Title: Improving management of patients with advanced cancer.
Journal: Patient preference and adherence 20100101
Title: The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.
Journal: PloS one 20100101
Title: Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
Journal: Minerva stomatologica 20100101
Title: Skull base osteomyelitis and bisphosphonate use in multiple myeloma: report of two cases and literature review.
Journal: The Laryngoscope 20100101
Title: Successful control of acute myelofibrosis with lenalidomide.
Journal: Case reports in medicine 20100101
Title: Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
Journal: Nucleus (Austin, Tex.) 20100101
Title: Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vγ9Vδ2 T cells.
Journal: Mediators of inflammation 20100101
Title: Regenerative frontiers in craniofacial reconstruction: grand challenges and opportunities for the mammalian transforming growth factor-β proteins.
Journal: Frontiers in physiology 20100101
Title: Immunotherapy of brain cancers: the past, the present, and future directions.
Journal: Clinical & developmental immunology 20100101
Title: Accumulation of VEGFR2 in zoledronic acid-treated endothelial cells.
Journal: Molecular medicine reports 20100101
Title: Protective effect of hypoxia on bisphosphonate‑related bone cell damage.
Journal: Molecular medicine reports 20100101
Title: Intravenous bisphosphonates for postmenopausal osteoporosis.
Journal: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20100101
Title: catena-Poly[zinc(II)-μ(3)-{hydrogen [1-hydr-oxy-2-(3-pyridinio)ethane-1,1-di-yl]diphospho-nato}].
Journal: Acta crystallographica. Section E, Structure reports online 20100101
Title: Endometrial cancer diagnosed by the presence of bone metastasis and treated with zoledronic Acid: a case report and review of the literature.
Journal: Case reports in oncology 20100101
Title: Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.
Journal: Drug, healthcare and patient safety 20100101
Title: Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.
Journal: Drug, healthcare and patient safety 20100101
Title: Pharmacoeconomic considerations in the treatment of breast cancer.
Journal: ClinicoEconomics and outcomes research : CEOR 20100101
Title: Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells.
Journal: Research in pharmaceutical sciences 20100101
Title: Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.
Journal: Ecancermedicalscience 20100101
Title: Zoledronic acid in metastatic bone disease: an audit based discussion.
Journal: Journal of Ayub Medical College, Abbottabad : JAMC 20100101
Title: Chronic suppurative osteomyelitis of maxilla mimicking actinimycotic osteomyelitis: A rare case report.
Journal: National journal of maxillofacial surgery 20100101
Title: Melorheostosis and its treatment with intravenous zoledronic acid.
Journal: BMJ case reports 20100101
Title: Bisphosphonate-related osteonecrosis of the jaw and left thumb.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210
Title: Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model.
Journal: Pathology oncology research : POR 20091201
Title: A novel bioassay model to determine clinically significant bisphosphonate levels.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20091201
Title: The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
Journal: Bone 20091201
Title: Bone morphogenetic proteins and zoledronic acid.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20091201
Title: Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases.
Journal: International journal of clinical practice 20091201
Title: The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer.
Journal: European journal of cancer (Oxford, England : 1990) 20091201
Title: Modulation of innate immunity by IL-18.
Journal: Journal of reproductive immunology 20091201
Title: Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer.
Journal: Cancer investigation 20091201
Title: Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates.
Journal: BJU international 20091201
Title: [New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20091201
Title: A rare case of Paget's disease of the bone in the Philippines.
Journal: International journal of rheumatic diseases 20091201
Title: CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses.
Journal: Blood 20091112
Title: Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110
Title: Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
Journal: Bone 20091101
Title: Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
Journal: International journal of cancer 20091101
Title: The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20091101
Title: Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.
Journal: Cell biology international 20091101
Title: Bisphosphonates in breast cancer: teaching an old dog new tricks.
Journal: Current opinion in oncology 20091101
Title: Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy.
Journal: The Journal of urology 20091101
Title: A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
Journal: Japanese journal of clinical oncology 20091101
Title: Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.
Journal: Journal of general internal medicine 20091101
Title: Quantitative determination of geranyl diphosphate levels in cultured human cells.
Journal: Lipids 20091101
Title: Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091101
Title: Locally delivered bisphosphonate for enhancement of bone formation and implant fixation.
Journal: The Journal of bone and joint surgery. American volume 20091101
Title: JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia.
Journal: Molecular cancer therapeutics 20091101
Title: Bisphosphonates and time to osteonecrosis development.
Journal: The oncologist 20091101
Title: Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects.
Journal: Current cancer drug targets 20091101
Title: Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials.
Journal: Current cancer drug targets 20091101
Title: Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial.
Journal: Obstetrics and gynecology 20091101
Title: Diaqua-bis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethyl-idenediphophonato-κO,O']zinc(II).
Journal: Acta crystallographica. Section E, Structure reports online 20091101
Title: Aquabis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethylidenediphophonato-κO,O']zinc(II) dihydrate.
Journal: Acta crystallographica. Section E, Structure reports online 20091101
Title: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
Journal: Therapeutic advances in medical oncology 20091101
Title: [A single infusion of zoledronic acid (Zometa) for prevention and treatment of steroid-induced osteoporosis].
Journal: Praxis 20091007
Title: Bisphosphonates for osteoporosis in people with cystic fibrosis.
Journal: The Cochrane database of systematic reviews 20091007
Title: [Management of serum calcium with cinacelet in parathyroid cancer].
Journal: Ugeskrift for laeger 20091005
Title: Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Journal: Journal of biomedical materials research. Part A 20091001
Title: Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
Journal: Breast cancer research and treatment 20091001
Title: The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis.
Journal: International journal of cancer 20091001
Title: Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20091001
Title: Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20091001
Title: Is zoledronic acid an anticancer drug?
Journal: Expert opinion on pharmacotherapy 20091001
Title: Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility.
Journal: Calcified tissue international 20091001
Title: Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.
Journal: Molecular cancer therapeutics 20091001
Title: Bifocal sarcomatous transformation of Paget's disease: a case report.
Journal: Joint, bone, spine : revue du rhumatisme 20091001
Title: MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells.
Journal: Anticancer research 20091001
Title: Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient.
Journal: International journal of clinical oncology 20091001
Title: Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice.
Journal: Cancer biotherapy & radiopharmaceuticals 20091001
Title: High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090915
Title: Superparamagnetic nanovector with anti-cancer properties: gamma Fe2O3@Zoledronate.
Journal: International journal of pharmaceutics 20090911
Title: Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials.
Journal: The Lancet. Oncology 20090909
Title: Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
Journal: Head & neck 20090901
Title: Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090901
Title: Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090901
Title: Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases.
Journal: Medical hypotheses 20090901
Title: Zoledronic acid may be a treatment option for hyperparathyroidism.
Journal: Medical hypotheses 20090901
Title: Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon.
Journal: Transfusion 20090901
Title: The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20090901
Title: Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
Journal: European journal of clinical investigation 20090901
Title: New results from the use of bisphosphonates in cancer patients.
Journal: Current opinion in supportive and palliative care 20090901
Title: Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.
Journal: The Journal of clinical endocrinology and metabolism 20090901
Title: Zoledronic acid decreases bone formation without causing osteocyte death in mice.
Journal: Archives of oral biology 20090901
Title: A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
Journal: The Annals of pharmacotherapy 20090901
Title: Clinical and therapeutic aspects of osteoporosis.
Journal: European journal of radiology 20090901
Title: New therapies for osteoporosis: zoledronic acid, bazedoxifene, and denosumab.
Journal: Current osteoporosis reports 20090901
Title: Chemotherapy for early-stage breast cancer: a brief history.
Journal: British journal of cancer 20090901
Title: Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
Journal: Expert review of anticancer therapy 20090901
Title: Docetaxel-based chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: factors predicting response and survival.
Journal: International journal of urology : official journal of the Japanese Urological Association 20090901
Title: Editorial Comment to docetaxel-based combination chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival.
Journal: International journal of urology : official journal of the Japanese Urological Association 20090901
Title: [Antitumor activity of zoledronic acid].
Journal: Magyar onkologia 20090901
Title: Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells.
Journal: European cytokine network 20090901
Title: Treatment of bone metastases in lung cancer: the actual role of zoledronic acid.
Journal: Reviews on recent clinical trials 20090901
Title: [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
Journal: Zhonghua nei ke za zhi 20090901
Title: Erratum: Case Report of Spontaneous, Nonspinal Fractures in a Multiple Myeloma Patient on Long-term Pamidronate and Zoledronic Acid.
Journal: HSS journal : the musculoskeletal journal of Hospital for Special Surgery 20090901
Title: Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801
Title: Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801
Title: Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.
Journal: Journal of pain and symptom management 20090801
Title: Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.
Journal: Experimental hematology 20090801
Title: The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090801
Title: [Osteonecrosis of the jaw].
Journal: La Revue de medecine interne 20090801
Title: Single infusion of zoledronic acid to prevent androgen deprivation therapy-induced bone loss in men with hormone-naive prostate carcinoma.
Journal: Cancer 20090801
Title: Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis.
Journal: Breast cancer research and treatment 20090801
Title: Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies.
Journal: Current medical research and opinion 20090801
Title: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090801
Title: Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20090801
Title: Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats?
Journal: Calcified tissue international 20090801
Title: [Numb chin syndrome caused by biphosphonates-induced osteonecrosis of the jaw].
Journal: Revista de neurologia 20090801
Title: Mandibular necrosis in beagle dogs treated with bisphosphonates.
Journal: Orthodontics & craniofacial research 20090801
Title: Multimodal therapy for vertebral involvement of systemic mastocytosis.
Journal: Spine 20090801
Title: Optimizing the management of advanced non-small-cell lung cancer: a personal view.
Journal: Current oncology (Toronto, Ont.) 20090801
Title: The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
Journal: Mini reviews in medicinal chemistry 20090801
Title: Corticosteroids: no drug prevention of fractures needed.
Journal: Prescrire international 20090801
Title: Zolendronate in osteogenesis imperfecta.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20090801
Title: Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
Journal: British journal of cancer 20090721
Title: Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.
Journal: Biochemical pharmacology 20090715
Title: Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study.
Journal: Annals of the rheumatic diseases 20090701
Title: Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients.
Journal: Bone marrow transplantation 20090701
Title: Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701
Title: An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible.
Journal: Contemporary clinical trials 20090701
Title: Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701
Title: Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
Journal: Experimental hematology 20090701
Title: Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
Journal: European journal of cancer (Oxford, England : 1990) 20090701
Title: The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090701
Title: Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090701
Title: Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.
Journal: Journal of palliative medicine 20090701
Title: Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancer.
Journal: Clinical lung cancer 20090701
Title: Effect of locally administered zoledronic acid on injury-induced intramembranous bone regeneration and osseointegration of a titanium implant in rats.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090701
Title: An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.
Journal: Current oncology (Toronto, Ont.) 20090701
Title: Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.
Journal: Current oncology (Toronto, Ont.) 20090701
Title: Comparison of phenotype of gammadelta T cells generated using various cultivation methods.
Journal: Immunology letters 20090630
Title: Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.
Journal: The Medical letter on drugs and therapeutics 20090629
Title: Prediction of bone density around orthopedic implants delivering bisphosphonate.
Journal: Journal of biomechanics 20090619
Title: Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells.
Journal: Cancer letters 20090608
Title: Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
Journal: Clinical endocrinology 20090601
Title: Comment on: Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Journal: Oral oncology 20090601
Title: Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090601
Title: Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy.
Journal: Clinical immunology (Orlando, Fla.) 20090601
Title: Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
Journal: British journal of pharmacology 20090601
Title: Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.
Journal: The American journal of pathology 20090601
Title: Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion.
Journal: Melanoma research 20090601
Title: Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601
Title: Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20090601
Title: Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Journal: Clinical breast cancer 20090601
Title: [The role of oncology nurses in treatment outcomes. What can we do for the patients' compliance treated with intravenous zoledronic acid?].
Journal: Magyar onkologia 20090601
Title: Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.
Journal: Cancer biology & therapy 20090601
Title: [Zoledronic acid blocks cell cycle and induces apoptosis in lung cancer cell line 95D cells and their mechanisms of action].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090601
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090515
Title: Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
Journal: The Prostate 20090501
Title: Hyperparathyroidism secondary to zoledronic acid infusion: case report.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090501
Title: Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090501
Title: Vascular endothelial growth factor activity after switching of bisphosphonate treatment for metastatic breast cancer.
Journal: Journal of clinical pathology 20090501
Title: Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.
Journal: Haematologica 20090501
Title: High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid.
Journal: The oncologist 20090501
Title: Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
Journal: Basic & clinical pharmacology & toxicology 20090501
Title: Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.
Journal: Clinical breast cancer 20090501
Title: Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
Journal: Bone 20090501
Title: The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.
Journal: Bone 20090501
Title: Evaluating the antifracture efficacy of bisphosphonates.
Journal: Reviews on recent clinical trials 20090501
Title: Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
Journal: Clinical therapeutics 20090501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090501
Title: 1-Carboxy-methyl-2-ethyl-4-methyl-1H-imidazol-3-ium chloride monohydrate.
Journal: Acta crystallographica. Section E, Structure reports online 20090501
Title: Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
Journal: Cancer 20090415
Title: Glucocorticoid-induced osteoporosis: hope on the HORIZON.
Journal: Lancet (London, England) 20090411
Title: Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Journal: Lancet (London, England) 20090411
Title: Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro.
Journal: Journal of biomedical materials research. Part A 20090401
Title: Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model.
Journal: Cancer immunology, immunotherapy : CII 20090401
Title: Re: Christian Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72.
Journal: European urology 20090401
Title: Bone structure and remodelling in stroke patients: early effects of zoledronate.
Journal: Bone 20090401
Title: Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20090401
Title: Zoledronic acid-induced regression of multiple metastases at nonskeletal sites.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090401
Title: Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090401
Title: Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer.
Journal: Nature reviews. Clinical oncology 20090401
Title: Hypercalcemia: an evidence-based approach to clinical cases.
Journal: Iranian journal of kidney diseases 20090401
Title: Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
Journal: Anticancer research 20090401
Title: Paget's disease of bone and osteonecrosis.
Journal: Dental update 20090401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090401
Title: Glucocorticoid-induced osteoporosis: treatment update and review.
Journal: Therapeutic advances in musculoskeletal disease 20090401
Title: [Inhibition of Zoledronic Acid on Cell Proliferation and Invasion of Lung Cancer Cell Line 95D.].
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer 20090320
Title: Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
Journal: AIDS (London, England) 20090313
Title: Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
Journal: JOP : Journal of the pancreas 20090309
Title: [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
Journal: MMW Fortschritte der Medizin 20090305
Title: Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
Journal: Journal of the National Cancer Institute 20090304
Title: Re: Christan Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72.
Journal: European urology 20090301
Title: Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate.
Journal: BJU international 20090301
Title: Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
Journal: British journal of haematology 20090301
Title: Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090301
Title: The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
Journal: Biomaterials 20090301
Title: Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.
Journal: Gynecologic oncology 20090301
Title: Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090301
Title: Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
Journal: Nature clinical practice. Oncology 20090301
Title: Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy.
Journal: International journal of molecular medicine 20090301
Title: The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090301
Title: Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090301
Title: Bisphosphonate-related osteonecrosis of the skull base.
Journal: The Laryngoscope 20090301
Title: Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture.
Journal: Current osteoporosis reports 20090301
Title: [Once-yearly administration of zoledronic acid to treat post-menopausal osteoporosis].
Journal: Der Unfallchirurg 20090301
Title: Low incidence of osteonecrosis of the jaw in postmenopausal women with osteoporosis taking zoledronic acid once yearly.
Journal: The journal of evidence-based dental practice 20090301
Title: Neurologic complications of Paget disease of bone.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090301
Title: [A case of bone marrow carcinosis from gastric cancer that presented hypocalcemia caused by zoledronic acid during the treatment of methotrexate/5-fluorouracil sequential therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090301
Title: The pharmacological management of skeletal-related events from metastatic tumors.
Journal: Orthopedics 20090301
Title: Cementless total hip replacement: past, present, and future.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090301
Title: Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
Journal: Hiroshima journal of medical sciences 20090301
Title: [Primary hyperparathyroidism. An alternative to the surgery].
Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20090301
Title: [Effect of zoledronic acid on the growth and CD138 expression of myeloma cell line KM3].
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090301
Title: Assessment of bone quality using finite element analysis based upon micro-CT images.
Journal: Clinics in orthopedic surgery 20090301
Title: Bisphosphonates and implants: an overview.
Journal: Acta orthopaedica 20090226
Title: Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study.
Journal: Acta orthopaedica 20090226
Title: Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model.
Journal: Cancer letters 20090218
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090212
Title: [Oncology].
Journal: Revue medicale suisse 20090204
Title: Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Journal: Oral oncology 20090201
Title: Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090201
Title: Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.
Journal: BJU international 20090201
Title: Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20090201
Title: Inhibition of bone resorption and growth of breast cancer in the bone microenvironment.
Journal: Bone 20090201
Title: The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.
Journal: The Journal of clinical endocrinology and metabolism 20090201
Title: Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats.
Journal: Bone 20090201
Title: Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer.
Journal: Nature clinical practice. Endocrinology & metabolism 20090201
Title: Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells.
Journal: Cell biology international 20090201
Title: Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090201
Title: Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series.
Journal: The Laryngoscope 20090201
Title: Prevention and management of bone metastases in lung cancer: a review.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090201
Title: The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial.
Journal: The Journal of bone and joint surgery. American volume 20090201
Title: [Bisphosphonates and other new therapeutic agents for the treatmednt of osteogenesis imperfecta].
Journal: Clinical calcium 20090201
Title: Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review.
Journal: Medical science monitor : international medical journal of experimental and clinical research 20090201
Title: Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
Journal: The American journal of medicine 20090201
Title: New findings with old drugs for osteoporosis.
Journal: Expert opinion on pharmacotherapy 20090201
Title: A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections.
Journal: PLoS pathogens 20090201
Title: Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Journal: Cancer investigation 20090201
Title: Prevention and treatment of senile osteoporosis and hip fractures.
Journal: Minerva medica 20090201
Title: Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience.
Journal: Anticancer research 20090201
Title: [Osteoporosis].
Journal: Revue medicale suisse 20090114
Title: Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells.
Journal: European journal of pharmacology 20090105
Title: [Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].
Journal: Ugeskrift for laeger 20090105
Title: A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.
Journal: AIDS (London, England) 20090102
Title: A rare case of paraganglioma of the sella with bone metastases.
Journal: Pituitary 20090101
Title: In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.
Journal: Cancer immunology, immunotherapy : CII 20090101
Title: Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C.
Journal: Medical oncology (Northwood, London, England) 20090101
Title: Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090101
Title: Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation.
Journal: The Journal of surgical research 20090101
Title: Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Journal: The British journal of oral & maxillofacial surgery 20090101
Title: Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090101
Title: Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090101
Title: Zoledronic acid for the treatment of appendicular osteosarcoma in a dog.
Journal: The Journal of small animal practice 20090101
Title: Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20090101
Title: Osteonecrosis of the jaw: who gets it, and why?
Journal: Bone 20090101
Title: Inhibition of osteoblast function in vitro by aminobisphosphonates.
Journal: Journal of cellular biochemistry 20090101
Title: Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.
Journal: British journal of haematology 20090101
Title: Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis.
Journal: Journal of bone and mineral metabolism 20090101
Title: Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090101
Title: Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
Journal: Scandinavian journal of urology and nephrology 20090101
Title: Activated V gamma 9V delta 2 T cells trigger granulocyte functions via MCP-2 release.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20090101
Title: San Antonio Breast Cancer Symposium.
Journal: The Lancet. Oncology 20090101
Title: [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].
Journal: Clinical calcium 20090101
Title: MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage.
Journal: Arthritis research & therapy 20090101
Title: Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO).
Journal: Pediatric rheumatology online journal 20090101
Title: Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Journal: Molecular cancer therapeutics 20090101
Title: Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports.
Journal: Journal of experimental & clinical cancer research : CR 20090101
Title: [A case of recurrent breast carcinoma metastasis successfully treated with S-1 and zoledronic acid therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090101
Title: Severe symptomatic hypocalcemia in a patient with RDEB treated with intravenous zoledronic acid.
Journal: Archives of dermatology 20090101
Title: New bisphosphonates and trends in drug therapy for osteoporosis: preface.
Journal: Clinical calcium 20090101
Title: Breast cancer in young women and its impact on reproductive function.
Journal: Human reproduction update 20090101
Title: Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
Journal: BMC cancer 20090101
Title: Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone.
Journal: Oncology 20090101
Title: Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
Journal: Journal of bone and mineral metabolism 20090101
Title: Effect of zoledronic acid on bone pain secondary to metastatic bone disease.
Journal: Medicine and health, Rhode Island 20090101
Title: Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.
Journal: PloS one 20090101
Title: Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.
Journal: Clinical & experimental metastasis 20090101
Title: Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers.
Journal: BMC cancer 20090101
Title: Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application.
Journal: Medscape journal of medicine 20090101
Title: Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20090101
Title: Multiple myeloma with paraneoplastic leucocytoclastic vasculitis.
Journal: Indian journal of cancer 20090101
Title: Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
Journal: Journal of computer assisted tomography 20090101
Title: [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
Journal: Reumatismo 20090101
Title: [Comparison of two formulae for the calculation of glomerular filtration in the dosage of zoledronic acid].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101
Title: RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.
Journal: Arthritis research & therapy 20090101
Title: [Development of primary hyperparathyroidism in the follow-up of a patient with Paget's disease].
Journal: Medicina 20090101
Title: Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.
Journal: Therapeutics and clinical risk management 20090101
Title: Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases.
Journal: BMC cancer 20090101
Title: What is your diagnosis? Osteonecrosis of the jaw; unknown cause(s).
Journal: Northwest dentistry 20090101
Title: Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
Journal: PloS one 20090101
Title: Treatment of osteoporosis and prevention of new fractures: role of intravenously administered bisphosphonates.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090101
Title: Diagnosis and management of osteoporosis in the older senior.
Journal: Clinical interventions in aging 20090101
Title: Once-yearly zoledronic acid in hip fracture prevention.
Journal: Clinical interventions in aging 20090101
Title: Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
Journal: Clinical interventions in aging 20090101
Title: Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy.
Journal: The journal of supportive oncology 20090101
Title: Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.
Journal: Trials 20090101
Title: Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.
Journal: Therapeutics and clinical risk management 20090101
Title: Residual (ghost) sockets in bisphosphonate use--evidence of poor healing and slow bone turnover.
Journal: General dentistry 20090101
Title: Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
Journal: Clinical interventions in aging 20090101
Title: Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells.
Journal: Immunopharmacology and immunotoxicology 20090101
Title: Bisphosphonate-associated adverse events.
Journal: Hormones (Athens, Greece) 20090101
Title: Zoledronic acid induced osteonecrosis of tibia and femur.
Journal: Indian journal of cancer 20090101
Title: Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates.
Journal: BMC musculoskeletal disorders 20090101
Title: Risedronate inhibits human osteosarcoma cell invasion.
Journal: Journal of experimental & clinical cancer research : CR 20090101
Title: ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.
Journal: Journal of hematology & oncology 20090101
Title: Anterior uveitis complicating zoledronic acid infusion.
Journal: Ocular immunology and inflammation 20090101
Title: Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
Journal: BMC cancer 20090101
Title: Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20090101
Title: The utilization of humanized mouse models for the study of human retroviral infections.
Journal: Retrovirology 20090101
Title: Management strategies for pulmonary sarcoidosis.
Journal: Therapeutics and clinical risk management 20090101
Title: Front line treatment of elderly multiple myeloma in the era of novel agents.
Journal: Biologics : targets & therapy 20090101
Title: [Case of acute kidney injury related to intravenous zoledronic acid in a patient with multiple myeloma].
Journal: Nihon Jinzo Gakkai shi 20090101
Title: Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.
Journal: Genome biology 20090101
Title: Management of osteoporosis in the aging male: focus on zoledronic acid.
Journal: Clinical interventions in aging 20090101
Title: Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women.
Journal: Therapeutics and clinical risk management 20090101
Title: Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.
Journal: BMC musculoskeletal disorders 20090101
Title: Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review.
Journal: Therapeutics and clinical risk management 20090101
Title: A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
Journal: Oncology research 20090101
Title: [Epidemiology of hip fractures and its social and economic impact. A revision of severe osteoporosis current standard of care].
Journal: Acta reumatologica portuguesa 20090101
Title: Renal cell carcinoma metastasis to the ovary: a case report.
Journal: Cases journal 20090101
Title: A woman with cystic fibrosis, severe hypoxaemia, an atrial thrombus and a patent foramen ovale: a case report.
Journal: Journal of medical case reports 20090101
Title: Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells.
Journal: Breast cancer research : BCR 20090101
Title: Progress in osteoporosis and fracture prevention: focus on postmenopausal women.
Journal: Arthritis research & therapy 20090101
Title: Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
Journal: American journal of otolaryngology 20090101
Title: Health-related quality of life after vertebral or hip fracture: a seven-year follow-up study.
Journal: BMC musculoskeletal disorders 20090101
Title: Update on the use of aromatase inhibitors in early-stage breast cancer.
Journal: Breast cancer research : BCR 20090101
Title: Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis.
Journal: Therapeutics and clinical risk management 20090101
Title: Impact of culture medium on the expansion of T cells for immunotherapy.
Journal: Cytotherapy 20090101
Title: Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases.
Journal: Drug design, development and therapy 20090101
Title: Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases?
Journal: Acta oncologica (Stockholm, Sweden) 20090101
Title: Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid.
Journal: Patient preference and adherence 20090101
Title: High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment.
Journal: International journal of medical sciences 20090101
Title: Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.
Journal: Clinical interventions in aging 20090101
Title: A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.
Journal: Arthritis research & therapy 20090101
Title: Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.
Journal: Breast cancer research : BCR 20090101
Title: Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6.
Journal: Breast cancer research : BCR 20090101
Title: Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?
Journal: Breast cancer research : BCR 20090101
Title: Bevacizumab-related osteneocrosis of the jaw.
Journal: International journal of immunopathology and pharmacology 20090101
Title: [Pathophysiological and therapeutic aspects of bone lesions in patients with multiple myelomas].
Journal: Klinicheskaia meditsina 20090101
Title: Osteoporosis: 'A risk factor for periodontitis'.
Journal: Journal of Indian Society of Periodontology 20090101
Title: The evolving role of zoledronic acid in early breast cancer.
Journal: OncoTargets and therapy 20090101
Title: Acute uveitis following zoledronic acid infusion.
Journal: Oman journal of ophthalmology 20090101
Title: A Challenging Picture of Cancer-and Inflammation-Related Changes.
Journal: Clinical medicine. Oncology 20090101
Title: Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect.
Journal: Core evidence 20090101
Title: Lasofoxifene: Evidence of its therapeutic value in osteoporosis.
Journal: Core evidence 20090101
Title: Recent advances in managing osteoporosis.
Journal: F1000 medicine reports 20090101
Title: Once-monthly risedronate for postmenopausal osteoporosis.
Journal: International journal of women's health 20090101
Title: Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review.
Journal: International journal of women's health 20090101
Title: Update on the management of prostate cancer with goserelin acetate: patient perspectives.
Journal: Cancer management and research 20090101
Title: Thrombotic thrombocytopenic purpura following zoledronic acid infusion with a fatal outcome.
Journal: BMJ case reports 20090101
Title: Avascular osteonecrosis of the mandible following bisphosphonate therapy.
Journal: American journal of therapeutics 20090101
Title: Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis.
Journal: Chemistry & biology 20081222
Title: Annual zoledronic acid did not increase renal abnormalities at 2 years in postmenopausal women with osteoporosis.
Journal: ACP journal club 20081216
Title: Clinical characterization might help in preventing osteonecrosis of the jaw.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081215
Title: Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Journal: European journal of pharmacology 20081214
Title: Bisphosphonate nephrotoxicity.
Journal: Kidney international 20081201
Title: Bisphosphonates in children with hypercalciuria and reduced bone mineral density.
Journal: Pediatric nephrology (Berlin, Germany) 20081201
Title: Clinical and radiologic response in patients with bone metastases managed with combined radiotherapy and bisphosphonates.
Journal: Journal of surgical oncology 20081201
Title: Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20081201
Title: Parathyroid carcinoma.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201
Title: Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Journal: The Lancet. Oncology 20081201
Title: Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer.
Journal: The Journal of rheumatology 20081201
Title: Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate: the importance of bioresorption to osteoconduction.
Journal: The Journal of bone and joint surgery. British volume 20081201
Title: Annual zoledronic acid for osteoporosis.
Journal: Drug and therapeutics bulletin 20081201
Title: A classical presentation of Paget disease of bone.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081201
Title: [Treatment for the electrolytic disorders in cancer patients].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20081201
Title: Fifth International Workshop on the CCN Family of Genes: Abstracts and Posters October 18-22, 2008.
Journal: Journal of cell communication and signaling 20081201
Title: Report on the fifth international workshop on the CCN family of genes.
Journal: Journal of cell communication and signaling 20081201
Title: Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.
Journal: Clinical interventions in aging 20081201
Title: Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment.
Journal: Clinical interventions in aging 20081201
Title: Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.
Journal: Clinical interventions in aging 20081201
Title: Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients.
Journal: Therapeutics and clinical risk management 20081201
Title: Denosumab: an investigational drug for the management of postmenopausal osteoporosis.
Journal: Biologics : targets & therapy 20081201
Title: Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism.
Journal: Journal of medicinal chemistry 20081113
Title: Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.
Journal: Journal of pharmaceutical and biomedical analysis 20081104
Title: Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
Journal: Oral oncology 20081101
Title: Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
Journal: Annals of hematology 20081101
Title: Bisphosphonate-laden acrylic bone cement: mechanical properties, elution performance, and in vivo activity.
Journal: Journal of biomedical materials research. Part B, Applied biomaterials 20081101
Title: Mechanisms of the action of zoledronic acid on human MG-63 osteosarcoma cells.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20081101
Title: Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.
Journal: Cancer treatment reviews 20081101
Title: Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Journal: European urology 20081101
Title: Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20081101
Title: Radiology quiz case. Osteonecrosis of the jaw: aminobisphosphonate epidemic.
Journal: Archives of otolaryngology--head & neck surgery 20081101
Title: [Bisphosphonates for osseus invasion caused by bronchial carcinoma].
Journal: Deutsche medizinische Wochenschrift (1946) 20081101
Title: Bisphosphonates: a once-yearly treatment option with Reclast.
Journal: South Dakota medicine : the journal of the South Dakota State Medical Association 20081101
Title: Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081010
Title: Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages.
Journal: Cancer immunology, immunotherapy : CII 20081001
Title: Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20081001
Title: Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001
Title: Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
Journal: Bone 20081001
Title: Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
Journal: European journal of clinical pharmacology 20081001
Title: Biodistribution and plasma protein binding of zoledronic acid.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20081001
Title: A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma.
Journal: Cancer 20081001
Title: Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
Journal: Haematologica 20081001
Title: STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20081001
Title: Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance.
Journal: Journal of internal medicine 20081001
Title: Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081001
Title: Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite.
Journal: The Journal of bone and joint surgery. American volume 20081001
Title: [Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
Journal: Clinical calcium 20081001
Title: Local application of zoledronic acid incorporated in a poly(D,L-lactide)-coated implant accelerates fracture healing in rats.
Journal: Acta orthopaedica 20081001
Title: [Multidisciplinary strategy for lung cancer patients with bone metastasis].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20081001
Title: A tale of three diseases of the bone.
Journal: Singapore medical journal 20081001
Title: Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20081001
Title: Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
Journal: Journal of palliative medicine 20081001
Title: Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective.
Journal: Best practice & research. Clinical endocrinology & metabolism 20081001
Title: Pathogenesis and management of osteoporosis in thalassemia.
Journal: Pediatric endocrinology reviews : PER 20081001
Title: Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.
Journal: Journal of medicinal chemistry 20080925
Title: Zoledronic acid infusion and orbital inflammatory disease.
Journal: The New England journal of medicine 20080925
Title: Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases: analysis of a national medical claims database.
Journal: Cancer 20080915
Title: Speeding up the evaluation of new agents in cancer.
Journal: Journal of the National Cancer Institute 20080903
Title: Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Journal: Oral oncology 20080901
Title: Manipulating the anabolic and catabolic response in bone graft remodeling: synergism by a combination of local BMP-7 and a single systemic dosis of zoledronate.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20080901
Title: Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women.
Journal: Kidney international 20080901
Title: Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080901
Title: Pattern of intravenous bisphosphonate use in outpatient care in Germany.
Journal: Pharmacoepidemiology and drug safety 20080901
Title: Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Journal: Oncology reports 20080901
Title: Once-yearly intravenous zoledronate does not impair renal function in postmenopausal women.
Journal: Kidney international 20080901
Title: Short-term effects of high-dose zoledronic acid treatment on bone mineralization density distribution after orthotopic liver transplantation.
Journal: Calcified tissue international 20080901
Title: Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats.
Journal: Calcified tissue international 20080901
Title: Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Journal: The Lancet. Oncology 20080901
Title: Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.
Journal: Current osteoporosis reports 20080901
Title: Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid.
Journal: HSS journal : the musculoskeletal journal of Hospital for Special Surgery 20080901
Title: The effect of zoledronic acid on the intrinsic material properties of healing bone: an indentation study.
Journal: Medical engineering & physics 20080901
Title: [Update on treatment of postmenopausal osteoporosis].
Journal: Revue medicale de Bruxelles 20080901
Title: Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.
Journal: Clinical interventions in aging 20080901
Title: Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature.
Journal: Clinical interventions in aging 20080901
Title: Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.
Journal: Journal of the National Cancer Institute 20080820
Title: Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20080801
Title: Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid.
Journal: Internal medicine journal 20080801
Title: Impact of skeletal complications on patients' quality of life, mobility, and functional independence.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080801
Title: Exploring the anti-tumour activity of bisphosphonates in early breast cancer.
Journal: Cancer treatment reviews 20080801
Title: Practical guidance for the management of aromatase inhibitor-associated bone loss.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080801
Title: Management of patients with Paget's disease: a consensus document of the Belgian Bone Club.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080801
Title: [Zoledronic acid for preventing fractures].
Journal: Der Internist 20080801
Title: Maximizing effectiveness of bisphosphonate therapy for osteoporosis.
Journal: Southern medical journal 20080801
Title: Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080801
Title: Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity: a novel molecular mechanism.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080801
Title: [Daily practice using the guidelines for prevention and treatment of osteoporosis. Evolution of bisphosphonate therapy. Intravenous injection].
Journal: Clinical calcium 20080801
Title: Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Journal: The oncologist 20080801
Title: Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Journal: Today's FDA : official monthly journal of the Florida Dental Association 20080801
Title: Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
Journal: Current oncology (Toronto, Ont.) 20080801
Title: The use of calcium and vitamin D in the management of osteoporosis.
Journal: Therapeutics and clinical risk management 20080801
Title: Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
Journal: Prescrire international 20080801
Title: Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study.
Journal: European cells & materials 20080731
Title: New treatment strategies provide more options for patients with breast cancer.
Journal: JAMA 20080723
Title: Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080715
Title: Zoledronic acid is effective against experimental malignant pleural effusion.
Journal: American journal of respiratory and critical care medicine 20080701
Title: Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid.
Journal: Cancer 20080701
Title: Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.
Journal: The Prostate 20080701
Title: Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders.
Journal: European journal of pediatrics 20080701
Title: The effects of bisphosphonates on osteoblasts in vitro.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080701
Title: Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Journal: The Annals of pharmacotherapy 20080701
Title: High-content assay to study protein prenylation.
Journal: Journal of biomolecular screening 20080701
Title: Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer: doubts no more.
Journal: Expert opinion on biological therapy 20080701
Title: Malignant pleural effusions: fixing the leaky faucet.
Journal: American journal of respiratory and critical care medicine 20080701
Title: Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080701
Title: Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging.
Journal: Nature medicine 20080701
Title: Rejuvenating premature aging.
Journal: Nature medicine 20080701
Title: [A case of hormone/docetaxel-refractory prostate cancer in which PSA level decreased after docetaxel+zoledronic acid treatment].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20080701
Title: [Zoledronic acid for bone metastases due to advanced renal cell carcinoma under chronic hemodialysis--a report of two cases].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20080701
Title: [Clinical analysis of therapeutic effect of zoledronic acid combined with radiotherapy for metastatic bone cancer].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080701
Title: Antitumour and antiangiogenic effects of Aplidin in the 5TMM syngeneic models of multiple myeloma.
Journal: British journal of cancer 20080617
Title: Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.
Journal: Journal of biomedical materials research. Part A 20080615
Title: Bisphosphonate derivatives of nucleoside antimetabolites: hydrolytic stability and hydroxyapatite adsorption of 5'-beta,gamma-methylene and 5'-beta,gamma-(1-hydroxyethylidene) triphosphates of 5-fluorouridine and ara-cytidine.
Journal: The Journal of organic chemistry 20080606
Title: Risks and benefits of bisphosphonates.
Journal: British journal of cancer 20080603
Title: Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.
Journal: British journal of cancer 20080603
Title: Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080601
Title: Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
Journal: Clinical endocrinology 20080601
Title: The use of bisphosphonate in the treatment of avascular necrosis: a systematic review.
Journal: Clinical rheumatology 20080601
Title: V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab.
Journal: International journal of cancer 20080601
Title: Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20080601
Title: Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype.
Journal: Cancer chemotherapy and pharmacology 20080601
Title: Treatment of Paget's disease of bone: a survey of clinical practice in Australia.
Journal: Bone 20080601
Title: RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.
Journal: The Prostate 20080601
Title: Osteogenesis Imperfecta: update on presentation and management.
Journal: Reviews in endocrine & metabolic disorders 20080601
Title: The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.
Journal: Apoptosis : an international journal on programmed cell death 20080601
Title: Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, Italy.
Journal: Expert opinion on biological therapy 20080601
Title: Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080601
Title: Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Journal: International journal of urology : official journal of the Japanese Urological Association 20080601
Title: Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells.
Journal: Journal of cellular and molecular medicine 20080601
Title: [Muscle and bone health as a risk factor of fall among the elderly. Prevention of fracture and bisphosphonate].
Journal: Clinical calcium 20080601
Title: Pulmonary strongyloidiasis mimicking cancer symptoms: a case of hyperinfection in a patient with metastatic lung cancer.
Journal: American journal of clinical oncology 20080601
Title: Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080601
Title: [Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate].
Journal: Vnitrni lekarstvi 20080601
Title: Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.
Journal: Clinical interventions in aging 20080601
Title: Clinical challenges in the management of osteoporosis.
Journal: Clinical interventions in aging 20080601
Title: Caspase-2 is required for cell death induced by cytoskeletal disruption.
Journal: Oncogene 20080529
Title: Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20080501
Title: Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.
Journal: Rheumatology (Oxford, England) 20080501
Title: Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Journal: Bone 20080501
Title: Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080501
Title: Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies.
Journal: Bioorganic & medicinal chemistry letters 20080501
Title: A once-yearly IV bisphosphonate for osteoporosis.
Journal: Obstetrics and gynecology 20080501
Title: Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update.
Journal: Medicina oral, patologia oral y cirugia bucal 20080501
Title: Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080501
Title: Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080501
Title: Single annual injectable treatment for postmenopausal osteoporosis.
Journal: Expert opinion on drug delivery 20080501
Title: Use of intravenous bisphosphonates in older women with breast cancer.
Journal: The oncologist 20080501
Title: Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
Journal: The oncologist 20080501
Title: [Effectiveness and tolerability of zoledronic acid in the treatment of metastatic prostate cancer].
Journal: Actas urologicas espanolas 20080501
Title: Hypertrophic osteoarthropathy effectively treated with zoledronic acid.
Journal: Clinical lung cancer 20080501
Title: Use of alendronate and risk of incident atrial fibrillation in women.
Journal: Archives of internal medicine 20080428
Title: Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080415
Title: Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
Journal: Journal of medicinal chemistry 20080410
Title: Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Journal: Cancer immunology, immunotherapy : CII 20080401
Title: New research findings on zoledronic acid: survival, pain, and anti-tumour effects.
Journal: Cancer treatment reviews 20080401
Title: Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080401
Title: Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
Journal: European journal of nuclear medicine and molecular imaging 20080401
Title: Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.
Journal: Bone 20080401
Title: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080401
Title: How effective is bisphosphonate treatment for preventing bone fractures after liver transplantation?
Journal: Nature clinical practice. Gastroenterology & hepatology 20080401
Title: [Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)].
Journal: Der Internist 20080401
Title: No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20080401
Title: Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.
Journal: Oral diseases 20080401
Title: Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080401
Title: Zoledronic acid for cancer therapy--induced and postmenopausal bone loss.
Journal: Expert opinion on pharmacotherapy 20080401
Title: [Bony lesion with prostate cancer].
Journal: Clinical calcium 20080401
Title: Osteonecrosis of the jaw.
Journal: Journal of the American Dental Association (1939) 20080401
Title: Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080401
Title: The effects of zoledronic acid on serum lipids in multiple myeloma patients.
Journal: Calcified tissue international 20080401
Title: Bisphosphonates and osteonecrosis of the jaw: a case report.
Journal: Clinics (Sao Paulo, Brazil) 20080401
Title: Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
Journal: Anti-cancer drugs 20080401
Title: The use of zoledronic acid for osteoporosis.
Journal: Current rheumatology reports 20080401
Title: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.
Journal: Clinical lymphoma & myeloma 20080401
Title: Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.
Journal: Therapeutics and clinical risk management 20080401
Title: Case records of the Massachusetts General Hospital. Case 9-2008. A 65-year-old woman with a nonhealing ulcer of the jaw.
Journal: The New England journal of medicine 20080320
Title: Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
Journal: The Medical journal of Australia 20080317
Title: [Osteoporosis--new therapeutic possibilities. The Danish Bone Society].
Journal: Ugeskrift for laeger 20080317
Title: Multicentric reticulohistiocytosis: a systemic osteoclastic disease?
Journal: Arthritis and rheumatism 20080315
Title: Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080301
Title: Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes.
Journal: The Journal of pharmacology and experimental therapeutics 20080301
Title: Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation.
Journal: Journal of leukocyte biology 20080301
Title: Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
Journal: Journal of surgical oncology 20080301
Title: Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse.
Journal: Journal of applied physiology (Bethesda, Md. : 1985) 20080301
Title: Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
Journal: Cancer 20080301
Title: A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Journal: Current medical research and opinion 20080301
Title: 'Bis-phossy jaws' - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20080301
Title: [Jaw fistulas in 75 years-old woman].
Journal: Revista clinica espanola 20080301
Title: Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080301
Title: Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography.
Journal: Calcified tissue international 20080301
Title: The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer.
Journal: Current opinion in oncology 20080301
Title: New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture.
Journal: Expert opinion on pharmacotherapy 20080301
Title: Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080301
Title: Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.
Journal: Cancer cell 20080301
Title: Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study.
Journal: The oncologist 20080301
Title: [Osteonecrosis of the jaw developing during bisphosphonate treatment].
Journal: Magyar onkologia 20080301
Title: Intravenous zoledronic acid for the treatment of osteoporosis.
Journal: Current osteoporosis reports 20080301
Title: Raloxifene for older women: a review of the literature.
Journal: Clinical interventions in aging 20080301
Title: Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management.
Journal: Quintessence international (Berlin, Germany : 1985) 20080301
Title: [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080301
Title: Zoledronate, fractures, and mortality after hip fracture.
Journal: The New England journal of medicine 20080227
Title: Zoledronate, fractures, and mortality after hip fracture.
Journal: The New England journal of medicine 20080227
Title: Zoledronate, fractures, and mortality after hip fracture.
Journal: The New England journal of medicine 20080227
Title: Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acid.
Journal: International journal of cancer 20080215
Title: Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.
Journal: Annals of internal medicine 20080205
Title: The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells.
Journal: European journal of pharmacology 20080202
Title: Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080201
Title: Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20080201
Title: Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).
Journal: Investigational new drugs 20080201
Title: Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Journal: Lung cancer (Amsterdam, Netherlands) 20080201
Title: Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
Journal: Photomedicine and laser surgery 20080201
Title: [Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study].
Journal: Deutsche medizinische Wochenschrift (1946) 20080201
Title: Reply to the article 'oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases' by J.-J. Body et al. (Ann Oncol 2007; 18: 1165-1171).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080201
Title: Acute adrenal crisis and hypercalcemia in a patient assuming high liquorice doses.
Journal: Minerva medica 20080201
Title: Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Journal: The oncologist 20080201
Title: Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future.
Journal: International journal of clinical oncology 20080201
Title: Bisphosphonates in the treatment of thalassemia-associated osteoporosis.
Journal: Journal of endocrinological investigation 20080201
Title: Osteonecrosis of the jaw.
Journal: Oncology (Williston Park, N.Y.) 20080201
Title: Zoledronic acid in the management of metastatic bone disease.
Journal: Therapeutics and clinical risk management 20080201
Title: [Prescription of bisphosphonates in prostate cancer].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080201
Title: NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.
Journal: Journal of the American Chemical Society 20080130
Title: [Trends in osteoporosis].
Journal: Revue medicale suisse 20080116
Title: Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110
Title: Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20080101
Title: Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080101
Title: The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.
Journal: Acta oncologica (Stockholm, Sweden) 20080101
Title: Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Journal: Bioorganic & medicinal chemistry 20080101
Title: Is yearly intravenous zoledronic acid comparable to weekly oral alendronate for postmenopausal osteoporosis?
Journal: Nature clinical practice. Endocrinology & metabolism 20080101
Title: Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy.
Journal: Joint, bone, spine : revue du rhumatisme 20080101
Title: Positive effects of intravenous zoledronic acid on bone remodeling and structure: are different effects on osteoblast activity to other oral bisphosphonates responsible?
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080101
Title: Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS 20080101
Title: Zoledronate-related osteonecrosis of the mandible.
Journal: Clinical nuclear medicine 20080101
Title: Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Journal: Journal of the American Dental Association (1939) 20080101
Title: Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Journal: Medicina oral, patologia oral y cirugia bucal 20080101
Title: Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males.
Journal: Arthritis research & therapy 20080101
Title: Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells.
Journal: Breast cancer research : BCR 20080101
Title: Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
Journal: Archives of ophthalmology (Chicago, Ill. : 1960) 20080101
Title: Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases.
Journal: Medical oncology (Northwood, London, England) 20080101
Title: PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.
Journal: Environmental health perspectives 20080101
Title: Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases.
Journal: Medical oncology (Northwood, London, England) 20080101
Title: Cancer treatment-related bone loss: a review and synthesis of the literature.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: Going beyond efficacy: strategies for cancer pain management.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: A primer of bone metastases management in breast cancer patients.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Journal: PLoS medicine 20080101
Title: Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
Journal: Acta haematologica 20080101
Title: Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
Journal: PharmacoEconomics 20080101
Title: Medical treatment of malignancy-associated hypercalcemia.
Journal: Current medicinal chemistry 20080101
Title: In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats.
Journal: Journal of veterinary internal medicine 20080101
Title: Intravenous zoledronic acid reduced new clinical fractures and deaths in patients who had recent surgery for hip fracture.
Journal: ACP journal club 20080101
Title: Zoledronic acid : a review of its use in the management of bone metastases of malignancy.
Journal: Drugs 20080101
Title: The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis.
Journal: Journal of veterinary internal medicine 20080101
Title: Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.
Journal: BMC cancer 20080101
Title: Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study.
Journal: BMC clinical pharmacology 20080101
Title: Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience.
Journal: Anticancer research 20080101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080101
Title: [Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies].
Journal: Recenti progressi in medicina 20080101
Title: Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies.
Journal: Cancer treatment reviews 20080101
Title: Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
Journal: Cancer treatment reviews 20080101
Title: Anti-tumor cytotoxicity of gammadelta T cells expanded from peripheral blood cells of patients with myeloma and lymphoma.
Journal: Medical oncology (Northwood, London, England) 20080101
Title: A case report: zoledronic acid-induced anterior uveitis.
Journal: Medical oncology (Northwood, London, England) 20080101
Title: Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model.
Journal: Anticancer research 20080101
Title: Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available.
Journal: BMC health services research 20080101
Title: Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients.
Journal: The Journal of international medical research 20080101
Title: Effect of pathologic fractures on survival in multiple myeloma patients: a case control study.
Journal: Journal of experimental & clinical cancer research : CR 20080101
Title: Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
Journal: Urologia internationalis 20080101
Title: Osteoclast targeted therapy for prostate cancer: bisphosphonates and beyond.
Journal: Urologic oncology 20080101
Title: A once-a-year intravenous treatment of osteoporosis in postmenopausal women: implications for the clinical nurse specialist.
Journal: Clinical nurse specialist CNS 20080101
Title: Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.
Journal: International braz j urol : official journal of the Brazilian Society of Urology 20080101
Title: Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents.
Journal: PloS one 20080101
Title: Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
Journal: Journal of postgraduate medicine 20080101
Title: The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
Journal: Anticancer research 20080101
Title: [Non-hormonal treatments of postmenopausal osteoporosis].
Journal: Gynecologie, obstetrique & fertilite 20080101
Title: Bone metastasis in hepatocellular carcinoma: need for reappraisal of treatment.
Journal: Journal of cancer research and therapeutics 20080101
Title: Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
Journal: Journal of translational medicine 20080101
Title: Therapy with zoledronic acid, 5 mg, for a patient with Paget disease of bone.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080101
Title: A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosis.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20080101
Title: Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Journal: Journal of experimental & clinical cancer research : CR 20080101
Title: Novel therapies in breast cancer: what is new from ASCO 2008.
Journal: Journal of hematology & oncology 20080101
Title: Characterization of a rat osteotomy model with impaired healing.
Journal: BMC musculoskeletal disorders 20080101
Title: Are new-generation bisphosphonates effective for the inhibition of calcium oxalate stone formation in a rat model?
Journal: Urologia internationalis 20080101
Title: Zoledronic acid: a review of its use in the treatment of osteoporosis.
Journal: Drugs & aging 20080101
Title: Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.
Journal: Journal of bone and mineral metabolism 20080101
Title: Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population.
Journal: Journal of managed care pharmacy : JMCP 20080101
Title: Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
Journal: Cytotherapy 20080101
Title: Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance.
Journal: Breast cancer research : BCR 20080101
Title: Zoledronic acid: a review of its use in breast cancer.
Journal: Drugs 20080101
Title: Synthesis of imidazol-1-yl-acetic acid hydrochloride: a key intermediate for zoledronic acid.
Journal: Beilstein journal of organic chemistry 20080101
Title: Randomized clinical stroke trials in 2007.
Journal: The open neurology journal 20080101
Title: Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse.
Journal: The open orthopaedics journal 20080101
Title: Analgesic efficacy of zoledronic acid and its effect on functional status of prostate cancer patients with metastasis.
Journal: Patient preference and adherence 20080101
Title: A multidisciplinary bone metastases clinic at Toronto Sunnybrook Regional Cancer Centre - A review of the experience from 1999 to 2005.
Journal: Journal of pain research 20080101
Title: Quality of life measurement in bone metastases: A literature review.
Journal: Journal of pain research 20080101
Title: Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.
Journal: Biomedical imaging and intervention journal 20080101
Title: Documentation of complete response in metastatic breast cancer to liver and bone achieved with trastuzumab and pegylated liposomal Doxorubicin.
Journal: Clinical medicine. Oncology 20080101
Title: A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer.
Journal: Yonsei medical journal 20071231
Title: Bisphosphonates incorporated in a poly(D,L-lactide) implant coating inhibit osteoclast like cells in vitro.
Journal: Journal of biomedical materials research. Part A 20071215
Title: A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
Journal: Cancer research 20071215
Title: The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
Journal: International journal of clinical practice 20071201
Title: A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid.
Journal: Skeletal radiology 20071201
Title: [Osteoporosis and bisphosphonates].
Journal: Zeitschrift fur Rheumatologie 20071201
Title: On the horizon: can bisphosphonates prevent bone metastases?
Journal: Breast (Edinburgh, Scotland) 20071201
Title: Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid.
Journal: Journal of clinical pharmacy and therapeutics 20071201
Title: Reducing the risk of bone loss associated with breast cancer treatment.
Journal: Breast (Edinburgh, Scotland) 20071201
Title: Death of a clinical trial: a speculative inclusion criterion gone wrong.
Journal: Internal medicine journal 20071201
Title: Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
Journal: Breast (Edinburgh, Scotland) 20071201
Title: Reclast approved for osteoporosis treatment in postmenopausal women.
Journal: The Nurse practitioner 20071201
Title: Annual zoledronic acid infusion lowers risk of fracture, death.
Journal: The Journal of family practice 20071201
Title: Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.
Journal: Cancer research 20071201
Title: [Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis].
Journal: Clinical calcium 20071201
Title: Emerging strategies in bone health management for the adjuvant patient.
Journal: Seminars in oncology 20071201
Title: Clinical benefits and considerations of bisphosphonate treatment in metastatic bone disease.
Journal: Seminars in oncology 20071201
Title: Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer.
Journal: Seminars in oncology 20071201
Title: Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma.
Journal: Molecular cancer therapeutics 20071201
Title: Zoledronic acid inhibits osteosarcoma growth in an orthotopic model.
Journal: Molecular cancer therapeutics 20071201
Title: Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration.
Journal: Journal of palliative medicine 20071201
Title: Zoledronic acid for Paget's disease of bone.
Journal: Drugs of today (Barcelona, Spain : 1998) 20071201
Title: Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture.
Journal: The American journal of geriatric pharmacotherapy 20071201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071201
Title: [Androgen-independent prostate cancer with bone metastasis successfully treated by intravenous administration of zoledronic acid and diethylstilbestrol diphosphate].
Journal: Hinyokika kiyo. Acta urologica Japonica 20071201
Title: Consultation corner. Bone loss drug gives users a break.
Journal: The Johns Hopkins medical letter health after 50 20071201
Title: Osteoporosis in the aging male: treatment options.
Journal: Clinical interventions in aging 20071201
Title: Paget disease of the spine manifested by thoracic and lumbar epidural lipomatosis: magnetic resonance imaging findings.
Journal: Spine 20071201
Title: Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors.
Journal: Clinical breast cancer 20071201
Title: New annual osteoporosis drug reduces risk of death, future fractures. Infused dose is more convenient for patients, enhances overall quality of life.
Journal: DukeMedicine healthnews 20071201
Title: Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.
Journal: Head and neck pathology 20071201
Title: Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report.
Journal: Head and neck pathology 20071201
Title: [Clinical study of bisphosphonates for bone metastasis in breast cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128
Title: [New bone density conservation agents for osteoporosis under research and development: Zoledronate].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128
Title: [Therapeutic guidelines in prostate cancer and role for bisphosphonates in bone metastasis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128
Title: Zoledronic acid and angiogenesis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20071115
Title: Non-inferiority trial design for recurrent events.
Journal: Statistics in medicine 20071110
Title: Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study.
Journal: British journal of cancer 20071105
Title: A once-yearly IV bisphosphonate for osteoporosis.
Journal: The Medical letter on drugs and therapeutics 20071105
Title: Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic Acid for detection of bone metastases progression.
Journal: European urology 20071101
Title: Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071101
Title: Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071101
Title: The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength.
Journal: Bone 20071101
Title: Zoledronic acid and secondary prevention of fractures.
Journal: The New England journal of medicine 20071101
Title: Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
Journal: European journal of haematology 20071101
Title: Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071101
Title: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
Journal: Expert opinion on pharmacotherapy 20071101
Title: Zoledronic acid for treatment of Paget's disease of bone.
Journal: Expert opinion on pharmacotherapy 20071101
Title: Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates.
Journal: Journal of dental research 20071101
Title: Intravenous bisphosphonate-associated osteonecrosis of the jaw.
Journal: Journal of periodontology 20071101
Title: Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro.
Journal: Molecular cancer therapeutics 20071101
Title: Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Journal: Annals of the New York Academy of Sciences 20071101
Title: Injectable bisphosphonates for the treatment of osteoporosis.
Journal: Women's health (London, England) 20071101
Title: Pathologic fractures correlate with reduced survival in patients with malignant bone disease.
Journal: Cancer 20071015
Title: A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
Journal: Cancer research 20071015
Title: [Advances in the field of osteoporosis].
Journal: La Revue du praticien 20071015
Title: Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20071001
Title: Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
Journal: European urology 20071001
Title: New treatment strategies in the management of hormone refractory prostate cancer (HRPC): only chemotherapy?
Journal: European urology 20071001
Title: Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20071001
Title: Re: 'A single zoleledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density' by Saag et al.
Journal: Bone 20071001
Title: Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001
Title: Pharmacokinetics and pharmacodynamics of a single dose of zoledronate in healthy dogs.
Journal: Journal of veterinary pharmacology and therapeutics 20071001
Title: Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
Journal: International journal of laboratory hematology 20071001
Title: Osteoporosis: non-hormonal treatment.
Journal: Climacteric : the journal of the International Menopause Society 20071001
Title: Angiogenesis inhibitors and the need for anti-angiogenic therapeutics.
Journal: Journal of dental research 20071001
Title: The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
Journal: Cancer research 20071001
Title: A once yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis.
Journal: Evidence-based medicine 20071001
Title: Letrozole in the extended adjuvant setting: MA.17.
Journal: Breast cancer research and treatment 20071001
Title: Safety of aromatase inhibitors in the adjuvant setting.
Journal: Breast cancer research and treatment 20071001
Title: Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.
Journal: Archives of ophthalmology (Chicago, Ill. : 1960) 20071001
Title: Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions.
Journal: La Radiologia medica 20071001
Title: Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells.
Journal: Cellular immunology 20071001
Title: Satraplatin in the treatment of hormone-refractory metastatic prostate cancer.
Journal: Therapeutics and clinical risk management 20071001
Title: Use of zoledronic acid in the treatment of Paget's disease.
Journal: Therapeutics and clinical risk management 20071001
Title: Preservation of bone health in prostate cancer.
Journal: Current opinion in supportive and palliative care 20071001
Title: Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070915
Title: Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
Journal: European journal of pharmacology 20070910
Title: Zoledronic acid-induced IPP/ApppI production in vivo.
Journal: Life sciences 20070908
Title: Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: preliminary results of an in vitro study.
Journal: Cell biology international 20070901
Title: Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070901
Title: Acute phase response and mineral status following low dose intravenous zoledronic acid in children.
Journal: Bone 20070901
Title: Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
Journal: Calcified tissue international 20070901
Title: Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates.
Journal: Chemical research in toxicology 20070901
Title: Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature.
Journal: European journal of internal medicine 20070901
Title: Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
Journal: Japanese journal of clinical oncology 20070901
Title: Spontaneous bilateral subcapital hip fracture due to multiple myeloma: an 18-month follow-up.
Journal: European journal of cancer care 20070901
Title: Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
Journal: Medicina oral, patologia oral y cirugia bucal 20070901
Title: Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.
Journal: The oncologist 20070901
Title: Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases.
Journal: Clinical genitourinary cancer 20070901
Title: Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastases.
Journal: Clinical genitourinary cancer 20070901
Title: The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
Journal: Journal of experimental & clinical cancer research : CR 20070901
Title: Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 year.
Journal: Supportive cancer therapy 20070901
Title: Yearly zoledronic acid in postmenopausal osteoporosis.
Journal: The New England journal of medicine 20070816
Title: Yearly zoledronic acid in postmenopausal osteoporosis.
Journal: The New England journal of medicine 20070816
Title: Yearly zoledronic acid in postmenopausal osteoporosis.
Journal: The New England journal of medicine 20070816
Title: Yearly zoledronic acid in postmenopausal osteoporosis.
Journal: The New England journal of medicine 20070816
Title: Yearly zoledronic acid in postmenopausal osteoporosis.
Journal: The New England journal of medicine 20070816
Title: Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Journal: Cancer immunology, immunotherapy : CII 20070801
Title: Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
Journal: Blood 20070801
Title: Anabolic effects of bisphosphonates on peri-implant bone stock.
Journal: Biomaterials 20070801
Title: Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070801
Title: Bone density in breast cancer: when to intervene?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801
Title: Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.
Journal: International journal of oncology 20070801
Title: Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070801
Title: Patient quality of life safeguarding: the primary aim in nonmetastatic prostate cancer patients.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801
Title: Osteonecrosis of the jaws and bisphosphonates. Report of fifteen cases. Therapeutic recommendations.
Journal: Medicina oral, patologia oral y cirugia bucal 20070801
Title: Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070801
Title: Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.
Journal: Cancer research 20070801
Title: Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer.
Journal: Urology 20070801
Title: A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Journal: Clinical therapeutics 20070801
Title: Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
Journal: British dental journal 20070728
Title: Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.
Journal: British journal of cancer 20070716
Title: Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.
Journal: Cancer 20070715
Title: Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis.
Journal: Journal of the National Cancer Institute 20070704
Title: Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070701
Title: A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma.
Journal: Leukemia 20070701
Title: Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070701
Title: Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
Journal: Bone 20070701
Title: Bisphosphonates and osteonecrosis of the jaw.
Journal: Rheumatology (Oxford, England) 20070701
Title: Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070701
Title: New and emerging treatments for osteoporosis.
Journal: Current opinion in rheumatology 20070701
Title: Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid.
Journal: BJU international 20070701
Title: An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting.
Journal: Current medical research and opinion 20070701
Title: Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070701
Title: Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20070701
Title: Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy.
Journal: Urology 20070701
Title: The osteoporosis revolution marches on.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20070701
Title: By the way, doctor. Should I take an intravenous drug for osteoporosis?
Journal: Harvard women's health watch 20070701
Title: Efficacy and safety of intravenous bisphosphonates in patients with bone metastases caused by metastatic breast cancer.
Journal: Clinical breast cancer 20070701
Title: Managing aromatase inhibitor-associated bone loss in breast cancer.
Journal: Women's health (London, England) 20070701
Title: [Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid].
Journal: Nederlands tijdschrift voor geneeskunde 20070630
Title: Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20070612
Title: American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070610
Title: Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
Journal: Cancer letters 20070608
Title: Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
Journal: British journal of cancer 20070604
Title: Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070601
Title: Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070601
Title: Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission.
Journal: British journal of haematology 20070601
Title: Bone turnover 18 months after a single intravenous dose of zoledronic acid.
Journal: International journal of clinical practice 20070601
Title: Bisphosphonate rescue in distraction osteogenesis: a case series.
Journal: Journal of pediatric orthopedics 20070601
Title: Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment.
Journal: The Journal of rheumatology 20070601
Title: Therapeutic role of bisphosphonate and radiation combination in the management of myeloma bone disease.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070601
Title: New developments of aminobisphosphonates: the double face of Janus.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070601
Title: [Mediastinal lymph nodes during the course of a metastatic prostate cancer].
Journal: Actas urologicas espanolas 20070601
Title: Androgen deprivation therapy for prostate cancer: new concepts and concerns.
Journal: Current opinion in endocrinology, diabetes, and obesity 20070601
Title: Biological targets for isatin and its analogues: Implications for therapy.
Journal: Biologics : targets & therapy 20070601
Title: Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.
Journal: British journal of cancer 20070521
Title: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
Journal: The New England journal of medicine 20070503
Title: Treatments for osteoporosis - looking beyond the HORIZON.
Journal: The New England journal of medicine 20070503
Title: Alendronate and atrial fibrillation.
Journal: The New England journal of medicine 20070503
Title: R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Journal: Journal of cellular physiology 20070501
Title: Docetaxel and beyond.
Journal: European urology 20070501
Title: A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
Journal: Bone 20070501
Title: A single infusion of zoledronate prevents bone loss after stroke.
Journal: Stroke 20070501
Title: Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
Journal: Calcified tissue international 20070501
Title: Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn.
Journal: European journal of haematology 20070501
Title: Bisphosphonate treatment as a cause of jaw osteonecrosis.
Journal: Oral diseases 20070501
Title: The safety of zoledronic acid.
Journal: Expert opinion on drug safety 20070501
Title: Zoledronic acid prevents bone loss.
Journal: The Lancet. Oncology 20070501
Title: [Zoledronate-associated end stage renal failure and hypocalcaemia].
Journal: Praxis 20070425
Title: Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Journal: International journal of cancer 20070415
Title: Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia.
Journal: Leukemia research 20070401
Title: Effect of zoledronic acid in an L6-L7 rabbit spine fusion model.
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20070401
Title: Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.
Journal: The Journal of clinical endocrinology and metabolism 20070401
Title: Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.
Journal: Bone 20070401
Title: Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells.
Journal: Leukemia 20070401
Title: Re: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer: C. W. Ryan, D. Huo, L. M. Demers, T. M. Beer and L. V. Lacerna. J Urol 2006; 176: 972-978.
Journal: The Journal of urology 20070401
Title: Managing metastatic bone pain: the role of bisphosphonates.
Journal: Journal of pain and symptom management 20070401
Title: Male breast cancer with mandibular metastasis. A case report.
Journal: Minerva stomatologica 20070401
Title: Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study.
Journal: International journal of urology : official journal of the Japanese Urological Association 20070401
Title: Zoledronic acid treatment at home: safety data from an observational prospective trial.
Journal: Journal of palliative medicine 20070401
Title: Potential effect of zoledronate therapy in heavy proteinuria.
Journal: Clinical nephrology 20070401
Title: Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assay.
Journal: Assay and drug development technologies 20070401
Title: Annual zoledronic acid: is less more?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320
Title: Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320
Title: The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro.
Journal: Journal of biomedical materials research. Part A 20070315
Title: The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.
Journal: Cancer 20070315
Title: Gamma delta T cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface.
Journal: Biochemical and biophysical research communications 20070309
Title: Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma.
Journal: Leukemia research 20070301
Title: Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070301
Title: Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro.
Journal: Biochemical pharmacology 20070301
Title: Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301
Title: Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301
Title: Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070301
Title: International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.
Journal: European journal of cancer (Oxford, England : 1990) 20070301
Title: Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070301
Title: Use of intravenous bisphosphonates in osteoporosis.
Journal: Current osteoporosis reports 20070301
Title: Bisphosphonates and jaw osteonecrosis: the UAMS experience.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20070301
Title: Bisphosphonates: mode of action and pharmacology.
Journal: Pediatrics 20070301
Title: Paraplegia due to extramedullary hematopoiesis in thalassemia treated successfully with radiation therapy.
Journal: Haematologica 20070301
Title: The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy.
Journal: Clinical genitourinary cancer 20070301
Title: Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma.
Journal: Clinical lymphoma & myeloma 20070301
Title: The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.
Journal: Clinical interventions in aging 20070301
Title: Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women.
Journal: Clinical interventions in aging 20070301
Title: Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
Journal: Biochemical and biophysical research communications 20070223
Title: Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
Journal: Journal of the National Cancer Institute 20070221
Title: Differential effects of bisphosphonates on breast cancer cell lines.
Journal: Cancer letters 20070208
Title: [Osteonecrosis of the jawbone as a side effect of intravenous treatment with bisphosphonates].
Journal: Nederlands tijdschrift voor geneeskunde 20070203
Title: Bisphosphonate-related jaw necrosis--severe complication in maxillofacial surgery.
Journal: Cancer treatment reviews 20070201
Title: Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070201
Title: Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events.
Journal: Pharmacotherapy 20070201
Title: Bisphosphonate-induced osteonecrosis of the jaw.
Journal: The Annals of pharmacotherapy 20070201
Title: Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer.
Journal: Urology 20070201
Title: New multidisciplinary prostate bone metastases clinic: first of its kind in Canada.
Journal: Current oncology (Toronto, Ont.) 20070201
Title: Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma.
Journal: British journal of cancer 20070129
Title: Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs.
Journal: Vaccine 20070122
Title: [Osteoporosis treatment].
Journal: Revue medicale suisse 20070117
Title: Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action.
Journal: Rheumatology international 20070101
Title: In silico prediction of pregnane X receptor activators by machine learning approaches.
Journal: Molecular pharmacology 20070101
Title: Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
Journal: Annals of hematology 20070101
Title: A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070101
Title: Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101
Title: Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status.
Journal: Molecular pharmacology 20070101
Title: Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
Journal: Journal of thrombosis and haemostasis : JTH 20070101
Title: Bone health in men receiving androgen deprivation therapy for prostate cancer.
Journal: The Journal of urology 20070101
Title: Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
Journal: Acta haematologica 20070101
Title: Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
Journal: International journal of urology : official journal of the Japanese Urological Association 20070101
Title: [Therapeutic agents for disorders of bone and calcium metabolism: Zoledronic acid].
Journal: Clinical calcium 20070101
Title: [Molecular mechanism and potential targets for bone metastasis].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20070101
Title: Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
Journal: BMC cancer 20070101
Title: [Efficacy of bisphosphonates for bone pain control].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20070101
Title: Therapeutic options in advanced prostate cancer: present and future.
Journal: Current urology reports 20070101
Title: Morphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment.
Journal: Annals of clinical and laboratory science 20070101
Title: Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization.
Journal: Journal of bone and mineral metabolism 20070101
Title: Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.
Journal: Leukemia & lymphoma 20070101
Title: [Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study].
Journal: Recenti progressi in medicina 20070101
Title: The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases.
Journal: Immunity & ageing : I & A 20070101
Title: [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
Journal: Therapie 20070101
Title: The effect of zoledronate on bone remodeling during the healing process.
Journal: Acta cirurgica brasileira 20070101
Title: Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.
Journal: Arthritis research & therapy 20070101
Title: Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
Journal: Drugs 20070101
Title: Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers.
Journal: The International journal of biological markers 20070101
Title: The boy who refused an IV: a case report of subcutaneous clodronate for bone pain in a child with Ewing Sarcoma.
Journal: Journal of medical case reports 20070101
Title: Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
Journal: The International journal of prosthodontics 20070101
Title: Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cells.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101
Title: Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells.
Journal: Endothelium : journal of endothelial cell research 20070101
Title: Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
Journal: American journal of otolaryngology 20070101
Title: Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date.
Journal: Drugs & aging 20070101
Title: Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis.
Journal: Acta oncologica (Stockholm, Sweden) 20070101
Title: The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden) 20070101
Title: External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer.
Journal: BMC cancer 20070101
Title: Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101
Title: Persistent effect of zoledronic acid in Paget's disease.
Journal: Clinical and experimental rheumatology 20070101
Title: Multiple myeloma/hypercalcemia.
Journal: Arthritis research & therapy 20070101
Title: Tumor metastasis to bone.
Journal: Arthritis research & therapy 20070101
Title: Clinical development of anti-RANKL therapy.
Journal: Arthritis research & therapy 20070101
Title: Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231(GFP) breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude rats.
Journal: Clinical & experimental metastasis 20070101
Title: Clinical value of bisphosphonates in cancer therapy.
Journal: Anticancer research 20070101
Title: Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan.
Journal: BMC musculoskeletal disorders 20070101
Title: Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
Journal: BMC cancer 20070101
Title: Zoledronic acid - a multiplicity of anti-cancer action.
Journal: Current medicinal chemistry 20070101
Title: A once-yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis.
Journal: ACP journal club 20070101
Title: Burden of bone disease.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070101
Title: Role of the nurse in preserving patients' independence.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070101
Title: Optimal management of metastatic bone disease.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070101
Title: The role of nurses in preserving patients' functional independence: Zoledronic acid--evidence and experience in metastatic bone disease.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070101
Title: Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma.
Journal: Medical oncology (Northwood, London, England) 20070101
Title: Zoledronic acid and clinical fractures and mortality after hip fracture.
Journal: The New England journal of medicine 20070101
Title: The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review.
Journal: BMC musculoskeletal disorders 20070101
Title: Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.
Journal: BMC pharmacology 20070101
Title: Complications & side effects. Zoledronic acid for thicker bones.
Journal: TreatmentUpdate 20070101
Title: Improvement of zoledronic-acid-induced jaw osteonecrosis with bortezomib.
Journal: Acta haematologica 20070101
Title: [Zoledronic acid free adjustment according to renal function: results of pharmacists interventions].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101
Title: In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells.
Journal: Anticancer research 20070101
Title: Adverse effects of bisphosphonates: current issues.
Journal: The journal of supportive oncology 20070101
Title: [Use of zoledromic acid on pain control in stages M1b of prostate cancer].
Journal: Actas urologicas espanolas 20070101
Title: Treatment of bone metastases and bone pain with bisphosphonates.
Journal: Supportive cancer therapy 20070101
Title: Update in palliative management of hormone refractory cancer of prostate.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: Use of bisphosphonates in prostate cancer: Current status.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: New therapeutic targets in the treatment of prostate cancer.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: Treatment of giant cell tumor of bone: Current concepts.
Journal: Indian journal of orthopaedics 20070101
Title: Osteonecrosis of the myeloma patients treated with bisphosphonates.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101
Title: Bisphosphonate-related osteonecrosis of the jaw: the Florence experience.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101
Title: Bisphosphonate - related osteonecrosis of the jaws: the point of view of the oral pathologist.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101
Title: Treatment of bisphosphonates-associated osteonecrosis.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101
Title: Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Journal: Journal of medicinal chemistry 20061214
Title: [Diagnostic work-up of bone metastases of genitourinary tumors and their treatment with bisphosphonates. Interdisciplinary consensus conference, Frankfurt, 2006].
Journal: Der Urologe. Ausg. A 20061201
Title: Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
Journal: British journal of haematology 20061201
Title: Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Journal: Blood 20061201
Title: Platelet-derived growth factor receptor-beta in Gorham's disease.
Journal: Nature clinical practice. Oncology 20061201
Title: The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma.
Journal: Haematologica 20061201
Title: Jaw osteonecrosis associated with bisphosphonates.
Journal: The New Zealand medical journal 20061201
Title: Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20061201
Title: Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061201
Title: Zoledronic acid in the management of metastatic bone disease.
Journal: Expert opinion on biological therapy 20061201
Title: Medical therapy in adults with fibrous dysplasia of bone.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201
Title: Zoledronate: efficacy and safety.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201
Title: Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201
Title: CALGB 90202.
Journal: Clinical advances in hematology & oncology : H&O 20061201
Title: Bisphosphonates.
Journal: Annals of the New York Academy of Sciences 20061201
Title: Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.
Journal: Clinical interventions in aging 20061201
Title: A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo.
Journal: British journal of cancer 20061120
Title: [Treatment of hormone-resistant prostate cancer].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061102
Title: Osteoclasts play a part in pain due to the inflammation adjacent to bone.
Journal: Bone 20061101
Title: 'The beneficial effects of zoledronic acid therapy following an acute stroke in rats' by Lee et al.
Journal: Bone 20061101
Title: Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease.
Journal: Onkologie 20061101
Title: Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines.
Journal: The Journal of urology 20061101
Title: Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Journal: The Lancet. Oncology 20061101
Title: Zoledronic acid palliation in bone-metastatic breast cancer.
Journal: The Lancet. Oncology 20061101
Title: I'm taking bisphosphonates for my osteoporosis, but I've heard it can cause a serious jaw condition. Is this something I should be concerned about?
Journal: DukeMedicine healthnews 20061101
Title: Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
Journal: Recent patents on anti-cancer drug discovery 20061101
Title: [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
Journal: Medicina clinica 20061028
Title: [Osteonecrosis of the jaw in patients with multiple myeloma during and after treatment with zoledronic acid].
Journal: Medicina clinica 20061021
Title: Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061020
Title: Breast cancer: bisphosphonate therapy for metastatic bone disease.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: Treatment for myeloma bone disease.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: Treatment-related osteoporosis in men with prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: Improving the outcome of patients with castration-resistant prostate cancer through rational drug development.
Journal: British journal of cancer 20061009
Title: A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
Journal: Bone 20061001
Title: Pharmacological management of SAPHO syndrome.
Journal: Expert opinion on investigational drugs 20061001
Title: Implications of androgen-deprivation therapy in patients with prostate cancer: A case study.
Journal: Clinical journal of oncology nursing 20061001
Title: [Treatment of Paget's disease of bone: importance of the zoledronic acid].
Journal: Arquivos brasileiros de endocrinologia e metabologia 20061001
Title: Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines.
Journal: Journal of medicinal chemistry 20060921
Title: Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival.
Journal: International journal of cancer 20060901
Title: Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial.
Journal: Annals of hematology 20060901
Title: Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.
Journal: British journal of haematology 20060901
Title: Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer.
Journal: The Journal of urology 20060901
Title: Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.
Journal: Internal medicine journal 20060901
Title: Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Journal: Human pathology 20060901
Title: Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
Journal: Anti-cancer drugs 20060901
Title: Zoledronic acid modulates function and differentiation of myeloid cells.
Journal: Haematologica 20060901
Title: Zoledronic acid for the treatment of thalassemia-induced osteonecrosis.
Journal: Haematologica 20060901
Title: The effect of zoledronic acid on the function and differentiation of myeloid cells.
Journal: Haematologica 20060901
Title: Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.
Journal: Haematologica 20060901
Title: Dental endosseous implants in patients on bisphosphonate therapy.
Journal: Implant dentistry 20060901
Title: Bone complications in multiple myeloma.
Journal: Cancer biology & therapy 20060901
Title: A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia.
Journal: Calcified tissue international 20060901
Title: Serious ocular complications of zoledronate.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20060901
Title: Scleritis complicating zoledronic acid infusion.
Journal: Clinical lymphoma & myeloma 20060901
Title: [Osteonecrosis associated with the use of biphosphonates: Case report].
Journal: Revista medica de Chile 20060901
Title: Management of age-related osteoporosis and prevention of associated fractures.
Journal: Therapeutics and clinical risk management 20060901
Title: A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer.
Journal: British journal of cancer 20060821
Title: The beneficial effect of intravenous zoledronic acid therapy following an acute stroke in rats.
Journal: Bone 20060801
Title: Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening of osteotropic modulators.
Journal: Microscopy research and technique 20060801
Title: Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.
Journal: Cancer 20060801
Title: Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.
Journal: Cancer 20060801
Title: Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20060801
Title: Developments in the pharmacotherapeutic management of osteoporosis.
Journal: Expert opinion on pharmacotherapy 20060801
Title: Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060801
Title: Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Journal: Mayo Clinic proceedings 20060801
Title: Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.
Journal: Mayo Clinic proceedings 20060801
Title: Efficacy of zoledronate against neuroblastoma.
Journal: Surgery 20060801
Title: Bisphosphonates: case report of nonsurgical periodontal therapy and osteochemonecrosis.
Journal: The International journal of periodontics & restorative dentistry 20060801
Title: Nursing implications of androgen deprivation therapy-associated bone loss.
Journal: Urologic nursing 20060801
Title: The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials.
Journal: The Canadian journal of urology 20060801
Title: Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
Journal: Wiener klinische Wochenschrift 20060801
Title: Aromatase inhibitors and bone loss.
Journal: Oncology (Williston Park, N.Y.) 20060801
Title: Paget's disease of bone.
Journal: Arquivos brasileiros de endocrinologia e metabologia 20060801
Title: Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Journal: Acta bio-medica : Atenei Parmensis 20060801
Title: Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
Journal: Bone 20060701
Title: Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060701
Title: Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Journal: International journal of oral and maxillofacial surgery 20060701
Title: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Journal: Haematologica 20060701
Title: Myeloma bone disease and treatment options.
Journal: European journal of cancer (Oxford, England : 1990) 20060701
Title: Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws.
Journal: Dento maxillo facial radiology 20060701
Title: In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction.
Journal: American journal of veterinary research 20060701
Title: Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060701
Title: Synergistic antimyeloma effects of zoledronate and simvastatin.
Journal: Anti-cancer drugs 20060701
Title: [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
Journal: MMW Fortschritte der Medizin 20060622
Title: Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060601
Title: Management of the adverse effects associated with intravenous bisphosphonates.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060601
Title: Anticancer effects of zoledronic acid against human osteosarcoma cells.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20060601
Title: Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers.
Journal: BJU international 20060601
Title: Acute retinal pigment epitheliitis associated with intravenous bisphosphonate.
Journal: The British journal of ophthalmology 20060601
Title: How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.
Journal: The Annals of pharmacotherapy 20060601
Title: Markers of bone metabolism and survival in men with hormone-refractory metastatic prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060601
Title: Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
Journal: The Lancet. Oncology 20060601
Title: Bisphosphonate-associated arthritis.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20060601
Title: Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates.
Journal: Nature clinical practice. Oncology 20060601
Title: Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.
Journal: International journal of hematology 20060601
Title: [The effect of bisphosphonates on bone metastasis of hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20060601
Title: Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?
Journal: Reviews in endocrine & metabolic disorders 20060601
Title: [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].
Journal: Ugeskrift for laeger 20060522
Title: The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20060516
Title: Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
Journal: Bone 20060501
Title: Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.
Journal: Bone 20060501
Title: Bisphosphonates for malignancy-related bone disease: current status, future developments.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060501
Title: First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Journal: European journal of haematology 20060501
Title: Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.
Journal: Molecular pharmacology 20060501
Title: Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Journal: Oncology reports 20060501
Title: The role of bisphosphonates in the management of prostate cancer.
Journal: Current oncology reports 20060501
Title: Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
Journal: Pharmacotherapy 20060501
Title: Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
Journal: Arthritis and rheumatism 20060501
Title: Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060501
Title: Bisphosphonate-associated mandibular osteonecrosis.
Journal: AJNR. American journal of neuroradiology 20060501
Title: [Therapeutic options for hormone-refractory prostate cancer].
Journal: Der Urologe. Ausg. A 20060501
Title: Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060501
Title: [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
Journal: Lakartidningen 20060501
Title: Is a single infusion of zoledronic acid superior to risedronate for the treatment of Paget's disease?
Journal: Nature clinical practice. Endocrinology & metabolism 20060501
Title: A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy.
Journal: Nature clinical practice. Endocrinology & metabolism 20060501
Title: Alendronate in bone cement: fatigue life degraded by liquid, not by powder.
Journal: Clinical orthopaedics and related research 20060401
Title: [Bisphosphonates for bone metastasis of malignant tumor].
Journal: Clinical calcium 20060401
Title: Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy.
Journal: Journal of periodontology 20060401
Title: Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Journal: Seminars in oncology 20060401
Title: Home infusions of biphosphonate in cancer patients: a prospective study.
Journal: Journal of chemotherapy (Florence, Italy) 20060401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20060401
Title: Bisphosphonates: from bench to bedside.
Journal: Annals of the New York Academy of Sciences 20060401
Title: Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Journal: Nature clinical practice. Rheumatology 20060401
Title: Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases.
Journal: Supportive cancer therapy 20060401
Title: Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
Journal: Journal of the American Chemical Society 20060322
Title: Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320
Title: Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb.
Journal: Bone 20060301
Title: Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
Journal: Oral oncology 20060301
Title: Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute.
Journal: Bone 20060301
Title: [Bisphosphonate-associated osteonecrosis of the jaw].
Journal: Mund-, Kiefer- und Gesichtschirurgie : MKG 20060301
Title: Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study.
Journal: Cell biology international 20060301
Title: Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.
Journal: Oncology reports 20060301
Title: Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers.
Journal: BJU international 20060301
Title: The use of zoledronic acid for Paget's disease of bone.
Journal: Current osteoporosis reports 20060301
Title: Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Journal: The New Zealand dental journal 20060301
Title: The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.
Journal: Clinical genitourinary cancer 20060301
Title: Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis.
Journal: Therapeutics and clinical risk management 20060301
Title: Differences between the bisphosphonates for the prevention and treatment of osteoporosis.
Journal: Therapeutics and clinical risk management 20060301
Title: Summaries for patients. Zolendronic acid prevents bone loss after liver transplantation.
Journal: Annals of internal medicine 20060221
Title: Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
Journal: Annals of internal medicine 20060221
Title: Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060220
Title: Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion-pairing agent.
Journal: Journal of chromatography. A 20060203
Title: A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.
Journal: British journal of pharmacology 20060201
Title: Pharmacological therapy of Paget's and other metabolic bone diseases.
Journal: Bone 20060201
Title: [Two cases of stage IV breast cancer with severe hypercalcemia].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20060201
Title: The extended adjuvant NCIC CTG MA.17 trials: initial and rerandomization studies.
Journal: Breast (Edinburgh, Scotland) 20060201
Title: Improving bone health in patients with early breast cancer by adding bisphosphonates to letrozole: the Z-ZO-E-ZO-FAST program.
Journal: Breast (Edinburgh, Scotland) 20060201
Title: Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling.
Journal: Acta orthopaedica 20060201
Title: Relationship between periodontal disease and systemic diseases.
Journal: Texas dental journal 20060201
Title: [Osteonecrosis of the jaw in the course of multiple myeloma treatment and bisphosphonate administration].
Journal: Vnitrni lekarstvi 20060201
Title: Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Journal: Clinical therapeutics 20060201
Title: Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients.
Journal: Cancer chemotherapy and pharmacology 20060101
Title: Two cases of endometrial cancer diagnosis associated with bone metastasis.
Journal: Gynecologic and obstetric investigation 20060101
Title: Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation.
Journal: Bone marrow transplantation 20060101
Title: Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats.
Journal: Journal of biomedical materials research. Part A 20060101
Title: Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication.
Journal: International immunology 20060101
Title: Osteonecrosis of the jaw associated with pamidronate therapy.
Journal: American journal of hematology 20060101
Title: Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Journal: Medicina oral, patologia oral y cirugia bucal 20060101
Title: [Present development of new drugs for osteoporosis].
Journal: Clinical calcium 20060101
Title: Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis.
Journal: Urologic oncology 20060101
Title: Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.
Journal: BMC cancer 20060101
Title: Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journal: Breast cancer research : BCR 20060101
Title: A prospective randomized controlled clinical trial of zoledronic acid for bone metastases.
Journal: The American journal of hospice & palliative care 20060101
Title: Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases.
Journal: Anticancer research 20060101
Title: Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Journal: Anticancer research 20060101
Title: Biphosphonates in advanced prostate and renal cell cancer--current status and potential applications.
Journal: Urologia internationalis 20060101
Title: The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?
Journal: BMC cancer 20060101
Title: Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
Journal: BMC cancer 20060101
Title: Jaw complications in breast and prostate cancer patients treated with zoledronic acid.
Journal: Acta oncologica (Stockholm, Sweden) 20060101
Title: Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells.
Journal: Cancer cell international 20060101
Title: Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20060101
Title: Hypercalcemia of malignancy remains a clinically relevant problem.
Journal: Cancer journal (Sudbury, Mass.) 20060101
Title: Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer.
Journal: Drugs 20060101
Title: Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.
Journal: Medical oncology (Northwood, London, England) 20060101
Title: Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
Journal: Oncology 20060101
Title: Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Journal: Cytotherapy 20060101
Title: The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice.
Journal: Clinical & experimental metastasis 20060101
Title: Additive/synergistic anti-tumoral effects of the combination of docetaxel and zoledronic acid on prostate cancer cells: possible mechanisms?
Journal: Acta oncologica (Stockholm, Sweden) 20060101
Title: Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?
Journal: BMC health services research 20060101
Title: Multimodal imaging analysis of tumor progression and bone resorption in a murine cancer model.
Journal: Journal of computer assisted tomography 20060101
Title: Endothelial progenitor cells display clonal restriction in multiple myeloma.
Journal: BMC cancer 20060101
Title: Molecular basis for action of bioactive glasses as bone graft substitute.
Journal: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 20060101
Title: In vitro effects of aminobisphosphonates on Vgamma9Vdelta2 T cell activation and differentiation.
Journal: International journal of immunopathology and pharmacology 20060101
Title: Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
Journal: The oncologist 20060101
Title: Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats.
Journal: BMC musculoskeletal disorders 20060101
Title: Drug induced osteonecrosis of the jaws.
Journal: The Journal of the Tennessee Dental Association 20060101
Title: Case studies in metastatic bone disease: understanding the unique nature of bone loss due to malignancy.
Journal: ONS news 20060101
Title: In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells.
Journal: Breast cancer research : BCR 20060101
Title: Fever with rash following zolendronic acid administration.
Journal: Clinical and experimental rheumatology 20060101
Title: The role of bisphosphonates in early breast cancer.
Journal: The oncologist 20060101
Title: Ibandronate: its role in metastatic breast cancer.
Journal: The oncologist 20060101
Title: [Zoledronate-related maxillary osteonecrosis].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101
Title: Sore mandible. Bisphosphonate-associated osteonecrosis.
Journal: General dentistry 20060101
Title: Treatment- and disease-related complications of prostate cancer.
Journal: Reviews in urology 20060101
Title: Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.
Journal: Arthritis research & therapy 20060101
Title: [Acute kidney failure caused by zoledronic acid (Zometa)].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101
Title: Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer.
Journal: Anticancer research 20060101
Title: Bisphosphonate complications including osteonecrosis of the jaw.
Journal: Hematology. American Society of Hematology. Education Program 20060101
Title: [Avascular osteonecrosis of the jaws induced by diphosphonates].
Journal: Therapie 20060101
Title: Impact of zoledronic acid on renal function in patients with cancer: Clinical significance and development of a predictive model.
Journal: The journal of supportive oncology 20060101
Title: Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.
Journal: Drug safety 20060101
Title: Parathyroid cancer: etiology, clinical presentation and treatment.
Journal: Anticancer research 20060101
Title: The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Journal: Acta poloniae pharmaceutica 20060101
Title: A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.
Journal: Oncology 20060101
Title: Bortezomib: the evidence of its clinical impact in multiple myeloma.
Journal: Core evidence 20060101
Title: Consumer groups look to improve adverse event reporting systems.
Journal: Journal of the National Cancer Institute 20051221
Title: Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Journal: Biochemical and biophysical research communications 20051216
Title: Paget's disease and bisphosphonates.
Journal: The New England journal of medicine 20051215
Title: Paget's disease and bisphosphonates.
Journal: The New England journal of medicine 20051215
Title: [Optimizing therapy in Paget disease].
Journal: MMW Fortschritte der Medizin 20051215
Title: Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20051201
Title: Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
Journal: Biomaterials 20051201
Title: [Zoledronic acid in the treatment of prostate cancer].
Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20051201
Title: Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20051201
Title: Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice.
Journal: Cancer 20051201
Title: [The study landscape for prostate cancer].
Journal: Der Urologe. Ausg. A 20051201
Title: Newer drug treatments: their effects on fracture prevention.
Journal: Best practice & research. Clinical rheumatology 20051201
Title: [Therapy of hormone-refractory prostate cancer].
Journal: Der Urologe. Ausg. A 20051201
Title: Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
Journal: Internal medicine journal 20051201
Title: Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201
Title: Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
Journal: Endocrine-related cancer 20051201
Title: The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution.
Journal: Clinical orthopaedics and related research 20051201
Title: [Phase II randomized clinical trail of zoledronic acid in treating metastatic bone pain of malignancy].
Journal: Ai zheng = Aizheng = Chinese journal of cancer 20051201
Title: Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog.
Journal: Calcified tissue international 20051201
Title: Acute renal effects of intravenous bisphosphonates in the rat.
Journal: Basic & clinical pharmacology & toxicology 20051201
Title: In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
Journal: Basic & clinical pharmacology & toxicology 20051201
Title: Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge.
Journal: Journal of the American Dental Association (1939) 20051201
Title: By the way, doctor. I've heard that taking Fosamax for a long time causes the jawbone to deteriorate. Do you know anything about this?
Journal: Harvard women's health watch 20051201
Title: Therapy Insight: osteoporosis during hormone therapy for prostate cancer.
Journal: Nature clinical practice. Urology 20051201
Title: Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
Journal: The Medical journal of Australia 20051121
Title: Bisphosphonates for treatment and prevention of bone metastases.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051110
Title: RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
Journal: Blood 20051101
Title: The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio.
Journal: Leukemia 20051101
Title: Radiosensitizing effect of zoledronic acid in small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands) 20051101
Title: Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells.
Journal: Leukemia 20051101
Title: Zoledronic acid sensitizes tumor cells to radiation: in response to Algur et al. (Int J Radiat Oncol Biol Phys 2005;61:535-542).
Journal: International journal of radiation oncology, biology, physics 20051101
Title: Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20051101
Title: Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers.
Journal: BJU international 20051101
Title: Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051101
Title: [Treatment options for hormone-refractory prostate cancer].
Journal: Der Urologe. Ausg. A 20051101
Title: Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20051101
Title: Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.
Journal: Urology 20051101
Title: [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20051101
Title: S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer.
Journal: Clinical advances in hematology & oncology : H&O 20051101
Title: Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma.
Journal: Cancer 20051015
Title: [Osteoporosis and anti-androgenic therapy in case of prostate cancer].
Journal: Revue medicale suisse 20051005
Title: Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051001
Title: Alleviation of polyarticular syndrome in multicentric reticulohistiocytosis with intravenous zoledronate.
Journal: Annals of the rheumatic diseases 20051001
Title: Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
Journal: Anti-cancer drugs 20051001
Title: Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports.
Journal: Journal of endodontics 20051001
Title: Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20051001
Title: Review of treatment modalities for postmenopausal osteoporosis.
Journal: Southern medical journal 20051001
Title: The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers.
Journal: Journal of chemotherapy (Florence, Italy) 20051001
Title: [Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051001
Title: Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.
Journal: British journal of cancer 20050919
Title: A validated stability indicating ion-pair RP-LC method for zoledronic acid.
Journal: Journal of pharmaceutical and biomedical analysis 20050915
Title: [Bisphosphonates-related jaw osteonecrosis].
Journal: Presse medicale (Paris, France : 1983) 20050910
Title: Zoledronate induces apoptosis in cells from fibro-cellular membrane of unicameral bone cyst (UBC).
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050901
Title: Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro.
Journal: Anti-cancer drugs 20050901
Title: Pagetic hydrocephalus treated with zoledronate.
Journal: Annals of the rheumatic diseases 20050901
Title: Gorham's disease of the mandible mimicking periodontal disease on radiograph.
Journal: Journal of clinical periodontology 20050901
Title: Treatment of Paget's disease--taming the wild osteoclast.
Journal: The New England journal of medicine 20050901
Title: Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
Journal: The New England journal of medicine 20050901
Title: Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
Journal: Urology 20050901
Title: Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Journal: Human pathology 20050901
Title: Effects of zoledronate on markers of bone metabolism and subchondral bone mineral density in dogs with experimentally induced cruciate-deficient osteoarthritis.
Journal: American journal of veterinary research 20050901
Title: Important drug precaution for dental health professionals with patients being treated for cancer.
Journal: Texas dental journal 20050901
Title: Studies in osteonecrosis.
Journal: British dental journal 20050827
Title: Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy.
Journal: International journal of cancer 20050810
Title: The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
Journal: Endocrinology 20050801
Title: Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050801
Title: Myeloma bone disease: pathophysiology and management.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050801
Title: Treatment of Gorham's disease with zoledronic acid.
Journal: Oral oncology 20050801
Title: Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801
Title: The effect of bisphosphonates and titanium particles on osteoblasts: an in vitro study.
Journal: The Journal of bone and joint surgery. British volume 20050801
Title: Zoledronate synergises with imatinib mesylate to inhibit Ph primary leukaemic cell growth.
Journal: British journal of haematology 20050801
Title: Bone loss and the aromatase inhibitors.
Journal: British journal of cancer 20050801
Title: Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
Journal: Clinical therapeutics 20050801
Title: Evolving therapeutic role of bisphosphonates in multiple myeloma.
Journal: British journal of cancer 20050725
Title: Osteonecrosis of the jaw and bisphosphonates.
Journal: The New England journal of medicine 20050707
Title: Osteonecrosis of the jaw and bisphosphonates.
Journal: The New England journal of medicine 20050707
Title: Osteonecrosis of the jaw and bisphosphonates.
Journal: The New England journal of medicine 20050707
Title: Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma.
Journal: Bone 20050701
Title: Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.
Journal: Cancer 20050701
Title: Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Journal: Cancer 20050701
Title: Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
Journal: Medicina oral, patologia oral y cirugia bucal 20050701
Title: Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050701
Title: [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].
Journal: Mund-, Kiefer- und Gesichtschirurgie : MKG 20050701
Title: Survival-adjusted multiple-event analysis for the evaluation of treatment effects of zoledronic Acid in patients with bone metastases from solid tumors.
Journal: Supportive cancer therapy 20050701
Title: Stimulation of bone formation by zoledronic acid in particle-induced osteolysis.
Journal: Biomaterials 20050601
Title: The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
Journal: European journal of haematology 20050601
Title: New therapeutic agents for the treatment of bone diseases.
Journal: Expert opinion on biological therapy 20050601
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Ask us: Some drugs affect tooth movement.
Journal: American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20050601
Title: Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer.
Journal: Clinical prostate cancer 20050601
Title: Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, phase III trials.
Journal: Clinical breast cancer 20050601
Title: [A comparison of the antiresorptive effects of bisphosphonates and statins on polyethylene particle-induced osteolysis].
Journal: Biomedizinische Technik. Biomedical engineering 20050601
Title: Bone health in men with prostate cancer: diagnostic and therapeutic considerations.
Journal: The Canadian journal of urology 20050601
Title: Current status of treatment for patients with metastatic prostate cancer.
Journal: The Canadian journal of urology 20050601
Title: Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment.
Journal: Hematology (Amsterdam, Netherlands) 20050601
Title: Exercise and pharmacological countermeasures for bone loss during long-duration space flight.
Journal: Gravitational and space biology bulletin : publication of the American Society for Gravitational and Space Biology 20050601
Title: Special precautions.
Journal: British dental journal 20050528
Title: Longer-lasting osteoporosis drugs sought.
Journal: JAMA 20050525
Title: Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration.
Journal: British journal of cancer 20050523
Title: Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
Title: Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
Journal: Journal of medicinal chemistry 20050505
Title: Profound hypocalcaemia after zoledronic acid treatment.
Journal: The Medical journal of Australia 20050502
Title: The decrease of particle-induced osteolysis after a single dose of bisphosphonate.
Journal: Biomaterials 20050501
Title: Novel biomaterials for bisphosphonate delivery.
Journal: Biomaterials 20050501
Title: Bisphosphonates in breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050501
Title: The role of bisphosphonates in the treatment of prostate cancer.
Journal: BJU international 20050501
Title: Regarding 'recommendations for zoledronic acid treatment of patients with bone metastases'.
Journal: The oncologist 20050501
Title: The issue of renal safety of zoledronic acid from a nephrologist's point of view.
Journal: The oncologist 20050501
Title: 'Safety and convenience of a 15-minute infusion of zoledronic acid': not so safe.
Journal: The oncologist 20050501
Title: Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501
Title: Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.
Journal: Cancer research 20050501
Title: Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations.
Journal: Biological trace element research 20050501
Title: Bisphosphonates, cancer, and osteonecrosis--a single practice experience.
Journal: Delaware medical journal 20050501
Title: Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK.
Journal: Current medical research and opinion 20050501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20050501
Title: Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
Journal: Journal of medicinal chemistry 20050421
Title: Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors.
Journal: Cancer 20050415
Title: Bone turnover mediates preferential localization of prostate cancer in the skeleton.
Journal: Endocrinology 20050401
Title: The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050401
Title: Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.
Journal: Leukemia 20050401
Title: Should oral bisphosphonates be standard of care in women with early breast cancer?
Journal: Breast cancer research and treatment 20050401
Title: [Rapid drug information].
Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20050401
Title: [Effect of 2-methoxyestradiol on proliferation and apoptosis of myeloma cell lines].
Journal: Zhongguo shi yan xue ye xue za zhi 20050401
Title: Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
Journal: Clinical therapeutics 20050401
Title: Zoledronic acid: past, present and future roles in cancer treatment.
Journal: Future oncology (London, England) 20050401
Title: Management of bone metastases in breast cancer.
Journal: Current treatment options in oncology 20050301
Title: Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.
Journal: British journal of haematology 20050301
Title: Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20050301
Title: Phacilitate Cell and Gene Therapy Forum 2005. Cell and gene therapy: a corporate perspective. 24-26 January 2005, Washington, DC, USA.
Journal: IDrugs : the investigational drugs journal 20050301
Title: Zoledronic acid causes enhancement of bone growth into porous implants.
Journal: The Journal of bone and joint surgery. British volume 20050301
Title: Rapid prevention of vertebral fractures associated with osteoporosis.
Journal: Orthopedics 20050301
Title: [Multiple myeloma--recent advances in diagnosis and treatment].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20050301
Title: Zoledronic acid prevents cancer treatment-induced bone loss.
Journal: Oncology (Williston Park, N.Y.) 20050301
Title: Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer.
Journal: Clinical lung cancer 20050301
Title: Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.
Journal: British journal of cancer 20050214
Title: Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Journal: Journal of the National Cancer Institute 20050202
Title: Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy.
Journal: Eye (London, England) 20050201
Title: Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.
Journal: The Journal of clinical endocrinology and metabolism 20050201
Title: The role of bisphosphonates in hormone-refractory prostate cancer.
Journal: World journal of urology 20050201
Title: Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines.
Journal: International journal of radiation oncology, biology, physics 20050201
Title: Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma.
Journal: American journal of clinical oncology 20050201
Title: Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
Journal: Journal (Canadian Dental Association) 20050201
Title: Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
Journal: Tennessee medicine : journal of the Tennessee Medical Association 20050201
Title: [Use of zoledronic acid for high risk prostate cancer patients].
Journal: Der Urologe. Ausg. A 20050201
Title: Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer.
Journal: Clinical breast cancer 20050201
Title: Primary hyperparathyroidism and neuropsychiatric alterations in a nonagenarian woman.
Journal: Aging clinical and experimental research 20050201
Title: CALGB 78909: Phase III trial of intravenous zoledronic acid in the prevention of bone loss in localized breast cancer patients with chemotherapy-induced ovarian failure.
Journal: Clinical advances in hematology & oncology : H&O 20050201
Title: Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells.
Journal: International journal of cancer 20050120
Title: Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Journal: Journal of the National Cancer Institute 20050105
Title: Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Journal: Journal of the National Cancer Institute 20050105
Title: Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines.
Journal: Lung cancer (Amsterdam, Netherlands) 20050101
Title: In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer.
Journal: Anti-cancer drugs 20050101
Title: Recommendations for zoledronic acid treatment of patients with bone metastases.
Journal: The oncologist 20050101
Title: Re: Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid.
Journal: The oncologist 20050101
Title: Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration.
Journal: Bone 20050101
Title: Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Journal: Urology 20050101
Title: Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer.
Journal: Urology 20050101
Title: A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Journal: Japanese journal of clinical oncology 20050101
Title: The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Journal: Oncology 20050101
Title: The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses.
Journal: Oncology 20050101
Title: Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
Journal: Treatments in endocrinology 20050101
Title: In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
Journal: In vivo (Athens, Greece) 20050101
Title: Nonhealing extraction site.
Journal: General dentistry 20050101
Title: Zoledronic acid mediates Ras-independent growth inhibition of prostate cancer cells.
Journal: Oncology research 20050101
Title: Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.
Journal: Anticancer research 20050101
Title: Zoledronic Acid and renal toxicity: data from French adverse effect reporting database.
Journal: The Annals of pharmacotherapy 20050101
Title: Randomized, open label, prospective study on the effect of zoledronic acid on the prevention of bone metastases in patients with recurrent solid tumors that did not present with bone metastases at baseline.
Journal: Medical oncology (Northwood, London, England) 20050101
Title: Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma.
Journal: Medical oncology (Northwood, London, England) 20050101
Title: Noninvasive monitoring of changes in structural cancellous bone parameters with a novel prototype micro-CT.
Journal: Journal of bone and mineral metabolism 20050101
Title: Keystone symposium: the role of microenvironment in tumor induction and progression, Banff, Canada, 5-10 February 2005.
Journal: Breast cancer research : BCR 20050101
Title: Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.
Journal: Theoretical biology & medical modelling 20050101
Title: Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms.
Journal: Prostate cancer and prostatic diseases 20050101
Title: Myeloma bone disease.
Journal: Best practice & research. Clinical haematology 20050101
Title: Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer.
Journal: BMC cancer 20050101
Title: Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
Journal: Treatments in endocrinology 20050101
Title: Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.
Journal: Acta oncologica (Stockholm, Sweden) 20050101
Title: Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients.
Journal: Oncology 20050101
Title: Reversible metastatic visceral calcification detected by 99mTc-methylene diphosphonate bone scanning in breast cancer.
Journal: Journal of bone and mineral metabolism 20050101
Title: Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
Journal: Acta oncologica (Stockholm, Sweden) 20050101
Title: Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.
Journal: BMC cancer 20050101
Title: Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid.
Journal: Journal of pain & palliative care pharmacotherapy 20050101
Title: Drug-induced osteonecrosis of the jaws: a new clinical entity.
Journal: CDS review 20050101
Title: Anti-tumour activity of zoledronic acid.
Journal: Cancer treatment reviews 20050101
Title: Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.
Journal: Cancer treatment reviews 20050101
Title: Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101
Title: Moving into the future: treatment of bone metastases and beyond.
Journal: Cancer treatment reviews 20050101
Title: Bisphosphonate treatment recommendations for oncologists.
Journal: The oncologist 20050101
Title: Zoledronic acid(ZOMETA): a significant improvement in the bone metastases.
Journal: Pathology oncology research : POR 20050101
Title: Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years.
Journal: The oncologist 20050101
Title: Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
Journal: BMC cancer 20050101
Title: Bone metabolic effects of single-dose zoledronate in healthy dogs.
Journal: Journal of veterinary internal medicine 20050101
Title: [Treatment of Paget's disease of bone with zoledronic acid].
Journal: Revue medicale de Bruxelles 20050101
Title: [Zoledronic acid and osseous pathologies in the course of neoplasia. Part II].
Journal: Tumori 20050101
Title: [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
Journal: Tumori 20050101
Title: Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws.
Journal: LDA journal 20050101
Title: The buzz about bisphosphonates.
Journal: LDA journal 20050101
Title: Zometa in the treatment of diseminated prostate cancer.
Journal: Acta chirurgica Iugoslavica 20050101
Title: Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.
Journal: The Biochemical journal 20041215
Title: Skeletal morbidity in men with prostate cancer: quality-of-life considerations throughout the continuum of care.
Journal: European urology 20041201
Title: Zoledronic acid-associated thrombotic thrombocytopenic purpura.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20041201
Title: Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20041201
Title: The role of bisphosphonates in breast cancer.
Journal: Breast (Edinburgh, Scotland) 20041201
Title: Long-term implications of bone loss in breast cancer.
Journal: Breast (Edinburgh, Scotland) 20041201
Title: Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.
Journal: Seminars in oncology 20041201
Title: Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
Journal: British journal of cancer 20041101
Title: Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
Journal: Oncology reports 20041101
Title: Short-term safety assessment in the use of intravenous zoledronic acid in children.
Journal: The Journal of pediatrics 20041101
Title: Re: Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.
Journal: The Journal of urology 20041101
Title: Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications.
Journal: Clinical lung cancer 20041101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20041101
Title: Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041015
Title: Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Journal: Journal of the National Cancer Institute 20041006
Title: Osteoclast-targeted therapy for prostate cancer.
Journal: Current treatment options in oncology 20041001
Title: Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041001
Title: Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
Journal: Gynecologic oncology 20041001
Title: Bisphosphonates in the treatment of skeletal metastases.
Journal: Seminars in oncology 20041001
Title: Profiling the safety and tolerability of bisphosphonates.
Journal: Seminars in oncology 20041001
Title: Patient management issues in metastatic bone disease.
Journal: Seminars in oncology 20041001
Title: The effect of intravenous zoledronic acid on glucocorticoid-induced multiple vertebral fractures in juvenile systemic lupus erythematosus.
Journal: Revista do Hospital das Clinicas 20041001
Title: Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040915
Title: The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate.
Journal: Oncogene 20040909
Title: Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040901
Title: Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040901
Title: Zoledronate-induced remission of acute panmyelosis with myelofibrosis.
Journal: European journal of haematology 20040901
Title: Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.
Journal: European urology 20040901
Title: Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer.
Journal: BJU international 20040901
Title: High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Journal: Cancer 20040901
Title: An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.
Journal: The Journal of clinical investigation 20040901
Title: Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis.
Journal: Clinical orthopaedics and related research 20040901
Title: Intravenous bisphosphonates and osteonecrosis.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20040901
Title: Successful treatment of SAPHO syndrome with zoledronic acid.
Journal: Arthritis and rheumatism 20040901
Title: Benefit of extended zoledronate therapy for patients with bone metastases from hormone-refractory prostate cancer.
Journal: Clinical prostate cancer 20040901
Title: In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Journal: Anti-cancer drugs 20040901
Title: Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
Journal: British journal of cancer 20040816
Title: Re: A Randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Journal: Journal of the National Cancer Institute 20040804
Title: Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
Journal: British journal of haematology 20040801
Title: Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Journal: Calcified tissue international 20040701
Title: Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
Journal: Current oncology reports 20040701
Title: Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.
Journal: BJU international 20040701
Title: Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040701
Title: Bisphosphonates: environmental protection for the joint?
Journal: Arthritis and rheumatism 20040701
Title: Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Journal: Arthritis and rheumatism 20040701
Title: Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis.
Journal: Arthritis and rheumatism 20040701
Title: [Separation of zoledronic acid and its related substances by ion-pair reversed-phase high performance liquid chromatography].
Journal: Se pu = Chinese journal of chromatography 20040701
Title: Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.
Journal: Cancer 20040615
Title: Hypocalcaemia after intravenous bisphosphonate: read the product information first.
Journal: BMJ (Clinical research ed.) 20040612
Title: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Journal: Journal of the National Cancer Institute 20040602
Title: Bisphosphonate infusions: patient preference, safety and clinic use.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040601
Title: Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040601
Title: The role of bisphosphonates in breast and prostate cancers.
Journal: Endocrine-related cancer 20040601
Title: The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair.
Journal: Current medical research and opinion 20040601
Title: Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells.
Journal: The Prostate 20040501
Title: High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Journal: Cancer 20040501
Title: Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.
Journal: Cancer 20040501
Title: Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Journal: The Urologic clinics of North America 20040501
Title: Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer.
Journal: Urology 20040501
Title: New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
Journal: Oncology (Williston Park, N.Y.) 20040501
Title: From labdanes to drimanes. Degradation of the side chain of dihydrozamoranic acid.
Journal: Molecules (Basel, Switzerland) 20040430
Title: Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415
Title: Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.
Journal: British journal of haematology 20040401
Title: Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.
Journal: The Journal of urology 20040401
Title: Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
Journal: European urology 20040401
Title: Parathyroid hormone-related peptide as a cause of hypercalcemia in squamous cell carcinoma of the head and neck: a case presentation and subject review.
Journal: Head & neck 20040401
Title: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.
Journal: British journal of cancer 20040322
Title: Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
Journal: The Annals of pharmacotherapy 20040301
Title: Nephrotoxicity of third-generation, intravenous bisphosphonates.
Journal: Toxicology 20040301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040301
Title: Bisphosphonates to prevent skeletal morbidity in patients with lung cancer with bone metastases.
Journal: Clinical lung cancer 20040301
Title: Severe hypocalcaemia after being given intravenous bisphosphonate.
Journal: BMJ (Clinical research ed.) 20040207
Title: Heteromeric geranyl diphosphate synthase from mint: construction of a functional fusion protein and inhibition by bisphosphonate substrate analogs.
Journal: Archives of biochemistry and biophysics 20040201
Title: Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions.
Journal: Medical care 20040201
Title: [Bisphosphonates in malignant hypercalcemia and bone pain].
Journal: Revue medicale de la Suisse romande 20040201
Title: Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.
Journal: Acta radiologica (Stockholm, Sweden : 1987) 20040201
Title: Role of bisphosphonates in prostate cancer.
Journal: European urology 20040101
Title: Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation.
Journal: Kidney international 20040101
Title: 8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16-19 September 2003.
Journal: Breast cancer research : BCR 20040101
Title: Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.
Journal: Cancer 20040101
Title: Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
Journal: Journal of medicinal chemistry 20040101
Title: Hypercalcemia of malignancy.
Journal: Seminars in nephrology 20040101
Title: The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.
Journal: Bone 20040101
Title: The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040101
Title: A systematic review of the role of bisphosphonates in metastatic disease.
Journal: Health technology assessment (Winchester, England) 20040101
Title: Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.
Journal: International journal of hematology 20040101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040101
Title: Advances in the use of bisphosphonates in the prostate cancer setting.
Journal: Prostate cancer and prostatic diseases 20040101
Title: Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties.
Journal: Medical hypotheses 20040101
Title: Zoledronic acid: a review of its use in patients with advanced cancer.
Journal: Drugs 20040101
Title: Safety and convenience of a 15-minute infusion of zoledronic acid.
Journal: The oncologist 20040101
Title: [Ibandronate: keep life in motion].
Journal: Tumori 20040101
Title: Is hypocalcemia during therapy with zoledronic acid or other bisphosphonates beneficial to cancer patients?
Journal: Medical hypotheses 20040101
Title: Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
Journal: The journal of supportive oncology 20040101
Title: Bisphosphonates: preclinical review.
Journal: The oncologist 20040101
Title: Bisphosphonates: clinical experience.
Journal: The oncologist 20040101
Title: Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.
Journal: The oncologist 20040101
Title: Toward new horizons: the future of bisphosphonate therapy.
Journal: The oncologist 20040101
Title: Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
Journal: Medical hypotheses 20040101
Title: Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
Journal: The oncologist 20040101
Title: Management of androgen-independent prostate cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center 20040101
Title: The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Journal: Oncology 20040101
Title: [Metabolic emergencies in the oncology patient].
Journal: Anales del sistema sanitario de Navarra 20040101
Title: Hypercalcemia and gallium nitrate.
Journal: The journal of supportive oncology 20040101
Title: [How to treat tumor-induced hypercalcemia].
Journal: La Revue du praticien 20031215
Title: Bisphosphonates to prevent skeletal complications in men with metastatic prostate cancer.
Journal: The Journal of urology 20031201
Title: Management of bone loss in men with prostate cancer.
Journal: The Journal of urology 20031201
Title: Re: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
Journal: The Journal of urology 20031201
Title: Bone resorption predicts for skeletal complications in metastatic bone disease.
Journal: British journal of cancer 20031201
Title: [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Journal: Zeitschrift fur Rheumatologie 20031201
Title: The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.
Journal: International journal of hematology 20031201
Title: [Prostatic carcinoma. Zoledronic acid raises bone density].
Journal: Aktuelle Urologie 20031201
Title: Treatment strategies for myeloma bone disease.
Journal: Oncology (Williston Park, N.Y.) 20031201
Title: Bisphosphonates and avascular necrosis of the jaws.
Journal: Australian dental journal 20031201
Title: The evolving role of androgen deprivation therapy in the management of prostate cancer.
Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20031201
Title: Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma.
Journal: Journal of experimental & clinical cancer research : CR 20031201
Title: The bisphosphonates alendronate and zoledronate are inhibitors of canine and human osteosarcoma cell growth in vitro.
Journal: Veterinary and comparative oncology 20031201
Title: 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.
Journal: Journal of medicinal chemistry 20031120
Title: American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101
Title: Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20031101
Title: Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20031101
Title: Bisphosphonate therapy in the oncology setting.
Journal: Expert opinion on emerging drugs 20031101
Title: Zoledronic acid: a new parenteral bisphosphonate.
Journal: Clinical therapeutics 20031101
Title: Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt.
Journal: The Journal of biological chemistry 20031031
Title: Renal failure with the use of zoledronic acid.
Journal: The New England journal of medicine 20031023
Title: Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
Journal: Cancer 20031015
Title: Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
Journal: International journal of cancer 20031010
Title: Avascular necrosis of the jaws: risk factors in metastatic cancer patients.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20031001
Title: Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors.
Journal: Seminars in oncology 20031001
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20031001
Title: Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease.
Journal: Seminars in hematology 20031001
Title: The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats.
Journal: Toxicology 20030930
Title: The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.
Journal: Blood 20030915
Title: Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.
Journal: Blood 20030915
Title: Bisphosphonates in prostate cancer: where are we and where should we go?
Journal: Journal of the National Cancer Institute 20030903
Title: Clinical trials test bisphosphonates in hormone-sensitive prostate cancer.
Journal: Journal of the National Cancer Institute 20030903
Title: A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).
Journal: Journal of the National Cancer Institute 20030903
Title: Osteoporosis and prostate cancer.
Journal: British journal of cancer 20030901
Title: Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.
Journal: Cancer 20030901
Title: Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20030901
Title: The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia.
Journal: Palliative medicine 20030901
Title: Zoledronic acid inhibits osteoclastogenesis in vitro and in a mouse model of inflammatory osteolysis.
Journal: The Annals of otology, rhinology, and laryngology 20030901
Title: Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815
Title: Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Journal: Journal of the National Cancer Institute 20030806
Title: Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines.
Journal: American journal of clinical oncology 20030801
Title: Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030801
Title: Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030801
Title: Cancer patients with bone complications prefer infusion of zoledronic acid.
Journal: Oncology (Williston Park, N.Y.) 20030801
Title: Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.
Journal: Bone 20030801
Title: Proven efficacy of zoledronic acid in the treatment of bone metastases in patients with breast cancer and other malignancies.
Journal: Breast (Edinburgh, Scotland) 20030801
Title: The anti-tumor potential of zoledronic acid.
Journal: Breast (Edinburgh, Scotland) 20030801
Title: Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions.
Journal: Breast (Edinburgh, Scotland) 20030801
Title: Injectable bisphosphonates in the treatment of postmenopausal osteoporosis.
Journal: Aging clinical and experimental research 20030801
Title: Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival.
Journal: British journal of cancer 20030707
Title: A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.
Journal: Journal of medicinal chemistry 20030703
Title: Toxic acute tubular necrosis following treatment with zoledronate (Zometa).
Journal: Kidney international 20030701
Title: Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Journal: The Journal of urology 20030701
Title: Bisphosphonates: new indications and methods of administration.
Journal: Current opinion in rheumatology 20030701
Title: The use of bisphosphonates in prostate cancer.
Journal: BJU international 20030701
Title: How myeloma cells escape bisphosphonate-mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeutics.
Journal: British journal of haematology 20030701
Title: Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030701
Title: Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030701
Title: Zoledronic Acid in the treatment of bone metastases from the breast and prostate carcinoma.
Journal: Ortopedia, traumatologia, rehabilitacja 20030630
Title: Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.
Journal: British journal of cancer 20030616
Title: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
Journal: The Journal of urology 20030601
Title: Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment.
Journal: Cancer treatment reviews 20030601
Title: Management of treatment-related osteoporosis in men with prostate cancer.
Journal: Cancer treatment reviews 20030601
Title: [Malignancy-associated hypercalcemia].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030601
Title: Highlights from the 98th annual meeting of the American Urological Association Chicago, IL.
Journal: Clinical prostate cancer 20030601
Title: New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.
Journal: British journal of cancer 20030519
Title: Aetiology of bone disease and the role of bisphosphonates in multiple myeloma.
Journal: The Lancet. Oncology 20030501
Title: Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease.
Journal: Expert opinion on pharmacotherapy 20030501
Title: Selected therapy-related clinical research topics in osteoporosis.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20030501
Title: Bisphosphonate treatment of osteoporosis.
Journal: Clinics in geriatric medicine 20030501
Title: In focus: prostate cancer.
Journal: Clinical advances in hematology & oncology : H&O 20030501
Title: Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer.
Journal: Ortopedia, traumatologia, rehabilitacja 20030430
Title: Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Journal: Calcified tissue international 20030401
Title: Bone metastases in breast cancer.
Journal: Current treatment options in oncology 20030401
Title: Zoledronic acid: a new advance in managing skeletal events in prostate cancer.
Journal: BJU international 20030401
Title: Novel therapies for osteoporosis.
Journal: Expert opinion on investigational drugs 20030401
Title: Zoledronic acid: an advance in tumour bone disease therapy and a new hope for osteoporosis.
Journal: Expert opinion on pharmacotherapy 20030401
Title: Zoledronic acid (Zometa) use in bone disease.
Journal: Expert review of anticancer therapy 20030401
Title: Treatment of tumor-induced hypercalcemia: a solved problem?
Journal: Expert review of anticancer therapy 20030401
Title: [The role of bisphosphonates in the treatment of bone metastases from urogenital cancer ].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20030401
Title: The role of bisphosphonates in breast cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20030401
Title: The role of intravenous zoledronic acid in the management of high-risk prostate cancer.
Journal: Current opinion in urology 20030301
Title: Zoledronate treatment in active Paget's disease.
Journal: Annals of the rheumatic diseases 20030301
Title: Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030301
Title: Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
Journal: Kidney international 20030301
Title: Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Journal: Journal of the National Cancer Institute 20030219
Title: Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Journal: Journal of the National Cancer Institute 20030219
Title: Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Journal: Journal of the National Cancer Institute 20030219
Title: Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma.
Journal: Cancer 20030201
Title: Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Journal: Cancer 20030201
Title: Mechanisms of osteolytic bone metastases in breast carcinoma.
Journal: Cancer 20030201
Title: Antitumor effects of bisphosphonates.
Journal: Cancer 20030201
Title: Bisphosphonates and metastatic breast carcinoma.
Journal: Cancer 20030201
Title: Effectiveness and cost of bisphosphonate therapy in tumor bone disease.
Journal: Cancer 20030201
Title: Current and future status of adjuvant therapy for breast cancer.
Journal: Cancer 20030201
Title: The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function.
Journal: Journal of clinical pharmacology 20030201
Title: Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy.
Journal: Drugs 20030101
Title: Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer.
Journal: Drugs & aging 20030101
Title: The diagnosis and management of hypercalcaemia.
Journal: Annals of the Academy of Medicine, Singapore 20030101
Title: 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research.
Journal: Breast cancer research : BCR 20030101
Title: Drugs in development: bisphosphonates and metalloproteinase inhibitors.
Journal: Arthritis research & therapy 20030101
Title: Breakthroughs in the management of multiple myeloma.
Journal: Drugs 20030101
Title: Intermittent infusions of zoledronic acid are as effective as daily bisphosphonates in increasing bone mineral density in port-menopausal women.
Journal: Clinical and experimental rheumatology 20030101
Title: Bisphosphonates in oncology: physiopathologic bases and clinical activity.
Journal: Tumori 20030101
Title: Advances in supportive care of patients with cancer and bone metastases: nursing implications of zoledronic acid.
Journal: Clinical journal of oncology nursing 20030101
Title: Bisphosphonates in the management of metastatic prostate cancer.
Journal: Oncology 20030101
Title: New insights into the molecular mechanisms of action of bisphosphonates.
Journal: Current pharmaceutical design 20030101
Title: Should all adjuvant breast cancer patients receive a bisphosphonate?
Journal: Breast cancer research : BCR 20030101
Title: Bone loss and the evolving role of bisphosphonate therapy in prostate cancer.
Journal: Urologic oncology 20030101
Title: Current management strategies for hypercalcemia.
Journal: Treatments in endocrinology 20030101
Title: Pharmacological treatments for prostate cancer.
Journal: Expert opinion on investigational drugs 20021201
Title: Monosodium [1-hydroxy-2-(1H-imidazol-3-ium-4-yl)ethane-1,1-diyl]bis(phosphonate) tetrahydrate (monosodium isozoledronate).
Journal: Acta crystallographica. Section C, Crystal structure communications 20021201
Title: Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain.
Journal: Pain 20021201
Title: The anti-tumour activity of bisphosphonates.
Journal: Cancer treatment reviews 20021201
Title: Advances in the biology and treatment of myeloma bone disease.
Journal: Seminars in oncology 20021201
Title: Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
Journal: American journal of clinical oncology 20021201
Title: Broad clinical activity of zoledronic acid in osteolytic to osteoblastic bone lesions in patients with a broad range of solid tumors.
Journal: American journal of clinical oncology 20021201
Title: Efficacy of zoledronic acid and pamidronate in breast cancer patients: a comparative analysis of randomized phase III trials.
Journal: American journal of clinical oncology 20021201
Title: Future directions in the treatment and prevention of bone metastases.
Journal: American journal of clinical oncology 20021201
Title: Preclinical pharmacology of zoledronic acid.
Journal: Seminars in oncology 20021201
Title: Treatment of hypercalcemia of malignancy with bisphosphonates.
Journal: Seminars in oncology 20021201
Title: Treatment of bone complications in advanced prostate cancer: rationale for bisphosphonate use and results of a phase III trial with zoledronic acid.
Journal: Seminars in oncology 20021201
Title: Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors.
Journal: Seminars in oncology 20021201
Title: Bisphosphonates for the prevention of bone metastases.
Journal: Seminars in oncology 20021201
Title: Zoledronic acid (Zometa): bisphosphonate for prostate cancer/bone metastases.
Journal: Urologic nursing 20021201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20021201
Title: Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to bone.
Journal: Clinical prostate cancer 20021201
Title: Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Journal: Cancer research 20021115
Title: Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine.
Journal: Journal of pharmaceutical and biomedical analysis 20021107
Title: Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma.
Journal: British journal of haematology 20021101
Title: Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.
Journal: British journal of haematology 20021101
Title: Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases.
Journal: Journal of clinical pharmacology 20021101
Title: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
Journal: Journal of the National Cancer Institute 20021002
Title: The IL-6 receptor super-antagonist Sant7 enhances antiproliferative and apoptotic effects induced by dexamethasone and zoledronic acid on multiple myeloma cells.
Journal: International journal of oncology 20021001
Title: Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
Journal: The Journal of urology 20021001
Title: Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
Journal: Cancer research 20021001
Title: Zoledronic acid: new preparation. Just a me-too: no advance in hypercalcemia of malignancy.
Journal: Prescrire international 20021001
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20021001
Title: [Bisphosphonates in bone metastases. Fewer fractures, less pain].
Journal: MMW Fortschritte der Medizin 20020926
Title: Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Journal: The Journal of pharmacology and experimental therapeutics 20020901
Title: American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901
Title: Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Journal: Journal of medicinal chemistry 20020815
Title: Bisphosphonates: biological response modifiers in breast cancer.
Journal: Clinical breast cancer 20020801
Title: Adaptive dose finding for phase I clinical trials of drugs used for chemotherapy of cancer.
Journal: Statistics in medicine 20020715
Title: An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
Journal: Journal of medicinal chemistry 20020704
Title: Zoledronate once-yearly increases bone mineral density--implications for osteoporosis.
Journal: Expert opinion on pharmacotherapy 20020701
Title: Novel therapeutic options for osteoporosis.
Journal: Current opinion in rheumatology 20020701
Title: Bisphosphonates for cancer patients: why, how, and when?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20020701
Title: Osteoporosis: challenges and new opportunities for therapy.
Journal: Current opinion in drug discovery & development 20020701
Title: New drugs 2002, part III.
Journal: Nursing 20020701
Title: The effects of local administration of Zoledronate solution on the tooth movement and periodontal ligament.
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology 20020701
Title: Bisphosphonates and osteoporosis.
Journal: The New England journal of medicine 20020627
Title: Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
Journal: Journal of endocrinological investigation 20020601
Title: Novel approaches to the management of bone metastases in patients with breast cancer.
Journal: Seminars in oncology 20020601
Title: Zoledronic acid is effective in the treatment of prostate cancer patients with bone metastases.
Journal: Clinical prostate cancer 20020601
Title: The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.
Journal: British journal of cancer 20020506
Title: Treatment of malignant hypercalcaemia.
Journal: Expert opinion on pharmacotherapy 20020501
Title: Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
Journal: British journal of cancer 20020422
Title: FDA approves ZOMETA for treatment of cancer-related bone complications.
Journal: Expert review of anticancer therapy 20020401
Title: Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Journal: Biochemical and biophysical research communications 20020301
Title: The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage.
Journal: Osteoarthritis and cartilage 20020301
Title: Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines.
Journal: Anti-cancer drugs 20020301
Title: Bisphosphonates and osteoporosis.
Journal: The New England journal of medicine 20020227
Title: Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
Journal: The New England journal of medicine 20020227
Title: Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.
Journal: British journal of haematology 20020201
Title: Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.
Journal: Breast cancer research and treatment 20020201
Title: The role of osteoclastic activity in prostate cancer skeletal metastases.
Journal: Drugs of today (Barcelona, Spain : 1998) 20020201
Title: Multiple myeloma: present and future.
Journal: Current opinion in oncology 20020101
Title: Direct effects of bisphosphonates on breast cancer cells.
Journal: Breast cancer research : BCR 20020101
Title: The present and future role of bisphosphonates in the management of patients with breast cancer.
Journal: Breast cancer research : BCR 20020101
Title: Development of bisphosphonates.
Journal: Breast cancer research : BCR 20020101
Title: Actions of bisphosphonates in animal models of breast cancer.
Journal: Breast cancer research : BCR 20020101
Title: Zoledronic acid. A bisphosphonate for hypercalcemia of malignancy and osteolytic metastases.
Journal: Cancer practice 20020101
Title: Electrolyte abnormalities with zoledronic acid therapy.
Journal: Cancer journal (Sudbury, Mass.) 20020101
Title: The role of bisphosphonates in breast cancer management: review article.
Journal: Current medical research and opinion 20020101
Title: U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid.
Journal: The oncologist 20020101
Title: Zoledronic acid.
Journal: Clinical journal of oncology nursing 20020101
Title: The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.
Journal: Cancer investigation 20020101
Title: Zoledronic acid improves the mechanical properties of normal and healing bone.
Journal: Clinical biomechanics (Bristol, Avon) 20020101
Title: Bisphosphonate therapy in multiple myeloma: past, present, future.
Journal: European journal of haematology 20020101
Title: The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.
Journal: The oncologist 20020101
Title: The use of bisphosphonates in patients with breast cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center 20020101
Title: Management of primary osteoporosis.
Journal: Acta clinica Belgica 20020101
Title: Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Journal: Acta poloniae pharmaceutica 20020101
Title: Zolendronate (zometa).
Journal: The Medical letter on drugs and therapeutics 20011210
Title: Advances in the biology and treatment of myeloma bone disease.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011115
Title: Conventional treatment of hypercalcemia of malignancy.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011115
Title: Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20011101
Title: From the Food and Drug Administration.
Journal: JAMA 20011003
Title: New bisphosphonic acid approved by FDA.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001
Title: A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20011001
Title: Paget's disease of the spine and its management.
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20011001
Title: Bisphosphonates in the treatment of metastatic breast cancer.
Journal: Journal of mammary gland biology and neoplasia 20011001
Title: FDA grants priority review for ZOMETA.
Journal: Expert review of anticancer therapy 20011001
Title: Bisphosphonates for osteoporosis.
Journal: Drug and therapeutics bulletin 20010901
Title: Bisphosphonates and nephrocalcinosis in a rabbit leg lengthening model: a histological and therapeutic comparison.
Journal: Pharmacology & toxicology 20010901
Title: Analysis of skeletal-related events in breast cancer and response to therapy.
Journal: Seminars in oncology 20010801
Title: Should bisphosphonates be the treatment of choice for metastatic bone disease?
Journal: Seminars in oncology 20010801
Title: Dosing regimens and main adverse events of bisphosphonates.
Journal: Seminars in oncology 20010801
Title: Adjuvant bisphosphonate therapy: the future.
Journal: Seminars in oncology 20010801
Title: [Bisphosphonates in the treatment of breast carcinoma].
Journal: Polskie Archiwum Medycyny Wewnetrznej 20010801
Title: Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010715
Title: [Tumor-induced hypercalcemia. Review of bisphosphonate treatment].
Journal: La Revue de medecine interne 20010701
Title: The effects of MMP inhibitors on human salivary MMP activity and caries progression in rats.
Journal: Journal of dental research 20010601
Title: Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
Journal: International journal of palliative nursing 20010601
Title: The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone.
Journal: Bone 20010501
Title: Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.
Journal: Bone 20010501
Title: Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.
Journal: Cancer 20010401
Title: The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
Journal: British journal of cancer 20010401
Title: New advances in the biology and treatment of myeloma bone disease.
Journal: Seminars in hematology 20010401
Title: Unmet needs in metastatic bone disease and its complications: is progress possible?
Journal: Seminars in oncology 20010401
Title: Chemical and biological prerequisites for novel bisphosphonate molecules: results of comparative preclinical studies.
Journal: Seminars in oncology 20010401
Title: The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases.
Journal: Seminars in oncology 20010401
Title: Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program.
Journal: Seminars in oncology 20010401
Title: Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials.
Journal: Seminars in oncology 20010401
Title: Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.
Journal: Seminars in oncology 20010401
Title: Zoledronic acid: an evolving role in the treatment of cancer patients with bone disease.
Journal: Seminars in oncology 20010401
Title: Bisphosphonate treatment inhibits the growth of prostate cancer cells.
Journal: Cancer research 20010315
Title: [Bone metastasis. Can a new bisphosphonate offer control?].
Journal: MMW Fortschritte der Medizin 20010301
Title: A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010301
Title: Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Journal: The Journal of pharmacology and experimental therapeutics 20010201
Title: Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115
Title: The bisphosphonate zoledronate prevents vertebral bone loss in mature estrogen-deficient rats as assessed by micro-computed tomography.
Journal: European cells & materials 20010110
Title: A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
Journal: Cancer 20010101
Title: Zoledronic acid.
Journal: Drugs 20010101
Title: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Journal: Cancer journal (Sudbury, Mass.) 20010101
Title: Bisphosphonates induce breast cancer cell death in vitro.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20001101
Title: Bisphosphonates induce apoptosis in human breast cancer cell lines.
Journal: British journal of cancer 20000401
Title: An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates.
Journal: Calcified tissue international 19971101
Title: Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19940501
